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Pseudomonas syringae is a Gram-negative bacterial pathogen that infects 
many crops. A central virulence strategy P. syringae uses to successfully infect 
plants is the injection of type III effector proteins (T3Es) into plant cells through a 
type IIII protein secretion system (T3SS). The T3SS is a molecular syringe found 
in many Gram-negative bacterial pathogens of plants and animals that transport 
T3Es from the bacterial cytosol into eukaryotic cells. T3Es disrupt host processes 
in the plant immune system required to restrict pathogen ingress. The plant 
innate immune system is divided in two branches, pathogen-associated 
molecular patterns (PAMP)-triggered immunity (PTI) and effector-triggered 
immunity (ETI). The first branch recognizes conserved molecules found in 
microbes, known as PAMPs, and the second has the capacity to recognize 
injected T3Es. T3Es can suppress both PTI and ETI allowing P. syringae to 
circumvent the plant immune system and multiply in plant tissue. The majority of 
T3Es plant targets, their enzymatic activity and the mechanism of suppression of 
plant immunity are not known. P. syringae pv. tomato (Pto) DC3000 injects about 
35 T3Es into plant cells. 
In this study I characterized two T3Es from Pto DC3000. Firstly, I focused on 
the T3E HopD1. HopD1 suppresses plant immunity associated with ETI but not 
	  	  
PTI, suggesting that HopD1 was acquired later in the co-evolution of the 
pathogen and plant. HopD1 is targeted to the endoplasmic reticulum of plant 
cells where it interacts with the Arabidopsis NAC transcription factor NTL9. 
HopD1’s function in virulence involves the inhibition of NTL9-regulated genes 
during ETI. Secondly, I focused on the T3E HopA1. This T3E exists in two 
classes, which I found are recognized differently in plants. HopA1 suppresses 
PTI and its structure resembles phosphothreonine lyases form animal pathogens. 
The putative active site of HopA1 was identified and I found that site-directed 
mutations in the active site abrogated HopA1-dependent phenotypes. HopA1 
localizes mainly to plasma membrane of plant cells where it interacts with the 
Arabidopsis type 2C phosphatases PLL4 and PLL5. These phosphatases play 
roles in plant immunity as negative regulators and HopA1 likely prevents their 
deregulation preventing induction of the plant immune system. 
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This chapter provides a literature review on the plant innate immune system and 
strategies used by plants to counteract microbial infections. In addition, it 
describes the bacterial plant pathogen Pseudomonas syringae and mechanisms 
of pathogenicity that rely on the type III protein secretion system and type III 
effector proteins (T3Es). Targets of T3Es in plants are detailed to understand the 
sophisticated ways used by pathogens to suppress the plant immune system. 
 
Plant immunity 
Eukaryotic and bacterial pathogens infect a plethora of plant species causing 
devastating diseases that have caused significant yield and quality loss to crops. 
To counteract microbial infections plants have evolved two immune systems: 
pathogen associated-molecular pattern (PAMP)-triggered immunity (PTI) and 
effector-triggered immunity (ETI) (90). Plants likely first evolved PTI mediated by 
extracellular immune receptors to detect the presence of microbes, and then ETI 
mediated by intracellular immune receptors that recognize the presence of, in the 
case of bacterial pathogens, bacterial virulence proteins injected into plant cells. 
Therefore, the activation of these immunity pathways depends on the type of 
pathogen-specific molecules recognized by plants. Altogether, these pathways 
are responsible for resistance to pathogens and are described below. 
a. PAMP-triggered immunity  
The first layer of immunity mounted by plants is PTI. PAMPs are highly 
conserved molecules found in microbes, both pathogenic and nonpathogenic 
strains (90). Examples of PAMPs include bacterial flagellin and elongation factor 
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EF-Tu; components of the outer membranes and cells walls of microbes such as 
lipopolysaccharide and peptidoglycan of bacteria and fungal chitin (122). Plants 
possess extracellular receptor kinases known as pattern recognition receptors 
(PRRs) that perceive PAMPs and activate several immune responses. PRRs are 
plasma membrane-localized leucine-rich repeat receptor kinases (LRR-RKs) with 
an extracellular LRR domain and a cytoplasmic serine/threonine protein kinase 
domain (27). PAMPs are perceived by the LRR domain of PRRs and the signal is 
transferred to the cytoplasmic kinase domain through phosphorylation. Animals 
and insects possess similar proteins involved in innate immunity (145). PAMP 
recognition induces several immune responses including stomatal closure, 
oxidative burst, cell wall fortification, and hormone signaling (185). Plant 
immunity activates signal transduction pathways through mitogen-activated 
protein kinases (MAPKs) and calcium-dependent kinases (CDPKs), which results 
in transcriptional reprogramming of immunity-related genes. 
 The most studied example of PTI is the one activated by the Arabidopsis 
flagellin-sensing 2 (FLS2), an extracellular receptor kinase that senses bacterial 
flagellin (Fig. 1). A 22-amino acid peptide (flg22) from the N-terminus of bacterial 
flagellin is sufficient to trigger PTI (200). Upon flg22 recognition, FLS2 forms a 
complex with the LRR-RK BAK1 and the receptor-like cytoplasmic kinase BIK1 
inducing transphosphorylation and immune signaling events (35, 74, 119, 192). 
After flg22 recognition, FLS2 undergoes endocytosis and subsequent 
degradation (20, 118, 158). In agreement with PRRs being at the front line of  
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Fig. 1. A model for flg22-triggered immune responses and signal 
transduction pathways. (A) The resting state of FLS2 and BAK1 at the plasma 
membrane without microbial infection. In the absence of microbial elicitor flagellin, 
FLS2 and BAK1 may not form a stable complex. BAK1 is associated with BIK1 
and PUB12/13 and FLS2 is also associated with BIK1. (B) Flg22-triggered 
immune responses and signal transduction pathways. Flg22 perception induces 
FLS2 and BAK1 association and phosphorylation. Activated BAK1 
phosphorylates BIK1, which in turn transphosphorylates the FLS2/BAK1 complex. 
Phosphorylated BIK1 is released from the FLS2/BAK1complex. FLS2 and BAK1 
association also recruits PUB12/13 into the receptor complex. BAK1 directly 
phosphorylates PUB12/13, which in turn ubiquitinates FLS2 leading to FLS2 
degradation and downregulation of FLS2 signaling. Activation of the receptor 
complex leads to the activation of Ca2+ flux through Ca2+ channel, Cl− efflux and 
H+/K+ movement across the plasma membrane. MAPK and CDPK cascades are 
initiated downstream of the activated receptor complex and further mediate the 
immunity gene expression. This figure is from Wu et al. (185). 
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immunity, FLS2 is expressed in plant tissues vulnerable to bacterial invasion, 
such as stomata, hydathodes and lateral roots in response biotic stresses (19). 
 Another example of PAMP recognition is when the bacterial elongation factor 
EF-Tu is recognized by the LRR-RK EF-Tu receptor (EFR). EFR recognizes the 
N-terminus of EF-Tu comprising the first 18 amino acids (elf18), inducing similar 
immune responses to flg22 recognition (97). BAK1 and BIK1 also form 
complexes with EFR and other PRRs following PAMP perception (119, 153, 162, 
168, 192). Therefore, BAK1 and BIK1 are positive regulators of PTI that act 
downstream of PRRs to activate plant immunity. Recognition of EF-Tu by EFR 
seems to be restricted to the Brassicaceae family, as EFR is not found in other 
plant families (97, 199). 
 Plants also perceive fungal pathogens. The component of fungal cell walls, 
chitin, is a PAMP recognized by chitin elicitor receptor kinase 1 (CERK1) also 
known as lysine motif receptor-like kinase (LysM RLK1) (133, 177). CERK1 has 
an extracellular LysM instead of a LRR domain. CERK1, as well as two other 
LysM proteins (LYM1, LYM3) also recognize the bacterial PAMP peptidoglycan 
(181). Several other microbial PAMPs have been characterized but their 
corresponding PRRs remain to be identified (27).  
b. Effector-triggered immunity 
The second way plant immunity can be induced is by the recognition of pathogen 
virulence factors. Plant intracellular receptors known as resistance (R)-proteins 
can recognize bacterial proteins that are delivered into plant cells to suppress 
PTI. In the case of the bacterial plant pathogen P. syringae, it injects effector 
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proteins through a molecular syringe known as the type III protein secretion 
system (T3SS). Therefore, these virulence proteins are termed type III effector 
proteins. The specific recognition of an effector protein by an R protein is 
historically known as the gene-for-gene hypothesis and recognized effectors 
were historically known as avirulence (Avr) proteins (55).  
There are at least five classes of R proteins. The largest class of R proteins 
are composed of three domains, a central nucleotide binding (NB) domain, a C-
terminal LRR domain and an N-terminal that can either be a coiled coil (CC) or 
toll-interleukin 1-receptor (TIR) domain (51). The N-terminal domain of NB-LRR 
proteins dictates the requirement for downstream signaling components. While 
the resistance regulator Enhanced Disease Susceptibility 1 (EDS1) is required by 
TIR-NB-LRRs to activate immune responses, Non-race specific Disease 
Resistance 1 (NDR1) is required for CC-NB-LRRs-mediated resistance (1). In 
Arabidopsis there are 159 members of the NB-LRR R protein family (71).  
The majority of R proteins do not directly recognize T3Es; instead they 
recognize a host protein modified by a T3E. The guard hypothesis explains this 
indirect recognition, in which modification of a host protein (the guardee) by a 
T3E is guarded by an R protein (90). A variation of the guard hypothesis is the 
decoy model (175). This model states that plants have evolved host proteins that 
mimic bona fide T3E targets to function as decoys for the presence and/or 
activity of T3Es. These decoy proteins are thought to have arose as gene 
duplications or splice variants of T3E targets, and have no other function in plant 
cells other than to attract effectors to induce ETI. 
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Similar immune responses are activated by both PTI and ETI, with different 
amplitude and timing, whereas ETI elicits a more prolonged and robust immune 
response (90). ETI is usually associated with the hypersensitive response (HR), 
a programmed cell death response. The HR, a necrotic lesion at the site of 
infection, prevents the spread of the pathogen. While PTI is effective against a 
broad range of pathogens, ETI is specific and requires recognition of a particular 
effector by the corresponding R protein. Immune responses induced during plant 
immunity are described below. 
 
Plant immune responses 
a. Ion fluxes 
Immune responses include changes in ion fluxes across the plasma membrane, 
including H+, K+, Cl2 and Ca2+. Ca2+ influx has been observed as an early PTI 
response (157). Ca2+ amplitude and duration differ between PAMP treatments, 
with flg22 inducing the highest Ca2+ amplitude. Increased Ca2+ influx from the 
apoplast to the cytoplasm is perceived by calcium binding sensors like 
calmodulin (CAM), calcineurin B-like proteins and CDPKs. These Ca2+ sensors 
activate downstream immunity signal transduction pathways (101). Four CDPKs 
(CDPK4, 5, 6, and 11) belong to a CDPK sub-clade that are global regulators of 
immunity-related genes required for flg22-induced responses (28). In addition, 
CDPK28 interacts with PRR complexes to regulate immune responses (135). 
These data indicate the importance of CDPKs in PTI signaling. Ca2+ signals also 
activate biosynthesis of the hormone salicylic acid (SA) through transcriptional 
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activation of ICS1/SID2 by the CAM-binding transcription factor CBP60g. 
ICS1/SID2 encodes the isochorismate synthase I, an enzyme required for SA 
biosynthesis (178, 192). 
b. Oxidative burst 
PTI and ETI induce the production of reactive oxygen species (ROS) within few 
minutes. ROS act as antimicrobial agents, strengthen cell walls and induce 
immune responses by transcriptional reprogramming (11). ROS include 
superoxide anion (O2-) and hydrogen peroxide (H2O2) that are produced primarily 
by plasma membrane NADPH oxidases encoded by RBOH genes (173). 
Additionally, ROS is also produced in other subcellular compartments. For 
example it is also produced by cell wall peroxidases. CDPKs also play an 
important role in inducing the oxidative burst by activation of RBOH through 
phosphorylation (50, 96). 
c. MAPK activation 
Immune responses also include activation of MAPK signal transduction pathways. 
There are two distinct MAPK cascades, one that positively regulates immunity 
(MEKK1/MKKs-MKK4/5-MPK3/6) and one that negatively regulates immunity 
(MEKK1-MKK1/2-MPK4) (61, 151, 156). MAPK signaling activates WKRY 
transcription factors and expression of immunity-related genes (172). 
d. Transcriptional reprogramming 
Activation of plant immunity induces expression of immunity-related genes. A 
similar set of genes is activated by several PAMPs indicating that immune 
signaling converges at the transcriptional level. Families of transcription factors 
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that are global regulators of immune signaling include bZIP (basic leucine zipper 
motif), AP2/ERF (APETALA2/ETHYLENE-RESPONSIVE ELEMENT BINDING 
FACTORS), MYB (myelobastosis related), MYC (myelocytomatosis related), 
NAC (no apical meristem (NAM) Arabidopsis transcription activation factor 
(ATAF) and cup-shaped cotyledon (CUC)), and WRKY (amino acid sequence 
WRKYGQK) (8). WRKY transcription factors are regulated by MAPKs and 
CDPKs. Some examples of the involvement of WRKYs in immunity include the 
following: (i) WRKY33 is phosphorylated by MPK3/6 inducing immunity 
responses against the necrotrophic fungi Botrytis cinerea (126), (ii) WRKY22/29 
are also activated by MPK3/6 (13), (iii) MPK4 phosphorylates MKS1 and this 
leads to activation of WRKY33/25 (10, 156), and (iv) CDPK4/5/6/11 activate a 
group of WRKYs including WRKY8/28/48/46 (62). These data indicate that 
MAPKs and CDPKs synergistically activate WRKY transcription factors to induce 
expression of immunity-related genes. 
e. Cell wall fortification 
Callose deposition represents a late PTI response. Upon PAMP perception, 
plants deposit callose (β-1,3-glucan) in cell wall appositions called papillae to 
create a physical barrier against pathogens invasion (176). Callose is produced 
at the cell wall by the callose synthase Powdery Mildew Resistant 4, also known 
as glucan synthase-like 5. Antimicrobial compounds such as phenolic 
compounds, lignin, ROS, peroxidases and thionins can also be deposited in the 
callose matrix to create a physical barrier against pathogens (176). 
f. Hormone signaling 
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Phytohormones contribute to the immune signaling response. SA and jasmonic 
acid (JA) are the main hormones involved in immunity, although ethylene (ET), 
absicic acid (ABA), auxin and cytokinin play also important roles. While SA is 
associated with resistance to biotroph and hemibiotroph pathogens, JA and ET 
are associated with resistance against necotrophs and herbivorous insects (150). 
Perception of pathogens by plants induces SA biosynthesis, which signals 
through the Nonexpressor of pathogenesis related genes 1 (NPR1). NPR1 then 
induces the expression of several immunity-related genes. Activation of the SA 
pathway at the site of infection leads to a similar response in distal plant parts to 
protect the entire plant from subsequent pathogen invasion; this phenomenon is 
known as systemic acquired resistance (186). Disruption of SA signaling affects 
many immunity-related genes and plants are more susceptible to different 
pathogens.  
g. Stomatal closure 
Stomata, pores in the epidermis of aerial plant organs, represent an important 
entry point for pathogens. PAMP treatments induce stomatal closure to restrict 
pathogenic invasion. However, pathogens have evolved strategies to open 
stomata to gain access to the plant apoplast. For example, P. syringae secretes 
the bacterial toxin coronatine, a jasmonate-isoleucine (JA-Ile) mimic, to reopen 
stomata upon PAMP perception (130). 
h. Gene silencing 
RNA silencing also plays a role in immunity. MicroRNAs (miRNAs) and small 
interfering RNAs (siRNAs) are involved in plant resistance to bacterial pathogens. 
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For example, flg22 treatment downregulates auxin responses by upregulating 
miRNA393 that reduces levels of the auxin receptors TIR1, AFB2, and AFB3 
(138). Repression of auxin signaling results in restriction of P. syringae 
multiplication. The RNA silencing factor RNA-dependent RNA polymerase 6 
(RDR6) and miR472 target mRNAs of members of the CC-NB-LRRs family of R 
proteins. RDR6 and miR472 are negative regulators of immunity since CC-NB-
LRR R genes are induced in the rdr6 and miR472 mutants and plants are more 
resistant to P. syringae pv. tomato DC3000 (Pto DC3000) and the Pto DC3000 
strain expressing the T3E AvrPphB, which induces ETI in Arabidopsis. These 
data indicate that both miR472- and RDR6-mediated signaling pathways 
modulate disease resistance genes post-transcriptionally to regulate PTI and ETI 
responses (26). In addition, proteins required for small RNA biogenesis have 
been implicated in resistance to pathogens. Two proteins required for 
biosynthesis of miRNAs and long siRNAs, Dicer-like 1 and Hua enhancer1, are 
required for PTI responses (139). The miRNA effector protein Argonaute 1 is 
required for flg22-induced callose deposition, gene expression, and seedling 
growth inhibition (113). 
 
Pseudomonas syringae 
P. syringae is a Gram-negative plant pathogenic bacterium that infects a wide 
variety of economically important plant species. It belongs to the 
Pseudomonadaceae family, Pseudomonadales order and Gammaproteobacteria 
class (147, 183). This aerobic bacterium has rod shape with four polar flagella for 
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motility. It has a characteristic yellow fluorescent color when grown in the iron-
deficient medium King’s B due to the production of the siderophore pyoverdin 
(63). Siderophores are iron-binding molecules produced by pathogenic bacteria 
and are responsible for iron acquisition in iron-limited environments (38).  
P. syringae lives as an epiphyte on aerial parts of the plant (78). It becomes 
pathogenic when it enters the plant apoplast through wounds or natural openings 
like stomata, where it multiplies. Disease symptoms start to develop about 5 to 7 
days after initial infection. Typical disease symptoms include necrotic spots 
surrounded by chlorosis margins (129). Bacteria can be dispersed to other plants 
through wind, rain, or insects. 
Individual strains of P. syringae are capable of infecting a wide variety of plant 
species. It is classified into 50 pathovars based on the plant species they infect 
and then into races based on the ability among strains of a pathovars to cause 
disease on a host plant (4, 146). Therefore, P. syringae is a host-specific 
pathogen. To become a pathogen in a particular host, P. syringae relies on 
several virulence factors for pathogenicity, including T3Es and phytotoxins. 
These virulence factors sabotage the plant immune system to favor infection.  
In non-host plants, P. syringae is not able to cause disease or is recognized 
by an R protein eliciting the HR. The HR is generally associated with an ETI 
response. The majority of P. syringae strains are pathogenic, although some 
evidence indicates that few strains cannot cause disease (78). Some of the 
nonpathogenic strains lack a functional T3SS, which highlights the importance of 
the T3SS for P. syringae pathogenicity (37, 134). 
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Among P. syringae pathovars, Pto DC3000 causes bacterial speck on tomato 
(Solanum lycopersicum), which results in necrotic lesions on leaves and fruits 
(89). The genome of Pto DC3000 was the first P. syringae genome to be 
sequenced (31). Its genome (6.5 megabases) consists of a circular chromosome 
and two plasmids and encodes 5,763 open reading frames. Pto DC3000 is also 
pathogenic on the model plant Arabidopsis, which was the first plant genome to 
be sequenced (81). Arabidopsis has one of the smallest plant genomes (157 
megabases) arranged in five linear chromosomes. Arabidopsis is a great model 
system because it has a small genome and is a relatively small plant with a rapid 
lifecycle, produces abundant seeds, and can be easily manipulated in the 
laboratory. Therefore, the Pto DC3000-Arabidopsis pathosystem represents a 
great model system to study plant-microbe interactions at the molecular level 
(92). Research using this pathosystem has led to the identification of key P. 
syringae virulence factors and important components of plant immunity. 
 
Phytotoxins 
Phytotoxins and T3Es are the main virulence factors used by P. syringae to 
suppress plant immune responses and successfully infect its host. Coronatine is 
a major toxin produced by several P. syringae strains (21). It is a non-host-
specific polyketide that structurally mimics the jasmonate-isoleucine (JA-Ile), a JA 
derivative involved in JA signaling in plants. Coronatine has two moieties, the 
polyketide coronafacic acid and the ethylcyclopropyl amino acid coronamic acid. 
Coronatine has different roles in P. syringae virulence. It has been implicated in 
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the development of disease symptoms as a Pto DC3000 coronatine-deficient 
mutant has reduced chlorosis and necrosis, typical disease symptoms caused by 
P. syringae infections (30). Another role of coronatine is in systemic induced 
susceptibility (SIS), an enhanced secondary bacterial growth in uninfected leaves, 
since SIS is not induced in a coronatine-deficient mutant and is induced after 
treatment with purified coronatine (45). Coronatine also contributes to 
pathogenicity by inducing the opening of stomata during bacterial infection (130). 
This allows P. syringae to access the plant apoplast where it multiplies and 
causes disease. Coronatine induces stomatal opening by promoting interaction 
between COI1 (coronatine-insensitive 1; an F-box subunit of the SCFCOI1 
ubiquitin ligase involved in 26S proteasome-mediated degradation) and JAZ 
repressors (jasmonate zim domain proteins; transcriptional repressors in JA 
signaling) (190). Coronatine binding to the COI1-JAZ complex leads to 
ubiquitination and degradation of JAZ repressors by the 26S proteasome and 
activation of JA-responsive genes. 
 Another group of toxins, syringomycin and syringopeptin, makes pores in host 
membranes that induce electrolyte leakage leading to plant necrosis (21). The 
phytotoxin syringolin A (SylA), a product of nonribosomal peptide and polyketide 
synthetase, is a proteasome inhibitor (69). A SylA-negative mutant has 
decreased disease symptoms and thus acts as a virulence factor. SylA is a type 
member of a new class of proteasome inhibitor toxins known as syrbactins. SylA 
is taken up in plants by Yellow stripe like 7 (YSL7) and YSL8 transporters (167). 
SylA suppresses stomatal immunity and inhibits SA-dependent immune 
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responses through proteasome inhibition of NPR1 degradation (167). Another 
function of SylA is to help P. syringae escape primary infection sites and colonize 
adjacent regions along the vascular tissue by suppressing SA-dependent 
resistance in those distal regions (132). 
Phaseolotoxin and tabtoxin are present in certain P. syringae strains. 
Phaseolotoxin is a sulfodiaminophosphinyl peptide that inhibits enzymes in the 
ornithine metabolism important for cell cycle control and senescence (16). In 
general, most P. syringae phytotoxins lack host-specificity, are not required for 
pathogenicity but are important virulence factors and influence disease symptom 
development. Toxins inducing chlorosis are coronatine, phaseolotoxin and 
tabtoxin, and toxins inducing necrosis are syringomycin and syringopeptin (21). 
 
Type III secretion system 
P. syringae and other Gram-negative bacterial pathogens utilize a molecular 
syringe to translocate T3Es into plant cells to suppress immune responses. This 
molecular syringe is known as the type III secretion system and is the most 
important virulence determinant of many plant and animal Gram-negative 
bacterial pathogens (59). Because of similarities in the secretion of T3Es and 
flagella, which is also secreted by a type III system, the virulence-associated 
T3SS is sometimes referred to as an injectisome or non-flagellar type III system 
(41, 52). 
The T3SS is encoded by the hypersensitive response and pathogenicity (hrp) 
and hrp conserved (hrc) gene cluster (5). These genes actually encode the type 
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III secretion apparatus and some secreted proteins that function in the 
translocation of T3Es into plant cells. For example, Pto DC3000 strain with a 
mutation in the hrcC gene, which is within the hrp/hrc cluster, is defective in type 
III secretion and cannot inject any T3Es (191). The Pto DC3000 hrcC mutant 
strain is widely used as a nonpathogenic strain as well as a PTI-inducing strain 
since it cannot inject any T3Es and plants can sense bacterial PAMPs from this 
strain. The hrp/hrc genes are within the Hrp pathogenicity island flanked by two 
gene clusters that carry T3E genes: the conserved effector locus (CEL) and the 
exchangeable effector locus (EEL) (3, 40). The genes within the EEL are variable 
in different P. syringae strains and the genes within the CEL are conserved in all 
P. syringae strains and encode T3Es important for virulence. Deletion of the CEL 
in Pto DC3000 (encoding T3E genes hopN1, hopAA1-1, hopM1, and avrE) 
impairs growth in host plants. 
The type III system is not constitutively expressed in bacteria and is induced 
only when the pathogen gains access to the plant apoplast. The alternative 
sigma factor HrpL drives the expression of genes encoding the T3SS and T3Es 
by binding to sequences in the promoter region of these genes (54, 189). These 
promoter sequences are known as hrp boxes and are highly conserved 
(GGAACC-N16-CCACNNA) (56). Therefore, the consensus sequence of hrp 
boxes was used and is still used to identify T3Es genes from sequenced P. 
syringae genomes (114, 165). Recently, chromatin immunoprecipitation and 
mRNA sequencing techniques (ChIP-Seq and RNA-Seq) were used to identify 
additional HrpL-binding sites (99, 137). Twenty new hrp promoters have been 
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identified and are upstream of a diverse set of genes coding for regulators, 
enzymes, and hypothetical proteins. Interestingly, these new HrpL-regulated 
genes do not appear to encode T3Es. It remains to be elucidated if these non-
T3Es play a role in bacterial virulence. 
Induction of HrpL depends on transcriptional activators hrpS and hrpR (80, 
189). HrpS and HrpR belong to the NtrC family of two-component regulator 
proteins and form heterodimers before activation of hrpL. The pilus forming 
protein HrpA1 is a positive regulator that activates HrpL upstream of HrpS and 
HrpR, while HrpV is a negative regulator (154, 180). Deletion of hrpA1 or 
overexpression of hrpV suppresses the HrpS-HrpR-HrpL cascade activation. 
HrpG acts further upstream as anti-anti-activator by suppressing HrpV, thus 
activating HrpS and HrpL (180).  
The assembly of the T3SS apparatus is a highly regulated process and 
requires specific interactions among genes encoding the T3SS (5, 40). The T3SS 
has three components. First, the basal body is constructed, which spans inner 
and outer bacterial membranes. HrcJ is a constituent protein of the inner 
membrane and HrcC is in the outer membrane and belongs to the secretin family 
of proteins (47). Second, the pilus or needle-like syringe is assembled. HrpA1 is 
secreted through the basal body and polymerizes to form the Hrp pilus (88, 108). 
Third, translocator proteins are secreted through the T3SS to create pores or 
channels at the host plasma membrane to allow injection of T3Es into plant cells 
(128). Harpin proteins are also implicated in translocation of T3Es. Harpins elicit 
an HR and immune responses in plants. Pto DC3000 encodes four harpins 
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(HrpZ1, HrpW1, HopAK1 and HopP1) and the translocator HrpK1 (98, 149). HrpJ 
is important for pathogenicity as the Pto DC3000 hrpJ mutant strain has reduced 
disease symptoms in Arabidopsis and reduced HR in tobacco (42, 57). HrpJ is 
also important for translocation since the hrpJ mutant strain cannot secrete 
HrpW1, HrpZ1, and HopAK1. This suggests that HrpJ is a multifunctional 
regulator for the T3SS.  
Pto DC3000 perceives signals from host plants to induce T3SS genes and 
initiate infection. Metabolomics analyses by gas chromatography-mass 
spectrometry (GC-MS) identified pyroglutamic, citric, shikimic, 4-hydroxybenzoic, 
and aspartic acids as type III-inducing plant-derived metabolites (9). These 
metabolites have been implicated in regulating different aspect of Pto DC3000 
virulence, like chemotaxis and production of the phytotoxin coronatine.  
 
Type III effectors 
T3Es are secreted into plant cells through the T3SS. Inside plant cells, T3Es 
interfere with various cellular pathways associated with immunity to promote 
pathogen multiplication and development of disease. Based on a comparative 
genomic analysis of 19 P. syringae strains, there are 58 families of T3Es in P. 
syringae (18). The T3E repertoire among P. syringae genomes ranges from a 
minimum of 9 T3Es in P. syringae pv. japonica to a maximum of 39 T3Es in Pto 
DC3000. 
P. syringae T3Es share three common features in their N-terminal region: (i) 
enrichment of polar amino acids, more than 10% serine in the first 50 amino 
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acids, (ii) aliphatic amino acid or proline at position 3 or 4, and (iii) lack of acidic  
amino acids in the first 12 amino acids (72, 148). These features provided 
bioinformatic tools for the identification of candidate T3E genes from sequenced 
genomes. 
T3Es likely first evolved to suppress immune responses activated by PRRs 
after PAMP recognition (i.e., PTI) and then to suppress immunity induced by the 
recognition of specific T3Es by R proteins (i.e., ETI). As a way to classify Pto 
DC3000 T3Es based on their ability to suppress PTI, a functional screen was 
performed to identify T3Es able to suppress the flg22-mediated induction of the 
Arabidopsis NHO1 gene (112). NHO1 is required for resistance to nonhost P. 
syringae strains but is ineffective against pathogenic Pto DC3000, and is strongly 
induced by flg22. T3Es with PTI suppression abilities were HopS1, HopAI1, 
HopAF1, HopT1-1, HopT1-2, HopAA1-1, HopF2, HopC1, and AvrPto (112). In 
addition, Pto DC3000 T3Es have been classified based on their ability to 
suppress the HR elicited in tobacco by the T3E HopA1 (6). There are four 
classes of ETI suppressors, with AvrPtoB, HopD1, HopE1, HopF2, HopK1, 
HopS2, HopX1, and HopAM1 belonging to class I, which consists of effectors 
that displayed the most robust suppression of ETI (70, 82).  
 
Type III effector targets  
T3Es evolved to suppress plant innate immunity and allow P. syringae strains to 
multiply and cause diseases in their host plants. T3Es function in different ways 
inside plant cells. They have diverse host targets, disrupt signal transduction 
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pathways, and localize to different organelles to perform their virulence function. 
However, the majority of T3E enzymatic activities and plant targets are not 
known and this represents an important area of research. Activities and targets of 
P. syringae T3Es are described below and summarized in figure 2 and table 1. 
Unless specified, the majority of P. syringae T3E targets haven been identified in 
Arabidopsis. 
a. PAMP-receptor kinases complexes 
PAMP recognition is the first layer of immunity mediated by PRRs at the plasma 
membrane of plant cells. Several T3Es have been identified to target PRRs to 
suppress downstream signaling events associated with PTI. 
Two T3Es, AvrPto and AvrPtoB, target the cytoplasmic kinase domain of 
PRRs. AvrPtoB (also known as HopAB2) is an E3 ubiquitin ligase that promotes 
degradation of PRRs FLS2, EFR and CERK1 in a proteasome-dependent 
manner by ubiquitinating these PRRs (65, 68). The N-terminus of AvrPtoB 
interacts with the cytoplasmic kinase domains of FLS2, EFR, CERK1 and its C-
terminus carries an ubiquitin E3 ligase domain that mediates degradation of its 
targets. AvrPto targets FLS2 and EFR to inhibit their kinase activities (188).  
AvrPto and AvrPtoB also target the FLS2 co-receptor BAK1 and interfere with 
the BAK1-FLS2 association activated by flg22 (168, 198). The plasma membrane 
localization of AvrPto is required to dissociate the BAK1-FLS2 complex since an 
AvrPto derivative with a mutation (G2A) in the AvrPto myristoylation site no 
longer interferes with this complex (168, 169). The N-terminal 387 amino acids of 
AvrPtoB are required for the disruption of the BAK1-FLS2 complex. The crystal 
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structure of the AvrPtoB250-359-BAK1 complex was determined and shows that 
amino acids 250-359 of AvrPtoB define the minimal BAK1-interacting domain as 
shown by Isothermal titration calorimetry (33). These reports show that AvrPto 
targets BAK1. However, there is conflicting evidence for this interaction (187). 
Therefore it is unclear whether BAK1 and/or PRRs are the true virulence targets 
of AvrPto.  
HopF2 is a T3E that targets multiple components of PTI and localizes to the 
plasma membrane of plants (159). It was first shown that HopF2 blocks flg22-
induced BIK1 phosphorylation (184). The myristoylation site of HopF2, 
responsible for its plasma membrane localization, is required for HopF2 
suppression of BIK1 phosphorylation. However, HopF2 does not directly interact 
with BIK1 and does not inhibit BIK1 kinase activity, likely targeting components 
upstream of BIK1 in the FLS2/BAK1 complex. HopF2 also inhibits flg22-induced 
phosphorylation of PBL1, a BIK1 homolog (198). It was recently shown that 
HopF2 interacts with BAK1, a PTI component upstream of BIK1 (198). HopF2 
interacts with BAK1 in the fls2 mutant, indicating that this interaction is 
independent of FLS2. 
HopAO1 is a protein-tyrosine phosphatase (53) that targets EFR (121). 
Phosphorylation of the EFR tyrosine residue Y836 upon elf18 binding is required 
for EFR activation and subsequent immune responses. HopAO1 
dephosphorylates EFR upon elf18 treatment, therefore suppressing PTI 
responses. Although FLS2 tyrosine phosphorylation could not be evaluated, 
HopAO1 interacts with FLS2 and inhibits flg22-induced immune responses.  
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b. MAPK pathways 
Mitogen-activated protein kinases act downstream of PAMP recognition to initiate 
a cascade of immunity-associated signaling events. Therefore, MAPK pathways 
are important hubs targeted by T3Es.  
Besides targeting PRR complexes, HopF2 blocks multiple MAPKs. HopF2 
inhibits flg22-activation of the MAPK kinase 5 (MKK5), which acts upstream of 
MPK3 and MPK6 in the MEKK1/MKKs-MKK4/5-MPK3/6 cascade (179). 
Therefore, HopF2 inhibits MPK3 and MPK6 phosphorylation and suppresses PTI. 
HopF2 interacts with several other MKKs, including MKK3, MKK4, MKK6 and 
MKK10; however, MKK4 and MKK5 appear to be the main HopF2 targets. 
HopF2 has ADP-ribosyltransferase activity and ADP-ribosylates the amino acid 
residue Arg-313 and possible other residues in the C-terminal 38 amino acids of 
MKK5 to block its kinase activity (179). HopF2 also inhibits flg22-activation of 
MPK4 by suppression of BIK1 phosphorylation (198). 
HopAI1 is a phosphotreonine lyase that irreversibly inactivates MPK3 and 
MPK6 by dephosphorylation of a phosphotreonine residue in MPK3 and MPK6 
upon flg22 treatment (193). HopAI1 therefore blocks MAPK signaling upon 
PAMP activation. HopAI1 also targets MPK4 to inhibit its kinase activity (195). 
c. R-protein receptor complexes 
To overcome PTI suppression, plants evolved a second pathway to detect the 
presence of the pathogen. That is, by recognizing the presence of a T3E inside 
plant cells. The result is the induction of an immunity pathway referred to as ETI. 
ETI is a more robust and prolonged response compared to PTI. However, P.  
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Fig. 2. Host targets of Pseudomonas syringae type III effectors. Type III 
effectors (TE3s) (red text) are injected into the host cytoplasm through the type III 
secretion system. T3Es target host proteins (blue text) to suppress plant innate 
immunity at different levels. Some T3Es block PAMP-receptor complexes to 
suppress the PAMP-triggered immunity (PTI) pathway. PTI activates MAPK 
signaling cascades to induced transcriptional reprogramming. MAPK cascades 
and transcription of immunity-related genes are also inactivated by several T3ES. 
One T3E is known to act postranscriptionally to block RNA binding proteins to 
bind to their target RNAs. Another important component of the innate immune 
system is the effector-triggered immunity (ETI) pathway mediated by R protein 
complexes. This immunity pathway is targeted by a large group of T3Es. Few 
effectors are targeted to organelles like mitochondria and chloroplast to suppress 
immune responses. T3Es also interfere with vesicle trafficking and the 
cytoskeleton (microtubules and actin) to suppress cell wall mediated immune 
responses. 
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syringae evolved or acquired new T3Es that have the ability to suppress R 
protein complexes to inactive ETI. 
RPM1-interacting protein (RIN4) is a negative regulator of plant immunity 
that is localized to the plasma membrane and is targeted by several T3Es. 
Perturbations on RIN4 by T3Es are perceived by R proteins inducing ETI. 
AvrRpm1 and AvrB are two T3Es with N-terminal myristoylation sites that 
mediate plasma membrane localization in plant cells (141). AvrRpm1 and AvrB 
induce RIN4 phosphorylation to enhance the negative regulatory function of RIN4 
and to suppress immunity (125). However, RIN4 phosphorylation is perceived by 
the R protein RPM1 activating immune responses. AvrB- and to a lesser extend 
AvrRpm1-mediated RIN4 phosphorylation at threonine residue T166 is critical for 
RPM1 activation (36). RIN4-interacting receptor-like protein kinase (RIPK) 
directly phosphorylates RIN4 induced by AvrRpm1 and AvrB (115). RIPK 
phosphorylates RIN4 specifically at amino acid residues T21, S160 and T166. 
AvrRpm1 has a fold related to the catalytic domain of poly(ADP-ribosyl) 
polymerase-1 (34). Mutations on the putative catalytic triad of AvrRpm1 abolish 
activation of RPM1 immunity but interestingly activate RPS2-mediated immunity. 
Two other T3Es target RIN4, AvrRpt2 and HopF2. AvrRpt2 is a cysteine protease 
that cleaves RIN4, which is perceived by the R protein RPS2 inducing ETI (14, 
15). AvrRpt2 mutant alleles that are not recognized by RPS2 fail to eliminate 
RIN4, suggesting that RPS2 initiates immune responses after AvrRpt2-mediated 
degradation of RIN4. HopF2 ADP-ribosylates RIN4 to block AvrRpt2-induced 
RIN4 degradation, suppressing RPS2-dependent ETI (182). Unlike AvrRpm1, 
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AvrB, and AvrRpt2, modification of RIN4 by HopF2 is not recognized by an R 
protein in Arabidopsis. Therefore, HopF2 does not induce ETI and promotes 
bacterial growth. 
Another R protein complex hub is EDS1, a resistance regulator required for 
immunity mediated by TIR-NB-LRR R proteins (2). The TIR-NB-LRR R proteins 
RPS4 and RPS6 recognize AvrRps4 and HopA1, respectively, inducing ETI (77, 
94). EDS1 directly interacts with RPS4 and RPS6 but this R protein complex is 
disrupted by AvrRps4 and HopA1 (23, 75). 
AvrPphB, also known as HopAR1, is a cysteine protease that localizes to the 
plasma membrane through acylation-dependent mechanism (49). AvrPphB 
cleaves the receptor-like cytoplasmic kinase PBS1, which is recognized by the 
CC-NB-LRR R protein RPS5 inducing ETI (2, 170, 192). PBS1 cleavage 
products but not its kinase activity are required for RPS5 activation, suggesting 
that RPS5 is activated by conformational changes in PBS1 (48). The plasma 
membrane localization of PBS1 mediated by S-acylation at its N-terminus is 
required for RPS5 activation (155). PBS1 carries the AvrPphB cleavage site in its 
N-terminus while the amino acid sequence (SEMPH) in its C-terminus is 
responsible for specific interaction with RPS5. The SEMPH motif represents the 
RPS5 recognition motif and is unique to PBS1. A new model suggests that RPS5 
detects modification of the SEMPH motif in PBS1 caused by AvrPphB, instead of 
its proteolytic cleavage (155). Actin depolymerizing factor 4 (ADF4) is required 
for expression of RPS5 and resistance to AvrPphB since expression of RPS5 is 
reduced in an adf4 mutant (152). 
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AvrPto and AvrPtoB are recognized in tomato by the Pto kinase leading to 
ETI (95). The N-terminal 387 amino acids of AvrPtoB is recognized by the Pto 
homologue, the Fen kinase, inducing immune responses (161). However, the C-
terminus of AvrPtoB carries the E3 ubiquitin ligase domain that ubiquitinates Fen, 
which results in the degradation of Fen by the 26S proteasome and suppression 
of Fen-dependent ETI. Pto escapes AvrPtoB-mediated ubiquitination and 
activates ETI by phosphorylating the E3 ligase domain of AvrPtoB (144). 
However, it was recently shown that Pto binds to an AvrPtoB N-terminal domain, 
distal to the E3 ligase domain, to avoid ubiquitination and activation of ETI (127). 
Both Pto- and Fen-mediated resistance require Prf, a CC-NB-LRR R protein 
(136). This is an example of the guard model, in which Prf perceives 
modifications on Pto and Fen induced by AvrPtoB to activate ETI responses. 
The HopZ family belongs to the YopJ super family of T3E with acetyl 
transferase and cysteine protease enzymatic activities (104). HopZ members 
have N-terminal myristoylation sites that mediate plasma membrane localization 
(103, 197). The Arabidopsis CC-NB-LRR R protein HopZ-activated resistance 1 
(ZAR1) recognizes HopZ1a (107). The CC domain of ZAR1 is evolutionary 
distinct from other CC-NB-LRR proteins and ZAR1 activates immunity 
independent of NDR1, a gene required for CC-NB-LRR R protein signaling. The 
pseudokinase HopZ-ETI-deficient 1 (ZED1) is required for ZAR1-mediated 
immunity, as the zed1 mutant cannot recognize HopZ1a (105). ZED1 interacts 
with HopZ1a and ZAR1 and HopZ1a acetylates ZED1 at residues T125 and 
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T177 activating ZAR1 immunity. It is still not clear whether ZED1 acts as a 
guardee or decoy mediating ZAR1 immunity. 
HopAI1 inactivates MPK4 to suppress PTI (195). However, HopAI1 mediated 
inactivation of MPK4 results in activation of SUMM2-mediated immune 
responses Thus, it is likely that the R protein SUMM2 evolved to sense bacterial 
perturbations to the MAPK signaling cascade. 
d. Transcription factors 
Chapter 2 of this thesis describes that HopD1 interacts with the membrane-
tethered transcription factor NTL9 at the plasma membrane to inhibit induction of 
NTL9-regulated genes (25). HopD1 suppresses immune responses associated 
with ETI but not PTI. NTL9-regulated genes are induced in an ETI-dependent 
manner and HopD1 blocks their induction. 
HopZ1a targets the JA pathway by degrading jasmonate ZIM-domain (JAZ) 
proteins (87). JAZ proteins are transcriptional repressors of the JA signaling 
pathway. The acetyltransferase activity of HopZ1a is required to acetylate and 
degrade JAZ proteins. Degradation of JAZ proteins by HopZ1a induces 
expression of JA-responsive genes. Therefore, HopZ1a activates JA signaling to 
promote bacterial infection. HopX1 is another T3E interfering with the JA 
pathway, in a similar manner as HopZ1a. HopX1 is a cysteine protease that 
degrades JAZ proteins, leading to activation of JA-induced immune responses 
and downregulation of SA responses (64). 
e. Post-transcriptional targets  
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HopU1 is a mono-ADP-ribosyltransferase that targets RNA-binding proteins 
including the glycine-rich RNA-binding proteins GRP7 and GRP8 (58). These 
RNA-binding proteins possess RNA-recognition motifs (RRMs). The arginine 
residue R49 in the GRP7 RRM is ADP-ribosylated by HopU1, and this 
modification blocks the ability of GRP7 to bind target RNAs (58, 86). GRP7 
interacts with translational components suggesting that it may function by 
modifying translation. GRP7 likely interacts with many immunity-related RNAs. 
However, the only published RNA interactors are the RNAs encoding the PRRs 
FLS2 and EFR (140). HopU1 inhibits binding of GRP7 to FLS2 and EFR 
transcripts and likely other immunity-related RNAs, thereby suppressing PTI. 
f. Vesicle trafficking 
HopM1 degrades AtMIN7 (A. thaliana HopM1 interactor 7) via the 26S 
proteasome (142). AtMIN7 is an ADP-ribosylation factor guanine nucleotide 
exchange factor that regulates vesicle trafficking. HopM1 blocks vesicle 
trafficking to suppress PTI and SA-regulated immunity, highlighting the 
importance of AtMIN7 for plant immunity. HopM1 and AtMIN7 localize to the 
trans-Golgi network/early endosome (TGN/EE) (143). This suggests that the 
TGN/EE is an important subcellular compartment mediating immunity. 
HopZ4 interacts with RPT6, a 26S proteasomal subunit, to inhibit proteasome 
activity (174). HopZ4 belongs to the YopJ family of T3Es. The conserved 
catalytic triad (H133, E152, and C194) and consensus myristoylation site 
characteristic of YopJ-like effector proteins are required for the HopZ4 inhibitory 
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effect on the proteasome. By inhibiting the proteasome, HopZ4 interferes with the 
secretory pathway.  
g. Cytoskeleton 
HopZ1a binds tubulin and microtubules, major constituents of the plant 
cytoskeleton (102). HopZ1a is an acetyltransferase activated by the co-factor 
phytic acid that acetylates itself and tubulin. A lysine in position 289 of HopZ1a is 
the putative autoacetylated site, and is important for HopZ1’s acetyltransferase 
activity. Tubulin acetylation by HopZ1a disrupts tubulin networks, inhibits protein 
secretion, and suppresses cell wall-mediated immunity. 
HopW1 disrupts the actin cytoskeleton by reducing filamentous actin (F-actin) 
networks (91). This modification inhibits endocytosis and trafficking of proteins to 
the ER and/or vacuoles, two actin-dependent processes. AvrPphB potentially 
targets the actin cytoskeleton by altering ADF4 phosphorylation (152). ADF4 is 
important in actin turnover mechanisms (76). 
h. Plant organelles 
At least four P. syringae T3Es are targeted to plant chloroplast to suppress 
immunity: HopI1, HopN1, HopK1 and AvrRps4. HopI1 is a T3E specifically 
targeted to the chloroplast through a N-terminal chloroplast targeting sequence 
(85). HopI1 has a J domain on its C-terminus that mediates activation of the 70 
kDa heat shock proteins (Hsp70). J domains with a conserved HPD loop are 
found in Hsp70 cochaperones and these proteins activate the ATPase activity 
and folding of Hsp70 (93). Once inside the chloroplast, HopI1 remodels 
chloroplast thylakoid structure and reduces SA levels, which is produced in 
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chloroplasts during plant immune responses (84, 85). The J domain activity of 
HopI1 is required to alter chloroplast morphology. In this manner, HopI1 
suppresses SA-mediated immunity. HopN1 is a cysteine protease that targets 
the tomato PsbQ, a chloroplast protein member of the oxygen-evolving complex 
of photosystem II (160). HopN1 degrades PsbQ to inhibit photosystem II activity 
and block ROS production. The catalytic triad (C1272, H283, D299) 
characteristic of cysteine proteases from the YopT/AvrPphB effector family is 
essential for the activity of HopN1 (116, 160). HopK1 and AvrRps4 are targeted 
to the chloroplast through an N-terminal cleavable chloroplast transit peptide to 
suppress PTI responses (109). Chloroplast localization of these T3Es is required 
for suppression of PTI-induced immune responses. 
HopG1 is a T3E that localizes to the mitochondria to disrupt its function (24). 
HopG1 does not have an obvious mitochondrial target peptide but its N-terminal 
263 amino acids are required for mitochondrial-localization. Inside mitochondria, 
HopG1 reduces respiration rates and increases ROS production. In addition, 
HopG1 alters plant morphology as transgenic plants overexpressing HopG1 
show dwarfism, increased branching and infertility. 
i. Hormones 
Several virulence targets have been identified for HopZ1a. In addition to 
disrupting tubulin networks and JAZ proteins, HopZ1a targets 2-
hydroxyisoflavone dehydratase (HID1), an enzyme involved in isoflavone 
biosynthesis in soybeans (196). Both HopZ1a and HopZ1b degrade HID1 to 
inhibit production of daidzein, major soybean isoflavone. Degradation of HID1 is 
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dependent on the acetyltransferase activity of HopZ1. Silencing HID1 in 
soybeans results in increased susceptibility to P. syringae infection, suggesting a 
role for isoflavone in plant immunity. 
AvrB also disrupts hormone signaling. As described earlier in this chapter, 
AvrB phosphorylates RIN4 to suppress immunity (125). AvrB interacts with RAR1, 
an important component required for ETI that functions as the HSP90 co-
chaperone (44). The AvrB-RAR1 interaction enables AvrB to associate with 
HSP90 and MPK4 and results in the phosphorylation of RIN4 by MPK4. In planta 
expression of AvrB results in increased expression of JA-responsive genes, 
which is dependent on the RAR1-HSP90-MPK4 complex. Ultimately this leads to 
the activation of JA signaling and disease susceptibility. 
HopQ1 activates cytokinin (CK) signaling (73). A characteristic aspartate motif 
in a putative hydrolase nucleoside domain present in HopQ1 suggests a 
nucleoside hydrolase activity (110). HopQ1 mimics the phosphoribohydrolase 
activity of LOG enzymes, which hydrolyze the CK precursor iPRMP to convert 
inactive CK nucleotides to active CK forms (73). HopQ1 hydrolyzes iPRMP to 
activate CK pathway and to upregulate CK-responsive genes. Induction of the 
CK pathway by HopQ1 attenuates FLS2 expression, which leads to suppression 
of PTI responses. 
AvrRpt2 is recognized by the R protein RPS2 (22, 131). In the rps2 mutant, 
AvrRpt2 increases levels of free indole acetic acid (IAA), a product of an auxin-
response gene (32).  In this manner, P. syringae delivers AvRrpt2 to modulate 
auxin physiology to promote disease susceptibility. Recent data indicate that 
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AvrRpt2 stimulates the turnover of Aux/IAA proteins, transcriptional repressors of 
auxin signaling stimulating auxin signaling (43). In addition, HopM1 degrades 
AtMin7 (142), a protein involved in vesicle trafficking and recycling of the auxin 
efflux carrier PIN1 (100). This suggests that HopM1 alters auxin efflux. 
Several P. syringae T3Es disrupt the ABA, ET and SA signaling pathways. 
AvrPtoB induces expression of NCED3, which encodes a key enzyme of ABA 
biosynthesis, facilitating bacterial growth (46). Expression of HopAM1 in planta 
enhances ABA responses and suppresses immune responses (67). AvrPtoB and 
AvrPto induce expression of two tomato genes involved in ethylene production, 
LeACO1 and LeACO2, enhancing disease development (39). HopI1 is targeted 
to chloroplasts to block SA biosynthesis (85). 
j. 14-3-3 proteins  
14-3-3 proteins are eukaryotic phosphopeptide-binding proteins that bind client 
proteins involved in different cellular processes. 14-3-3 proteins serve as scaffold 
proteins to regulate client stability, conformation, localization and/or protein-
protein interactions (29). In addition to activating CK signaling, HopQ1 interacts 
with several 14-3-3 proteins, including TFT1 and TFT5, in a phosphorylation 
dependent manner (66). The N-terminus of HopQ1 possesses a 14-3-3 binding 
site (RSXpSXP). Phosphorylation of the HopQ1 residue serine 51 in the 14-3-3 
binding site is required for binding to TFT1 and TFT5 to promote bacterial 
virulence in planta (66, 111). A second HopM1 target is AtMIN10, the 14-3-3 
protein GRF8 (142). GRF8 interacts with BZR1, a transcription factor in the 
brassinosteroid signaling, and GRF8 interferes with accumulation of BZR1 in the 
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nucleus (60, 163). In planta expression of HopM1 leads to nuclear accumulation 
of BZR1 (117). This indicates that HopM1 mimics the effect of disrupting the 
function of 14-3-3 proteins. HopM1 degrades GRF8 to disrupt interaction with its 
client proteins; therefore it suppresses PTI-induced ROS production and stomatal 
immunity. Until now it is not clear if 14-3-3 proteins are co-factors or direct targets 
of HopQ1 and HopM1. 
k. RNA silencing 
New evidence has shown that T3Es suppress host RNA silencing pathways in 
order to cause disease. Components of the small RNA pathway are induced by 
bacterial infections. For example, the microRNA miR393 is induced after PAMP-
perception and contributes to resistance against virulent Pto DC3000 by 
repressing auxin signaling (138). To counteract this pathogen restriction, P. 
syringae uses AvrPtoB, AvrPto, and HopT1-1 to suppress PAMP-induced 
miRNAs, including miR393a and miR393b (139). These T3Es suppress miRNAs 
transcriptional activation, biogenesis, stability or their activity. In addition, 
HopAB1, HopX1, and HopF2 have been shown to enhance gene silencing (164). 
However, the mechanism by which all of these T3Es manipulate host RNA 
silencing to suppress immunity remains to be elucidated.  
In summary, T3Es interfere with several immunity-associated complexes and 
organelles to hijack the plant innate immune system and allow bacterial 
multiplication. The diversity of T3E targets illustrates sophisticated mechanisms 
to suppress immunity to favor pathogenicity. 
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Table 1. P. syringae type III effector’s activity, plant targets and localization 
Effector Enzymatic activity Target Subcellular 
localization 
Reference 
AvrB Unknown RAR1/Hsp90/MPK4/
RIN4 
Plasma membrane 
 
(36, 44, 
115, 125, 
141) 
AvrPphB 
(HopAR1) 
Cysteine protease PBS1 and PBS1-like 
proteins (BIK1, 
PBL1, PBL2) 
Plasma membrane 
 
(2, 49, 170, 
194) 
AvrPto Kinase inhibitor FLS2, EFR, BAK1, 
Pto, miRNA pathway 
Plasma membrane (120, 139, 
168, 169, 
188) 
AvrPtoB 
(HopAB2) 
E3 ubiquitin ligase FLS2, EFR, CERK1, 
BAK1, Pto, Fen, 
miRNA pathway 
Unknown (65, 68, 83, 
127, 139, 
161, 168) 
AvrRpm1 Unknown RIN4 Plasma membrane 
 
(36, 115, 
125, 141) 
AvrRps4 Unknown EDS1 Nucleus and 
chloroplast 
(23, 75, 
109) 
AvrRpt2 Cysteine protease RIN4 Plasma membrane (14, 15, 
124) 
HopA1 Unknown EDS1 Nucleus and 
cytoplasm 
(23, 75) 
HopAI1 Phosphothreonine lyase MPK3, MPK6, MPK4 Unknown (193, 195) 
HopAO1 Tyrosine phosphatase EFR, FLS2 Unknown (53, 121) 
HopC1 Cysteine protease Unknown Plasma membrane (49) 
HopD1 Unknown NTL9 Endoplasmic 
reticulum 
(25) 
HopF2 Mono-ADP- 
ribosyltransferase 
BAK1, RIN4, MKK5 Plasma membrane (159, 179, 
182, 198) 
HopG1 Unknown Unknown Mitochondria (24) 
HopI1 J-domain protein Hsp70 Chloroplast (84, 85) 
HopK1 Unknown Unknown Chloroplast (109) 
HopM1 Unknown AtMin7 (ARF-
GEFP), 
AtMin10/GRF8 (14-
3-3 protein) 
trans-Golgi 
network/early 
endosome (TGN/EE) 
(117, 142, 
143) 
HopN1 Cysteine protease Tomato PbsQ Chloroplast (116, 160) 
HopQ1 Nucleoside hydrolase 14-3-3 proteins 
(TFT1 and TFT5), 
iPRMP (cytokinin 
precursor) 
Nucleus and 
cytoplasm  
(66, 73, 
111) 
HopT1-1 Unknown miRNA pathway Unknown (139) 
HopU1 Mono-ADP-
ribosyltransferase 
GRP7 and RNA-
binding proteins 
Unknown (58) 
HopW1 Unknown Actin cytoskeleton Unknown (91) 
HopX1 Cysteine protease JAZ Nucleus and 
cytoplasm 
(64) 
HopZ1a Acetyl 
transferase/cysteine 
protease 
ZED1, tubulin, 
GmHID1, JAZ 
Plasma membrane (87, 102, 
103, 105, 
196, 197) 
HopZ1b Acetyl transferase GmHID1 Plasma membrane (103, 196, 
197) 
HopZ1c Unknown Unknown Plasma membrane (103) 
HopZ2 Cysteine protease MLO2 Plasma membrane (103, 106) 
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The zigzag model of the plant immune system 
The zigzag model first introduced by Jones and Dangl (90) explains the evolution 
of the plant innate immune system (Fig. 3). When pathogens first infected plants, 
it was likely that the host plant was capable of recognizing PAMPs with PRRs 
inducing PTI. The next likely step in the evolutionary process was that the 
pathogens needed to acquire a virulence factor or factors to suppress PTI. In this 
manner, effector genes were acquired by the pathogens to suppress PTI and 
allowed pathogens to grow on plants inducing effector-triggered susceptibility 
(ETS). However, plants also acquired R genes to encode immune receptors that 
recognized these effectors. These R proteins resulted in the activation of ETI and 
inhibiting the ability of pathogens to grow in plants. Then natural selection drove 
pathogens to diversify/mutate the genes that encoded recognized effectors or 
acquire additional effector genes to encode novel effectors to again suppress ETI, 
resulting again in ETS. Finally plants acquired new R proteins that could 
recognize the new effectors, inducing ETI again. This coevolutionary arms race 
between plants and pathogens results in highly virulent pathogen isolates and 
plants more resistant to pathogen invasion. 
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Fig. 3. A zigzag model illustrates the quantitative output of the plant 
immune system. Plants detect pathogen-associated molecular patterns (PAMPs, 
red diamonds) via pattern recognition receptors (PRRs) to induce PAMP-
triggered immunity (PTI). Successful pathogens deliver effectors  (red circles) 
that interfere with PTI, or enable pathogen nutrition and/or dispersal, resulting in 
effector-triggered susceptibility (ETS). When one effector is recognized by an R 
protein (red arc), effector-triggered immunity (ETI) is activated. ETI often passes 
a threshold for induction of the hypersensitive response (HR). Pathogen isolates 
are selected that have lost the gene that encoded the recognized effector or 
gained new effector genes through horizontal gene transfer that encode novel 
effectors (blue circles) to help pathogens suppress ETI. Selection favors new 
plant R genes (blue arc) that encode immune receptors that can recognize the 
newly acquired effectors, resulting again in ETI. This figure is from Jones and 
Dangl (90). 
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Evolution of type III effector inventory in Pseudomonas syringae 
strains 
T3Es are key determinants in virulence and host-specificity of P. syringae strains. 
Genome comparisons in regards to the inventory of T3Es have contributed to 
understand the molecular basis for host range evolution of P. syringae pathovars. 
Genome sequencing and comparative genomic analyses of 19 diverse P. 
syringae strains revealed five T3E families conserved across all strains (18). The 
core families of T3Es include HopAA, AvrE, HopM, HopI and HopAH.  In addition, 
nine new families of T3Es were identified: HopAY1, HopAZ1, HopBA1, HopBB1, 
HopBC1, HopBD1, HopBE1, HopBF1 and HopBG1. Most recently, genome-wide 
transcriptional analyses have identified HopBH1 and HopBI1 as two new T3E 
families from P. syringae pv. oryzae 1_6 and the HopBM1 family from Pto 
DC3000 (137). 
The T3E repertoire between P. syringae strains is highly divergent, most likely 
as a result of selective pressures to suppress PTI and avoid host immune 
recognition. The most diverse T3E families identified by pairwise amino acid 
diversity are HopW, HopZ, AvrB, HopAO, HopT, HopAB and HopF (18). 
Phytotoxins (coronatine, tabtoxin, syringolin, syringopeptin, syringomycin, 
phaseolotoxin) are also important virulence factors influencing P. syringae host 
range. T3Es and phytotoxins content among P. syringae isolates representing 
multilocus sequence typing (MLST) groups is evolutionary dynamic. In particular, 
isolates from MLST group II contain fewer T3Es that are compensated by having 
more genes involved in phytotoxin biosynthesis. In agreement, the recently 
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sequenced P. syringae CC1557 strain contains the lowest number of T3Es but 
have acquired genes required for biosynthesis of the phytotoxin syringomycin 
(79). A new T3E, HopBJ1, with similarity to the Escherichia coli CNF1 toxin has 
been acquired by P. syringae CC1557 and is important for pathogenicity in N. 
benthamiana. This suggests a negative correlation between size of T3E 
repertoire and presence of toxins like syringomycin, syringopeptin and syringolin 
A. 
P. syringae pv. tomato T1 (Pto T1) causes bacterial speck disease in tomato 
(Solanum lycopersicum) but is nonpathogenic in Arabidopsis. Comparison of 
virulence genes in Pto T1 and its closely related strain Pto DC3000, which is 
pathogenic on Arabidopsis, revealed that the phytotoxin coronatine and a set of 
T3Es are missing from Pto T1 (7). Pto T1 deploys AvrRpt2, which is recognized 
in Arabidopsis by the R protein RPS2. While Pto T1 elicits an HR in wild type 
Arabidopsis but not in a mutant lacking functional RPS2 (rps2-101c), bacterial 
growth in the rps2-101c mutant is similar to that in wild type Arabidopsis. Thus, 
AvrRpt2 triggers an HR in Arabidopsis but is not responsible for resistance to Pto 
T1. This suggests that other Pto T1 T3Es induce ETI in Arabidopsis. HopAS1 
has been identified as a second T3E in Pto T1 that is recognized in Arabidopsis 
(171). Interestingly, hopAS1 is truncated in P. syringae strains that are 
pathogenic in Arabidopsis. 
In legumes, P. syringae pv. phaseolicola (Pph) and P. syringae pv. glycinea 
(Pgy) cause diseases in beans and soybeans, respectively. Genome-wide 
comparison of T3Es from Pgy R4 and Pph 1448a identified two effector genes 
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present in Pgy R4 but absent in Pph 1448a (17). HopC1 and HopM1 from the 
soybean pathogen Pgy R4 trigger avirulence responses in beans and thus 
contribute to host differentiation between glycinea and phaseolicola pathovars. 
This is consistent with HopC1 from P. syringae pv. pisi  being an Avr protein in 
several French bean cultivars (12). Pph 1448a has a core set of six effectors 
(AvrB2, HopAB1/AvrPtoB, HopI1, HopR1, HopAS1 and HopAU1) that contribute 
to virulence in beans (123). 
In order to more fully understand P. syringae T3Es, characterization of two 
T3Es was the primary focus for the research presented in this dissertation. 
Chapters 2-4 describe the TE3s HopD1 and HopA1 in regards to their activity, 
localization and targets in host cells. Chapter 5 summarizes the main discoveries 
of this dissertation and identifies questions that remain to be explored in our 
understanding of the molecular interactions of P. syringae with its host plant. 
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CHAPTER 2 
The Pseudomonas syringae type III effector HopD1 
suppresses effector-triggered immunity, localizes to the 
endoplasmic reticulum, and targets the Arabidopsis 
transcription factor NTL9 
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ABSTRACT 
Pseudomonas syringae type III effectors are known to suppress plant immunity 
to promote bacterial virulence. However, the activities and targets of these 
effectors are not well understood. We used genetic, molecular, and cell biology 
methods to characterize the activities, localization, and target of the HopD1 type 
III effector in Arabidopsis. HopD1 contributes to P. syringae virulence in 
Arabidopsis and reduces effector-triggered immunity (ETI) responses but not 
pathogen-associated molecular pattern-triggered immunity (PTI) responses. 
Plants expressing HopD1 supported increased growth of ETI-inducing P. 
syringae strains compared with wild-type Arabidopsis. We show that HopD1 
interacts with the membrane-tethered Arabidopsis transcription factor NTL9 and 
demonstrate that this interaction occurs at the endoplasmic reticulum (ER). A P. 
syringae hopD1 mutant and ETI-inducing P. syringae strains exhibited enhanced 
growth on Arabidopsis ntl9 mutant plants. Conversely, growth of P. syringae 
strains was reduced in plants expressing a constitutively active NTL9 derivative, 
indicating that NTL9 is a positive regulator of plant immunity. Furthermore, 
HopD1 inhibited the induction of NTL9-regulated genes during ETI but not PTI. 
HopD1 contributes to P. syringae virulence in part by targeting NTL9, resulting in 
the suppression of ETI responses but not PTI responses and the promotion of 
plant pathogenicity. 
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Introduction 
The Gram-negative bacterial pathogen Pseudomonas syringae pv. tomato 
DC3000 is the causative agent of bacterial speck disease on tomato and 
pathogenic on the model plant Arabidopsis thaliana. One of its primary virulence 
factors is its ability to inject type III effector (T3E) proteins into host cells using a 
type III protein secretion system. Once injected, T3Es target and disrupt various 
host processes in order to suppress plant immunity (5, 10, 13). 
Plant innate immunity can be broadly separated into two branches based 
on how microorganism recognition is achieved. The first of these branches 
involves the recognition of pathogen-associated molecular patterns (PAMPs) by 
extracellular pattern recognition receptors (PRRs; 23). This recognition induces 
multiple responses, including signaling cascades involving mitogen-activated 
protein kinases and calcium-dependent protein kinases. These signaling events 
lead to a rapid burst of reactive oxygen species (ROS) production and gene 
expression changes (32). Later responses include cell wall modifications such as 
the deposition of callose. The combined response arising from this recognition 
event is termed PAMP-triggered immunity (PTI; 23, 32). 
Pseudomonas syringae can use several of its injected T3Es to suppress 
PTI and achieve high growth rates within its host plants. To combat PTI 
suppression by T3Es and other pathogen effectors, plants evolved a second 
layer of immunity based on the recognition of effectors or their activities by plant 
immune receptors, know as resistance (R) proteins. The response from this 
recognition event is termed effector-triggered immunity (ETI) and induces many 
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of the same responses as PTI but often with different timing and amplitude (46). 
ETI is usually associated with a form of programmed cell death known as the 
hypersensitive response (HR). Thus, in order to maintain its pathogen status, P. 
syringae probably adapted/evolved T3Es to suppress PTI and/or ETI.  
If a P. syringae strain lacks the ability to successfully suppress ETI, 
bacterial growth is restricted. This is classically referred to as an incompatible 
interaction between an avirulent strain and a resistant plant (25). If the P. 
syringae strain can suppress PTI and ETI, or does not elicit ETI but suppresses 
PTI, it can be pathogenic and achieve high growth rates in plant tissue. This is 
classically referred to as a compatible interaction between a virulent strain and 
susceptible plant. Many P. syringae T3Es have been shown to suppress PTI 
responses and several suppress both PTI and ETI (7, 15, 13). However, it is less 
clear whether P. syringae T3Es have evolved to suppress ETI, but not PTI. 
In a previous study we screened DC3000 T3Es for their ability to suppress 
ETI responses induced by the T3E HopA1 in Nicotiana tabacum (22, 18). One of 
the strong ETI suppressors identified in this screen was HopD1. HopD1 is a 
homolog of AvrPphD from P. syringae pv. phaseolicola race 4 strain 1302A (52). 
A P. syringae pv. phaseolicola avrPphD mutant showed no difference in growth 
in either resistant or susceptible pea cultivars, indicating that its immune 
suppression/induction functions are probably redundant with other T3Es in this 
pathogen (2). Bacterial mutants lacking HopD1 homologs have differing effects 
on the virulence of other bacterial pathogens (17, 41). Therefore, depending on 
the pathogen and its likely redundancy with other T3Es, loss of hopD1 can 
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reduce the virulence of a pathogen. 
HopD1 has no known mechanism of action or homology to proteins with a 
known enzymatic function. A recent study used a high-throughput yeast two-
hybrid screen to define the interactomes of P. syringae T3Es and the effectors 
from the oomycete pathogen Hyaloperonospora arabidopsidis with Arabidopsis 
proteins (33). One potential interaction identified in this screen was that of HopD1 
and the Arabidopsis NTL9 (At4g35580) protein (33). NTL9 belongs to the NAC 
with Transmembrane Motif 1 (NTM1)-like family of transcription factors that are 
tethered to intracellular membranes (29). NAC transcription factors play a wide 
variety of roles in developmental and stress-related signaling and can also be 
involved in regulating cross-talk between different stresses (38). 
Here we show that HopD1 is an important DC3000 virulence factor. We 
show that it is a strong ETI suppressor in Arabidopsis but does not significantly 
suppress PTI responses. Additionally, we confirm that HopD1 interacts with 
NTL9 and that both HopD1 and NTL9 localize to the plant endoplasmic reticulum 
(ER). NTL9 is important for the Arabidopsis ETI response as ntl9 knockout plants 
allow for increased growth of ETI-inducing P. syringae strains and rescue the 
growth of a DC3000 hopD1 mutant. In addition, plants expressing constitutively 
active NTL9 are more resistant to virulent and ETI-inducing P. syringae strains, 
further indicating that NTL9 is a positive regulator of plant immunity. We identify 
several genes whose expression is induced by active NTL9 and show that 
HopD1 suppresses the induction of these genes during ETI but not PTI. These 
data indicate that HopD1 functions as a specific suppressor of ETI, in part by 
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inhibiting NTL9-mediated gene expression. 
 
Results 
HopD1 contributes to P. syringae virulence and enhances the growth of 
ETI-inducing P. syringae strains. To determine the extent of HopD1’s 
involvement in P. syringae virulence, we measured the in planta growth of a P. 
syringae pv. tomato DC3000 hopD1 mutant (UNL104; 22) in wild-type 
Arabidopsis (Col-0; Fig. 1A). Bacterial growth assays showed a slight but 
significant reduction in the growth of the hopD1 mutant in Arabidopsis when 
compared with wild-type DC3000. Wild-type growth rates were restored when 
hopD1 was reintroduced into the hopD1 mutant using a T7 expression system 
such that hopD1 was expressed in single copy from a type III promoter (Fig. 1A). 
These data show that HopD1 is required for the full virulence of P. syringae on 
Arabidopsis. 
Next we examined the ability of HopD1 to promote bacterial growth in 
planta using transgenic Arabidopsis constitutively expressing HopD1 fused to a 
C-terminal HA tag (HopD1-HA). These plants displayed no obvious phenotypes 
and we confirmed that they produced HopD1-HA (Fig. S1). Wild-type Arabidopsis 
and HopD1-HA expressing Arabidopsis plants were syringe inoculated with wild-
type DC3000, the DC3000 hrcC mutant defective in type III secretion, or DC3000 
strains carrying plasmids expressing the T3E genes avrRpm1 or avrRpt2, which 
encode ETI-inducing T3Es, rendering these strains avirulent. Growth of these 
strains was determined at 0 and 3 d postinoculation (Fig. 1B). In planta
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Fig. 1. HopD1 contributes to the virulence of DC3000. (a) Wild-type 
Arabidopsis (Col-0) plants were syringe-inoculated with 2 x 105 cells ml-1 of wild 
type Pseudomonas syringae (DC3000), the DC3000 hopD1 mutant or the hopD1 
mutant complemented with hopD1-flag using the Tn7 expression system. The 
type III secretion defective hrcC mutant was included as a nonpathogenic control. 
Bacterial growth was determined at 0 and 3 d postinoculation (letters are 
significantly different, P ≤0.05). (b) Wild-type Arabidopsis (Col-0) and transgenic 
Arabidopsis constitutively expressing HopD1-HA were syringe-inoculated with 2 x 
105 cells ml-1 of DC3000, DC3000 carrying a plasmid constitutively expressing 
the avr genes avrRpm1 or avrRpt2, or the DC3000 hrcC mutant. Bacterial growth 
was measured at 0 and 3 d postinoculation (different letters indicate the values 
are significantly different; P ≤0.05). (a, b) Error bars, ±SE. 
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expression of HopD1-HA led to significantly increased growth of the two ETI-
inducing avirulent strains but had no effect on the growth of wild-type DC3000 or 
the nonpathogenic hrcC mutant (Fig. 1B). These data show that HopD1 is a 
strong suppressor of ETI in Arabidopsis. The lack of an effect of HopD1 on the 
growth of the hrcC mutant, which cannot inject T3Es but carries PAMPs that 
induce PTI, suggests that HopD1 is unable to significantly suppress PTI. 
Bacterially delivered HopD1 can suppress AvrRpm1-induced ETI in 
Arabidopsis. The increased growth of avirulent P. syringae strains on 
Arabidopsis expressing HopD1-HA indicates that HopD1 can suppress ETI 
induced by AvrRpm1 and AvrRpt2 in Arabidopsis. To further characterize the 
ability of HopD1 to suppress ETI, we used a nonpathogenic Pf strain carrying 
pLN1965, which encodes a functional P. syringae type III secretion system (18), 
and two additional plasmids expressing HopD1-FLAG and AvrRpm1. This allows 
the effect of HopD1 on ETI to be determined in the absence of other T3Es that 
may be redundant to HopD1. 
To test the ability of HopD1 to suppress ETI, Pf(pLN1965 + pavrRpm1) 
carrying either a vector control or a plasmid constitutively expressing hopD1-flag 
were syringe-infiltrated into wild-type Arabidopsis leaves. The coexpression of 
hopD1-flag with avrRpm1 suppressed the macroscopic HR (Fig. 2A). AvrRpm1-
induced ion leakage was also measured in wild-type Col-0 infiltrated with these 
strains. Bacterial delivery of HopD1-FLAG suppressed ion leakage, which is 
correlated with cell death, to such an extent that it resembled that of leaves 
infiltrated with Pf lacking the ETI inducer AvrRpm1 (Fig. 2B). Furthermore, the 
	  	   66	  
 
Fig. 2. HopD1 suppresses effector-triggered immunity (ETI) in Arabidopsis. 
Wild-type Arabidopsis (Col-0) plants were syringe-inoculated with 1 x 108 cells 
ml-1 of Pseudomonas fluorescens (Pf)(pLN1965), which encodes a functional 
type III secret ion system, and a construct carrying avrRpm1 (Pf(pLN1965 + 
pavrRpm1)), carrying a vector control (Pf(pLN1965 + pvector)), or carrying 
avrRpm1 and a plasmid constitutively expressing hopD1-flag (Pf(pLN1965 + 
pavrRpm1 + phopD1-flag)). (a) The hypersensitive response (HR) was scored in 
eight leaves per treatment at 48 h postinoculation. (b) Ion leakage was measured 
in leaf disks over time to quantify cell death. (c) Wild-type Arabidopsis (Col-0) 
leaves were syringe-inoculated with 1 x 106 cells ml-1 of Pf(pLN1965) or 
Pf(pLN1965) carrying avrRpm1 with or without a plasmid constitutively 
expressing hopD1-flag and the number of callose foci were determined at 16 h 
postinoculation (different letters indicate that values are significantly different; P 
≤0.05). Each assay was repeated at least twice with similar results. (b, c) Error 
bars, ±SE. 
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ETI-induced deposition of callose in the plant cell wall of wild-type Arabidopsis 
leaves infiltrated with Pf(pLN1965 + pavrRpm1 + phopD1-flag) was significantly 
lower than that in leaves infiltrated with Pf(pLN1965 + pavrRpm1; Fig. 2C). These 
data show that HopD1 can suppress ETI-induced HR and callose deposition. 
To confirm that the HR and ion leakage suppression by HopD1 was the 
result of suppression of ETI, we included an Arabidopsis rpm1 knockout line that 
cannot recognize AvrRpm1 and, therefore, does not exhibit AvrRpm1-induced 
ETI responses. Using this Arabidopsis rpm1 mutant, there was no induction of an 
HR by either Pf(pLN1965 + pavrRpm1) or Pf(pLN1965 + pavrRpm1 + phopD1-
flag) and there was no difference in ion leakage (Fig. S2). Collectively, these data 
confirm that HopD1 can suppress AvrRpm1-induced ETI responses in 
Arabidopsis. 
HopD1 does not suppress PAMP-induced oxidative burst or callose 
deposition in Arabidopsis. To determine if HopD1 could suppress PTI, we 
evaluated its ability to inhibit the oxidative burst that occurs within minutes of 
PAMP recognition (34). To do this, we measured the production of ROS in wild-
type and HopD1- HA-expressing Arabidopsis after treatment with the PTI 
inducers flg22, elf18, and chitin. Flg22 is a 22-amino-acid peptide of the PAMP 
flagellin that is recognized by the plant receptor FLS2 and elf18 is an 18-amino-
acid peptide of the PAMP EF-Tu that is recognized by the receptor EFR. The 
PAMP chitin is recognized by the receptor CERK1 (32). No difference was 
observed in PAMP-induced ROS production between wild-type and HopD1-HA-
expressing Arabidopsis, indicating that HopD1 cannot suppress this early PTI  
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Fig. 3. HopD1 has no significant impact on pathogen-associated molecular 
pattern (PAMP)-induced reactive oxygen species (ROS) production or 
callose deposition in Arabidopsis. (a) Leaf disks were taken from wild-type 
Arabidopsis (Col-0; open bars) and transgenic Arabidopsis constitutively 
expressing HopD1-HA (closed bars) and were treated with water or the PAMPs 
flg22, elf18, or chitin. ROS production was measured for 30 min after treatment 
by quantifying luminescence of the luminol derivative L-012. (b) Callose 
deposition was determined in wild-type and HopD1-HA-expressing Arabidopsis in 
response to flg22 treatment. (c) Callose deposition was determined in wild-type 
Arabidopsis (Col-0) syringe-inoculated with Pf(pLN1965) containing either a 
vector control or a plasmid constitutively expressing hopD1-flag. Bacterial 
delivery of HopD1-FLAG had no effect on the production of callose in response 
to Pseudomonas fluorescens (Pf)(pLN1965) treatment. Each experiment was 
repeated at least twice with similar results and ±SE is indicated. 
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response (Fig. 3A). 
If HopD1 targets an intermediate stage in PTI signaling, it may suppress 
later PTI responses without altering ROS production. Therefore, we measured 
the ability of HopD1 to suppress PAMP-induced callose deposition, a late PTI 
response (36), in wild-type and HopD1-HA expressing Arabidopsis plants treated 
with flg22. No difference in flg22-induced callose deposition was observed 
between wild-type Arabidopsis and Arabidopsis expressing HopD1-HA (Fig. 3B). 
To confirm this lack of PTI suppression, we measured the extent that bacterially 
delivered HopD1 could suppress PAMP induced callose deposition in response 
to recognition of Pf PAMPs. To do this, wild-type Arabidopsis was infiltrated with 
Pf(pLN1965) carrying a vector control or a plasmid constitutively expressing 
hopD1-flag. No difference in PAMP-induced callose deposition as a result of the 
bacterial delivery of HopD1 was observed (Fig. 3C). These data suggest that 
while HopD1 is a strong suppressor of ETI, it has no detectable effect on these 
PTI responses. Therefore, it is likely that HopD1 suppresses ETI-specific 
components of plant immunity. 
HopD1 interacts with the membrane-tethered Arabidopsis transcription 
factor NTL9. A high-throughput yeast-two-hybrid screen that defined the P. 
syringae effector interactome with Arabidopsis proteins identified the Arabidopsis 
membrane tethered NAC transcription factor NTL9 as a possible interactor for 
HopD1 (33). Three splice variants have been identified for NTL9 owing to 
differential splicing of its fourth intron. Splice variant 1 is the only one with a C 
terminal transmembrane domain. RT-PCR analyses with primers flanking the 
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fourth intron of NTL9 were used to differentiate between splice variant 1 and 
splice variants 2 and 3 during biotic stress. We performed RT-PCR using these 
primers with RNA isolated from untreated Arabidopsis and Arabidopsis treated 
with Pf(pLN1965 + pavrRpm1) or Pf(pLN1965 + pavrRpm1 + phopD1-flag). In all 
treatments, splice variant 1 was the only form observed, indicating that it is the 
dominant form of this gene in these conditions (Fig. S3). 
As the interaction between NTL9 and HopD1 was identified using a yeast 
two-hybrid screen, we first confirmed this interaction by cloning hopD1 and NTL9 
into yeast two-hybrid system vectors. Yeast strains expressing both hopD1 and 
NTL9 grew on selective media while hopD1 and NTL9 with their respective 
empty vector controls did not, confirming the interaction between HopD1 and 
NTL9 in yeast (Fig. 4A). 
The interaction of two proteins in yeast does not necessarily translate into 
an interaction in planta. To confirm their interaction in planta, BiFC was 
performed. Nicotiana benthamiana was co-agroinfiltrated with NTL9 fused at its 
N-terminus to the N-terminal half of YFP and HopD1 fused at its C-terminus to 
the C-terminal half of YFP. Infiltrated leaves were examined with confocal 
microscopy and yellow fluorescence was observed in cells of the infiltrated 
leaves (Fig. 4B), indicating that these proteins interacted in planta. The reciprocal 
experiment with HopD1 fused at its C-terminus to the N-terminal half of YFP and 
NTL9 fused at its N-terminus to the C-terminal half of YFP also produced yellow 
fluorescence (Fig 4B). No yellow fluorescence was observed in leaves infiltrated 
with BiFC HopD1 or NTL9 constructs and their corresponding nYFP or cYFP 
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Fig. 4. HopD1 interacts with the membrane-tethered Arabidopsis 
transcription factor NTL9. (a) Yeast-two-hybrid analyses of HopD1 and NTL9 
show growth on selective media (Sc:-Leu-Trp-His + 1mM 3AT) when both HopD1 
and NTL9 are present. (b) Bimolecular fluorescence complementation (BiFC) 
analysis of HopD1 and NTL9 interactions in Nicotiana benthamiana cells. 
HopD1-cYFP and nYFP-NTL9 and HopD1-nYFP and cYFP-NTL9 were 
expressed in N. benthamiana using Agrobacterium-mediated transient 
expression. Yellow fluorescence indicates that yellow fluorescent protein (YFP) 
moieties are in close proximity to each other. Red fluorescence represents Chl 
autofluorescence. No YFP fluorescence was seen in coinfiltration experiments of 
hopD1 and NTL9 BiFC constructs with the respective cYFP control. 
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controls (Fig 4B). These data indicate that HopD1 interacts with NTL9 in planta. 
HopD1 and NTL9 localize to the plant endoplasmic reticulum. The reticulate 
pattern in the cytoplasm accompanied by a distinct ring around the nucleus 
observed in the BiFC experiments involving HopD1 and NTL9 is characteristic of 
ER-localized proteins. To investigate whether HopD1 and/or NTL9 localized to 
the plant ER, we performed colocalization experiments with a known ER marker. 
DNA encoding the ER-localized RFP marker CD3-960 (35) was agroinfiltrated 
into N. benthamiana with DNA encoding either HopD1 fused at its C-terminus to 
GFP or NTL9 fused at its N-terminus to GFP, both under the control of a 
constitutive CaMV 35S promoter. Confocal microscopy revealed colocalization of 
HopD1-GFP with ER-RFP (Fig. 5A) and GFP-NTL9 with ER-RFP (Fig. 5B). 
These data indicate that both HopD1 and NTL9 are localized to the ER in N. 
benthamiana. The most likely orientation for NTL9 is with its C-terminal 
transmembrane domain inserted in the ER membrane with a minor portion of 
NTL9 in the ER lumen and the majority of the protein in the cytoplasm. 
Membrane-tethered transcription factors are held in a ready state in the 
membrane and upon activation are cleaved at the cytoplasmic side of the 
transmembrane domain, releasing an active transcription factor that can enter 
the nucleus and regulate transcription (29). The protease that performs this 
cleavage for NTL9 has not been identified. The localization of HopD1 and NTL9 
to the ER and their interaction at this site as indicated in BiFC experiments 
suggests that HopD1 is targeting NTL9 while it is anchored in the ER membrane. 
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Fig. 5. HopD1 and NTL9 localize to the plant endoplasmic reticulum (ER). 
(a) Agrobacterium-mediated transient expression of a C-terminal fusion of HopD1 
to green fluorescent protein (GFP) (green) (HopD1-GFP) and an ER-localized 
mCherry (red) fused at its N-terminus with the signal peptide from AtWAK2 and 
at its C-terminus with the ER retention signal (ER-RFP) in Nicotiana benthamiana 
was visualized using confocal microscopy. (b) Agrobacterium-mediated transient 
expression of NTL9 with an N-terminal GFP fusion (GFP-NTL9) and ER-localized 
mCherry reporter in N. benthamiana and visualized using confocal microscopy. 
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NTL9 is involved in the Arabidopsis immune response to P. syringae. As 
HopD1 is a strong suppressor of ETI, it stands to reason that if it targets NTL9, 
NTL9 is likely a component of plant immunity. An emerging theme for NAC 
transcription factors is their multiple roles in biotic and abiotic stress, as well as 
an ability to coordinate multiple stress responses (38). This has been seen for 
the membrane-tethered NAC transcription factor NTL6 that coordinates the 
response to cold and pathogen attack as it up-regulates pathogenesis-related 
genes (42). A loss-of-function line for NTL9 (SALK-065051, ntl9-1) was isolated 
that is compromised in osmotic stress responses and has enhanced 
susceptibility to avirulent Hyaloperonospora arabidopsidis (53, 33), suggesting 
that NTL9 is involved in the response to both osmotic and pathogen stresses. 
To investigate the role of NTL9 in the response of Arabidopsis to P. 
syringae, wild-type Arabidopsis and the Arabidopsis ntl9-1 mutant were syringe 
inoculated with various P. syringae strains and bacterial growth was measured at 
0 and 3 d postinoculation (Fig. 6A). DC3000 grew to equivalent levels in wild-type 
and ntl9-1 Arabidopsis, as did the hrcC mutant. Interestingly, the reduced growth 
of the hopD1 mutant observed in wild-type Arabidopsis plants was restored to 
DC3000 values in ntl9-1 mutant plants. These data support the hypothesis that 
NTL9 is a target of HopD1. As expected, the DC3000 hopD1 mutant 
complemented with hopD1 showed equivalent growth to DC3000 in both wild 
type and ntl9-1 mutant plants. The avirulent P. syringae strains 
DC3000(pavrRpm1) and DC3000(pavrRpt2) showed enhanced growth in 
Arabidopsis ntl9-1 mutant plants compared with wild-type Arabidopsis, indicating  
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Fig. 6. NTL9 is important for the innate immune response of Arabidopsis to 
Pseudomonas syringae. (a) Wild-type Arabidopsis (Col-0) and the ntl9 
knockout mutant (ntl9-1) were syringe-inoculated with 2 x 105 cells ml-1 of wild-
type P. syringae (DC3000), the hopD1 mutant, hopD1 complemented using the 
Tn7 expression system (hopD1(Tn7-hopD1)), the type III secretion defective 
hrcC mutant, and avirulent P. syringae strains DC3000(pavrRpt2) and 
DC3000(pavrRpm1). Bacterial growth was measured at 0 and 3 d postinoculation. 
(b) Wild-type Arabidopsis (Col-0) and transgenic plants expressing constitutively 
active NTL9 (NTL91-330-HA) under the control of an estradiol-inducible promoter 
were sprayed with 20 µM estradiol and syringe-inoculated 24 h later with 2 x 105 
cells ml-1 of DC3000, hopD1, hopD1(Tn7-hopD1), hrcC, DC3000(pavrRpt2) or 
DC3000(pavrRpm1). Bacterial growth was measured at 0 and 3 d postinoculation. 
(a, b) These experiments were repeated three times with similar results (different 
letters indicate that the values are significantly different; P ≤0.05). Error bars, 
±SE. 
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that NTL9 is involved in ETI. These results are consistent with our earlier results 
(Figs. 1B, 2), indicating that HopD1 targets components of immunity associated 
with ETI. 
A truncated version of NTL9 that consisted of amino acids 1–330 (NTL91–
330) is constitutively active (53). We made transgenic Arabidopsis lines 
expressing NTL91-330-HA under the control of an estradiol-inducible promoter. 
Wild-type and NTL91-330-HA-expressing Arabidopsis were sprayed with estradiol 
to induce transgene expression. Twenty-four hours later the plants were syringe-
inoculated with 2 x 105 cells ml-1 of various P. syringae strains and bacterial 
growth was measured at 0 and 3 d postinoculation (Fig. 6B). Growth of both 
DC3000 and the complemented DC3000 hopD1 mutant were reduced to that of 
the hopD1 mutant in plants expressing activated NTL9. In addition, growth of the 
avirulent P. syringae strains was also reduced in the NTL91-330-HA-expressing 
lines. These data show that active NTL9 up-regulates plant immunity resulting in 
the restriction of P. syringae growth in planta. 
Identification of NTL9-induced genes involved in plant immunity. If HopD1 
functions by inhibiting NTL9’s activity during ETI, it would be likely that HopD1 
suppresses NTL9-dependent gene expression during ETI. NTL9 has been shown 
to regulate several genes involved in abiotic stress (53), yet its regulation of 
genes involved in plant immunity is not well understood. To determine if NTL9 
could regulate the expression of a subset of genes associated with immunity, 
FRK1, PAL1, and NHL10 expression was measured using qRT-PCR in wild-type 
and NTL91-330-HA-inducible Arabidopsis with and without estradiol treatment (Fig. 
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7A). The expression of all three immunity-related genes was induced exclusively 
in the estradiol-treated NTL91-330-HA plants showing that they are up-regulated 
either directly or indirectly by active NTL9. Because of the extensive overlap 
between ETI and PTI (46), we do not know if the expression of these genes 
represents an ETI or a PTI response in this experiment. 
In a previous study, Kim et al. used PCR-mediated random binding site 
selection to identify the sequence TTGCTTANNNNNNAAG as the DNA-binding 
site for NTL9 (26). We used this binding site to search for additional NTL9-
regulated Arabidopsis genes using RSA-tools-dna-pattern search 
(http://rsat.ulb.ac.be/genomescale-dna-pattern_form.cgi; 20). In all, 175 
Arabidopsis genes were identified with the binding site motif in their promoter 
within 1 kb of their predicted translational start site. We selected 20 of these 175 
genes for further analysis based on their possible role in innate immunity. Their 
possible involvement in immunity was established via literature searches or as a 
result of induction of their expression by DC3000 treatment according to the 
microarray database Arabidopsis eFP Browser 
(http://www.bar.utoronto.ca/efp/cgi-bin/efpWeb.cgi; 51). 
Expression of the 20 candidate genes was measured by qRT-PCR in wild-
type Arabidopsis and NTL91-330-HA-inducible plants with and without estradiol 
treatment (Table S1). Owing to the limited number of base pairs in the predicted 
binding site, the false positive rate was high and many of the genes tested did 
not show NTL9-regulated expression (Table S1). Despite this high error rate, four 
of the predicted genes were strongly up-regulated in estradiol-treated NTL91-330- 
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Fig. 7. HopD1 suppresses effector-triggered immunity (ETI) but not 
pathogen-associated molecular pattern (PAMP)-induced NTL9-regulated 
genes. (a) Wild-type (Col-0) and transgenic Arabidopsis expressing a 
constitutively active NTL9 derivative (NTL91-330-HA) under the control of an 
estradiol (EST)-inducible promoter were syringe-infiltrated with EST or a mock 
control. Leaf tissue was sampled 24 h later and gene expression was analyzed 
by quantitative reverse transcription polymerase chain reaction (qRT-PCR). (b) 
Wild-type (Col-0) Arabidopsis plants were syringe-inoculated with a mock control 
or 1 x 107 cells ml-1 of Pseudomonas fluorescens (Pf)(pLN1965 + pavrRpm1) 
with an empty vector control or with a plasmid constitutively expressing HopD1 
FLAG. Inoculated leaves were sampled 4 h later and gene expression was 
measured using qRT-PCR. Expression of the genes was increased in response 
to the ETI-inducer AvrRpm1 only in the absence of HopD1. (c) Wild-type (Col-0) 
and HopD1-HA-expressing Arabidopsis were syringe-infiltrated with 1 µM flg22 or 
a mock control. Infiltrated leaves were sampled 4 h later and gene expression 
was measured using qRT-PCR. Induction of gene expression by flg22 was not 
significantly altered by the presence of HopD1. In all experiments, expression is 
relative to untreated Col-0. (a–c) Different letters indicate the values are 
significantly different using ANOVA (P ≤0.05); error bars, ±SE. 
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HA-inducible lines. These genes were ADF6 (At2g31200), NIP2 (At2g17730), 
HAB1 (At1g72770) (Fig. 7A) and BZIP9 (At5g24800) (Table S1). 
HopD1 suppresses NTL9-regulated gene expression during ETI but not PTI. 
In order to investigate HopD1’s ability to suppress NTL9’s function in ETI, the 
expression of NTL9-regulated genes was measured in wild-type Arabidopsis 
plants infiltrated with a mock control, Pf(pLN1965 + pavrRpm1) or Pf(pLN1965 + 
pavrRpm1 + phopD1-flag). One of the genes tested (BZIP9) was repressed by 
Pf(pLN1965 + pavrRpm1) treatment (Fig. S4). The other six genes showed 
increased expression upon AvrRpm1-induced ETI and little if any increase in 
expression by AvrRpm1 in the presence of HopD1 (Fig. 7B). FRK1 is known 
primarily to be associated with PTI. However, it is induced during AvrRpm1- 
induced ETI (Fig. 7B). These data suggest that HopD1 inhibits ETI-induction of 
NTL9-regulated gene expression and, therefore, it interferes with NTL9 function 
during ETI. 
Because HopD1 specifically blocks ETI and not PTI responses, we 
examined the ability of HopD1 to affect the expression of the six NTL9-regulated 
marker genes during PTI. To accomplish this, wild-type and HopD1-HA-
expressing Arabidopsis were syringe-infiltrated with flg22 or a mock control. Leaf 
tissue was sampled 4 h later and gene expression was measured using qRT-
PCR (Fig. 7C). Three of the six genes, FRK1, PAL1 and NHL10, showed 
induction in response to flg22 treatment. However, the presence of HopD1-HA 
had no effect on the PTI induction of these genes. Thus, taken together, these 
data indicate that NTL9 is specifically involved in the ETI induction of immunity-
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related gene expression and the induction of a subset of these genes during PTI 
is probably controlled by other transcription factors. 
 
Discussion 
In this study we examined the role of the HopD1 T3E in the virulence of the 
bacterial pathogen P. syringae. Baltrus et al. (4) found that HopD1 was a well-
distributed T3E, which was found in all sequenced strains of group I, two thirds of 
the sequenced group III strains, and none of the six sequenced group II strains. 
We found that HopD1 was necessary for the full virulence of P. syringae (Fig. 1A) 
and that it was a strong suppressor of ETI (Fig. 2), but apparently not of PTI. The 
extent to which transgenically expressed HopD1 was capable of PTI suppression 
was evaluated with three commonly used PTI assays: the in planta growth of a P. 
syringae hrcC mutant (Fig. 1B), defective in type III secretion, or a nonpathogenic 
P. fluorescens strain (Fig. 3C); PAMP-induced ROS production (Fig. 3A); and 
PAMP-induced callose deposition (Fig. 3B). However, we did not test the extent 
to which HopD1 allowed better P. syringae growth in plants pretreated with a 
PAMP, which would be an additional assay to evaluate PTI suppression. 
Nevertheless, based on these commonly used PTI assays, it seems likely that 
HopD1 is not an effective PTI suppressor. 
We found that HopD1 interacts with the NAC transcription factor NTL9 and 
both localize to the ER of plants (Figs 4, 5). The growth of the P. syringae hopD1 
mutant and ETI-inducing P. syringae strains was enhanced in an Arabidopsis ntl9 
mutant (Fig. 6A), while expression of constitutively active NTL9 suppressed the 
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growth of both virulent and ETI-inducing P. syringae strains (Fig. 6B). This 
indicates that NTL9 is utilized in the Arabidopsis innate immune response to P. 
syringae. In addition, we observed that HopD1 suppressed ETI-induced but not 
PAMP-induced expression of NTL9-regulated genes (Fig. 7). Collectively, these 
data led us to conclude that HopD1 suppresses ETI and promotes virulence of P. 
syringae in part by blocking the ability of NTL9 to regulate ETI-induced gene 
expression. 
HopD1 was shown previously to suppress the HopA1-induced HR in 
tobacco (22, 18). The ability of HopD1 to suppress ETI in two different systems 
(tobacco and Arabidopsis) and in response to multiple recognized T3Es (HopA1, 
AvrRpm1 and AvrRpt2) indicates that one of its primary targets is a common 
component of ETI. Interestingly, we did not find any evidence that HopD1 
suppressed PTI. The specific effect of HopD1 on ETI suggests that the reduced 
virulence of the hopD1 mutant exhibited in Arabidopsis is probably the result of 
an ‘unmasking’ of recognized P. syringae T3Es owing to the loss of HopD1’s ETI 
suppression activity. Earlier reports provided pioneering genetic evidence 
suggesting that avr genes, encoding recognized T3Es, can reside in virulent P. 
syringae strains and can be ‘unmasked’ when other T3E genes, encoding ETI 
suppressors, are mutated (21, 45). Moreover, Arabidopsis mutants with defective 
R protein complexes allow for enhanced growth of a virulent P. syringae strain 
(54), consistent with ETI playing an immunity role against virulent P. syringae. 
Our research further supports that ETI contributes to immunity against virulent P. 
syringae and that HopD1 disables ETI as a virulence strategy. 
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The coevolution of plants and pathogens is elegantly illustrated in the 
zigzag model of the plant immune system (23). In this coevolutionary model, 
PRRs recognize PAMPs inducing PTI. To retain pathogenicity the pathogen must 
acquire or evolve an effector that can suppress PTI, resulting in effector-triggered 
susceptibility (ETS). Therefore, the earliest T3Es used in P. syringae virulence 
are predicted to be PTI suppressors. In the next phase, the plant evolves an R 
protein to recognize a specific pathogen effector, thereby inducing ETI. This 
would put selection pressure on the pathogen to disable the gene encoding the 
recognized effector or acquire another effector to suppress the ETI evoked from 
this recognition event, allowing the return of ETS. Importantly, the ability for the 
pathogen to regain ETS is probably dependent on its inventory of effectors that 
can suppress ETI and the strength of the ETI response induced by the 
recognized effector. P. syringae T3Es have been investigated mostly for their 
effect on PTI (13). However, there are several examples of P. syringae T3Es that 
suppress both PTI and ETI (1, 16, 14, 49, 50). This is perhaps not surprising 
given the highly overlapped nature of PTI and ETI (47). What is less common are 
examples of P. syringae T3Es that suppress ETI but not PTI. These effectors 
would be predicted to be acquired later in the coevolution of the pathogen–plant 
interaction after establishment of the R protein immune receptor surveillance 
system. HopD1 appears to be one such effector. 
We clearly show by yeast two-hybrid and BiFC assays that HopD1 
interacts with NTL9. GFP fusions of both of these proteins colocalize with an ER 
targeted RFP fusion and BiFC assays show that HopD1 and NTL9 interact at the 
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ER. NTL9 was previously reported to localize to the plasma membrane and 
nucleus of onion cells (53). The large vacuole of onion cells that oppresses the 
ER against the plasma membrane, coupled with the difficulty in distinguishing 
nuclear and perinuclear localization with epifluorescence microscopy, may have 
led to these observed differences in localization. 
NTL9 is one of over 110 NAC domain transcription factors in Arabidopsis 
(37), of which at least 13 have C-terminal transmembrane domains (28). There is 
precedent for pathogens to target NAC transcription factors, arguably the most 
well characterized of which is the capsid protein (CP) of Turnip crinkle virus 
(TCV) that interacts with the Arabidopsis NAC transcription factor TIP (39), 
blocking its ability to localize to the nucleus (40). We tested the extent to which 
HopD1 could affect the subcellular localization of NTL9 using Agrobacterium-
mediated transient assays in N. benthamiana of GFP-NTL9 with or without 
HopD1-HA and were unable to discern any difference in GFP-NTL9 localization 
(Fig. S5). However, based on these results, DC3000 can induce the 
relocalization of NTL9-GFP to the nucleus in N. benthamiana. Additionally, we 
tested whether HopD1 was able to inhibit NTL9 transcription using a yeast one-
hybrid system and were unable to detect a decrease in transcription in the 
presence of HopD1 (Fig. S6). Thus, HopD1 inhibits NTL9-dependent gene 
expression, but we do not yet know the mechanism of its inhibition. 
NAC transcription factors have also been implicated in the plant immune 
response to bacterial pathogens. For example, the plasma membrane-bound 
Arabidopsis NAC transcription factor NTL6 has been implicated in the cold 
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induction of innate immunity as a constitutively active form of NTL6 activates the 
expression of the pathogenesis-related genes PR1, PR2 and PR5 (42). 
Arabidopsis plants constitutively expressing active NTL6 are more resistant to P. 
syringae, and NTL6 RNAi lines are more susceptible to P. syringae after cold 
pretreatment (42). Another NAC transcription factor from Arabidopsis, ATAF1, is 
a negative regulator of immune responses against P. syringae (48). 
Relatively recently a report showed that ntl9 knockout Arabidopsis plants 
are subtly more resistant to P. syringae (27). These data led the authors to 
suggest that NTL9 is a negative regulator of innate immunity. However, we did 
not observe any statistically significant difference in the growth of P. syringae in 
ntl9 knockout plants compared with wild-type plants and often observed a slight 
increase in P. syringae growth (Fig. 6A), even though these experiments were 
repeated many times. Importantly, Arabidopsis plants expressing constitutively 
active NTL9 were more resistant to P. syringae (Fig. 6B), which suggests that 
NTL9 acts as a positive regulator. We cannot account for the differences 
between our P. syringae growth phenotypes and that reported in Kim et al. (27). 
However, their subtle P. syringae growth data and our own data suggest that the 
absence of NTL9 may be compensated for by other transcription factors in plant 
immunity. 
Our study shows that NTL9 induces the classic immune marker genes 
FRK1 (19), PAL1 (31) and NHL10 (55), as well as at least three genes that have 
not been characterized as to their role in innate immunity. These genes are 
HAB1, NIP2 and ADF6. NIP2 has no known role in immunity. Although no direct 
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role for ADF6 has been shown in the immune response to P. syringae infection, 
another actin-depolymerizing factor (ADF4) was shown to be specifically required 
for resistance triggered by the P. syringae effector AvrPphB (44). HAB1 is a 
negative regulator of ABA signaling. It is a 2C protein phosphatase that, in the 
absence of ABA, binds to SnRK2 kinases, inhibiting their activity (43). ABA has a 
negative role in plant immunity (8) and it would not be surprising, therefore, if the 
induction of a negative regulator of ABA signaling, such as HAB1, by NTL9 was 
important for immunity signaling. Other ETI-associated genes are also likely to be 
regulated by NTL9, but their identification will require extensive NTL9-dependent 
expression studies, which will be addressed in the future. Other future studies will 
examine HopD1’s effect on NTL9 and other NAC transcription factors during 
pathogen stress, which will help to elucidate how this T3E inhibits the function of 
NTL9 as well as understanding the role NTL9 plays in plant immunity. 
 
Materials and methods 
Cloning and expression constructs. Genes were cloned into the Gateway 
entry vector pENTR-D. The pENTR-D constructs and their respective cloning 
primers are as follows: hopD1 with a ribosome binding site (pLN3228) primers 
P0967 (5′-CACCGGGACAGCTGATAGAACAATGAATCCTCTACGCTC-3′) and 
P2892 (5′-GGGTGCGGGCTGCCGCGA-3′); hopD1 (pLN5056) primers P4373 
(5′-CACCATGAATCCTCTACGATCTATTCAACAC-3′) and P2892; NTL9 
(pLN5057) primers P4379 (5′-CACCATGGGTGCTGTATCGATGGAGTCG-3′) 
and P4393 (5′-TGAACTCACCAGTGTCCTCCACATCC-3′); and NTL91-330 
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(pLN5058) primers P4379 and P4382 (5′-
GAAAGCCATGAAGTCGTTGAAAGCATCCTCTG-3′). 
For the hopD1 bimolecular fluorescence complementation (BiFC) 
constructs, hopD1 with a 3′ XhoI restriction site was amplified with primers P4373 
and P4384 (5′-GATCCTCGAGGGGTGCGGGCTG CCGCGACGTG-3′); cyfp with 
a 5′ XhoI restriction site was amplified with primers P4342 (5′-
GATCCTCGAGATGGACAAGCAGAAGAACGGCATC-3′ – which contains an 
ATG start codon) and P4343 (5′-TCAGATAGATCTCTTGTACAGCTC-3′); and 
nyfp with a 5′ XhoI restriction site was amplified with primers P4340 (5′-
GATCCTCGAGATGGTGAGCAAGGG CGAGGAG-3′) and P4341 (5′-
TCAGGCCATGATATAGACGTTGTGG). The PCR products were then digested 
with XhoI and ligated. The ligation products were used as templates to clone 
hopD1-cyfp with primers P4373 and P4343 into pENTR-D, resulting in the 
construct pLN5066, and hopD1-nyfp with primers P4373 and P4341 into pENTR-
D, resulting in the construct pLN5067. For the NTL9 BiFC constructs, NTL9 with 
a 5′ XhoI restriction site was amplified with primers P4403 (5′-
GATCCTCGAGATGGTGCTGTATCGATGGAGTCG-3′) and P4393; cyfp with a 3′ 
XhoI restriction site was amplified with primers P4406 (5′-
CACCATGGACAAGCAAGCAGAAGAACGGCATC-3′) and P4407 (5′-
GATCCTCGAGGATAGATCTCTTGTACAGCTC-3′); and nyfp with a 3′ 
XhoI restriction site was amplified with primers P4404 (5′-
CACCATGGTGAGCAAGGCGAGGAG-3′) and P4405 (5′-
GATCCTCGAGGGCCTGATATAGACGTTGTGG-3′). The PCR products were 
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then digested with XhoI and ligated. The ligation products were used as 
templates to clone nyfp-NTL9 with primers P4404 and P4393 into pENTR-D, 
resulting in the construct pLN5068, and cyfp-NTL9 with primers P4406 and 
P4393 into pENTR-D, resulting in the construct pLN5069. 
The BiFC clones pLN5066, pLN5067, pLN5068 and pLN5069 were placed 
into the plant constitutive expression vector pLN462 (22), resulting in constructs 
pLN5070, pLN5071, pLN5072 and pLN5073, respectively. For plant expression, 
hopD1 (pLN5056) was fused to a C-terminal hemagglutinin (HA) tag by 
recombining into pLN462 with gateway technologies to give pLN5060 and to a C-
terminal green fluorescent protein (GFP) tag by recombining into pK7FWG2 (24) 
to give pLN5061. For complementation of the hopD1 mutant (UNL104), hopD1 
(pLN3228) was recombined into the Tn7 vector pLN2992 (9), resulting in 
construct pLN4908. This vector was then used to insert the resultant hopD1-ha 
into the chromosome of UNL104. To create an N-terminal GFP fusion to NTL9, 
pLN5057 was recombined with pK7WGF2 (24) to give pLN5062. To make an 
estradiol-inducible NTL91-330-HA, pLN5058 was recombined with the gateway-
compatible pER8 vector pLN604 (56) to give pLN5063.  
Pathogenicity assays. Pseudomonas syringae strains were grown overnight at 
30°C on King’s B (KB; 30) media with the appropriate antibiotics and 
resuspended to an OD600 of 0.2 (2 x 108 cells ml-1) in 10 mM MgCl2. Cells were 
serially diluted in 10 mM MgCl2 to the appropriate cell density and infiltrated into 
the fully expanded leaves of 4-wk-old Arabidopsis thaliana Col-0 wild-type, 
mutant, and/or transgenic plants using a needleless syringe. Plants were kept at 
	  	   88	  
100% humidity and 1 cm2 leaf disks were sampled at the indicated times, ground 
in 10 mM MgCl2, serially diluted and plated on KB agar plates. Plates were 
incubated for 48 h at 30°C and number of cells cm-2 was determined. Four to six 
leaf disks were sampled for each treatment and the statistical significance of the 
resulting data was analyzed by one-way ANOVA. 
HR and ion leakage. Pseudomonas fluorescens (Pf)(pLN1965), Pf(pLN1965 + 
pavrRpm1) and Pf(pLN1965 + pavrRpm1 + phopD1-flag; 18) were grown 
overnight at 30°C in KB media with appropriate antibiotics. Bacterial strains were 
resuspended at 1 x 108 cells ml-1 in 5 mM 2-(4-morpholino)-ethane sulfonic acid 
(MES), pH 5.6. Wild-type Arabidopsis (Col-0) and rpm1 mutant (12) leaves were 
infiltrated with bacterial suspensions using a needleless syringe. Nine leaf disks 
were harvested for each strain in each plant type using a 0.7 cm2 cork borer. 
Three leaf disks were placed in each 15 ml polypropylene tube with 5 ml of water 
and incubated in a shaker for 30 min at room temperature. Water was removed 
and 5 ml of fresh water was added to each sample and tubes were placed in a 
shaker. Electrolyte leakage was monitored at the indicated time points using an 
electrical conductivity meter (Fisher Scientific, Pittsburgh, PA, USA). Conductivity 
was measured in µS cm-1. For macroscopic HR, Pf(pLN1965 + pavrRpm1) and 
Pf(pLN1965 + pavrRpm1 + phopD1-flag) strains were infiltrated into leaves of 
wild-type Arabidopsis (Col-0) and the rpm1 mutant at 1 x 108 cells ml-1 using a 
needleless syringe. Leaves were photographed 2 d after infiltration. 
Callose assay. Wild-type (Col-0) and HopD1-HA transgenic lines were syringe-
infiltrated with 10 µM flg22, or wild-type Arabidopsis leaves were syringe 
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inoculated with 1 x 106 cells ml-1 of Pf(pLN1965), Pf(pLN1965 + phopD1-flag), 
Pf(pLN1965 + pavrRpm1) or Pf(pLN1965 + pavrRpm1 + phopD1-flag). Sixteen 
hours later, leaves were harvested and cleared with 100% (v/v) ethanol at 37°C 
for 4 h and washed twice with 70% (v/v) ethanol and three times with water. The 
completely cleared leaves were stained with 0.1% (w/v) aniline blue in a solution 
of 150 mM K2HPO4, pH 9.5, for 30 min and the callose deposits were 
enumerated as in Block et al. (6). 
Oxidative burst measurement. Leaf disks of 0.5 cm2 were cut from wild-type 
(Col-0) and HopD1-HA transgenic lines and floated on 0.1 ml of water in wells of 
a 96-well plate for 16 h in the dark. The water was then removed and replaced 
with 0.5 mM L-012 (Wako, Japan) in 10 mM MES buffer, pH 7.4. For PAMP 
treatment, 1 µM of flg22, elf18 or chitin was added to the buffer. The rate of ROS 
production was determined by counting photons from L-012-mediated 
chemiluminescence using a luminometer (3). The rates of ROS production were 
calculated as the number of photons released in 30 min after treatment with 
photons counted once a minute. 
Yeast-two hybrid analyses. Gateway entry constructs carrying hopD1 
(pLN5056) and NTL9 (pLN5057) were recombined by an LR reaction to the 
appropriate yeast two-hybrid destination vectors to generate pDEST-DB::hopD1 
(pLN4988) and pDEST-AD::NTL9 (pLN4970). A detailed protocol for yeast two-
hybrid analyses used is described in Dreze et al. (11). The yeast strains Y8930 
(MATα) and Y8800 (MATa) were transformed with expression plasmids pDEST-
DB::hopD1 and pDEST-AD::NTL9, respectively. Empty expression vectors (EVs) 
	  	   90	  
were also transformed into the corresponding yeast strains. Yeast Y8930 
(pDEST-DB::hopD1 or EV) was mated to Y8800 (pDEST-AD::NTL9 or EV) in a 
mating plate (yeast extract peptone dextrose). Growth was checked on Sc-Leu-
Trp and interactions were tested by plating mated strains in Sc-Leu-Trp-His + 1 
mM 3-amino-1,2,4-triazole (3AT). 
Agroinfiltration and confocal microscopy. Agrobacterium strains were 
coinfiltrated into N. benthamiana as in Block et al. (6). Leaves were imaged 48 h 
later using a Nikon A1 confocal mounted on an Eclipse 90i Nikon compound 
microscope using the following excitation (ex) and emission (em) wavelengths: 
GFP and yellow fluorescent protein (YFP), 488 nm (ex), 500–550 nm (em); red 
fluorescent protein (RFP), 561.5 nm (ex) and 570–620 nm (em); Chl, 641 nm (ex) 
and 662–737 nm (em). Dual color image acquisition was sequential. 
Semiquantitative reverse transcription polymerase chain reaction (RT-PCR). 
Wild-type Arabidopsis (Col-0) and pER8 NTL91-330-HA stable Arabidopsis lines 
were syringe-infiltrated with 0.2 mM estradiol or a water control. Leaf tissue was 
harvested for RNA extraction 24 h after treatment. Wild-type Arabidopsis (Col-0) 
plants were syringe-inoculated with water or 1 x 107 cells ml-1 of Pf(pLN1965 + 
pavrRpm1) or Pf(pLN1965 + pavrRpm1 + phopD1-flag). Leaf tissue was 
harvested for RNA extraction 4 h after infiltration. Total RNA was purified using 
RNeasy mini Kit with on-column DNase treatment (Qiagen). The reverse 
transcription of RNA was carried out using RETROscript (Ambion) using 
oligo(dT) primers with heat denaturation of the RNA. actin2 
(At3g18780) was used as a reference gene with primers P3774 (5′-
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GCACTTGTGTGTGACAAACTCTCTGG-3′) and P3775 (5′-
GGCATCAATTCGATCACTCTAGAGC-3′). The following gene-specific primers 
were used to measure expression levels in quantitative (qRT-PCR): HAB1 
(At1g72770) P4556 (5′-GCGGTGATTCGAGGGCGGTTT-3′) and P4557 (5′-
GCCACGTTTGTGTGATGTGCATT-3′); NIP2 (At2g17730) P4558 (5′-
TCTTCAGGATTTCCAGCTCGGTGAA-3′) and P4559 (5′-
CGGGCAAGAACCGTGTCTAAGGA-3′); ADF6 (At2g31200) P4560 (5′-
TTGCTTGGTCTCCTTCGACCTCTGG-3′) and P4561 (5′-
TCTCAGTTCGCTCGTTCGCGT-3′); PAL1 (At2g37040) P3922 (5′-
AGCAGCAAGAGCAGCCTACGATAA-3′) and P3923 (5′-
TGTTCCAAGCTCTTCCCTCACGAA-3′); FRK1 (At2g19190) P4476 (5′-
ACCCCGAGTACTATTCGACTCGCCA-3′) and P4477 (5′-
TGAGCTTGCAATAGCAGGTTGGCCT-3′); and NHL10 (At2g35980) P4562 (5′-
TCACTGTTCCTGTCCGTAACCCAA-3′) and P4563 (5′-
TGGTACTAAACCGCTTTCCTCGT-3′). qRT-PCR was run using IQTM SYBR® 
Green supermix (BioRad) on a BioRad iCycler. Gene expression relative to Col-0 
was calculated using 2-ΔΔCT with actin2 as the reference gene and mock-treated 
Col-0 as the reference sample. 
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Supplemental figures and tables 
Supplemental Table 1. Analysis of gene expression changes in Arabidopsis 
genes that contain a predicted NTL9 binding site in their promoters.  
Gene 
name 
Abbreviation Predicted NTL9 binding 
site 
 
Estradiol induced 
expression in NTL91-
330-HA lines 
At1g29330 ERD2 TTGCTTATAAAAGAAG 0.47 ± 0.04 
At1g29340 PUB17 TTGCTTATAAAAGAAG 0.69 ± 0.13 
At1g72770 HAB1 TTGCTTAAGAACAAAG 22.97 ± 5.57 
At2g17730 NIP2 TTGCTTAGTGGTTAAG 15.92 ± 3.02 
At2g22670 IAA8 TTGCTTAACAAGTAAG 1.42 ± 0.10 
At2g29580 MAC5A TTGCTTAGATCTGAAG 1.01 ± 0.02 
At2g31200 ADF6 TTGCTTAGTAATTAAG 54.60 ± 12.02 
At3g02040 SRG3 TTGCTTAAAAAAGAAG 0.95 ± 0.18 
At3g04580 EIN4 TTGCTTAAGCGAAAAG 1.45 ± 0.68 
At3g17880 TDX TTGCTTAGACAAGAAG 0.96 ± 0.14 
At4g20200 F1C12.120 TTGCTTAGTTAAGAAG 0.85 ± 0.59 
At4g23510 F16G20.210 TTGCTTAAGAAACAAG 0.37 ± 0.04 
At4g25470 CBF2 TTGCTTAAAATCGAAG 0.41± 0.08 
At4g30650 F17I23.10 TTGCTTAGATGGCAAG 1.03 ± 0.84 
At5g24800 BZIP9 TTGCTTAGCCATTAAG 98.13 ± 10.79 
At5g25050 T11H3.60 TTGCTTACATCAAAAG 1.24 ± 0.18 
At5g41740 MUF8.2 TTGCTTATTTTTCAAG 1.57 ± 0.15 
At5g50120 MPF21.14 TTGCTTATGAAGGAAG 1.58 ± 0.03 
At5g66640 DAR3 TTGCTTATATTACAAG 0.99 ± 0.25 
At5g67220 K21H1.18 TTGCTTAGAAATAAAG 1.13 ± 0.11 
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Supplemental Fig. 1. Immunoblots showing that transgenic Arabidopsis 
express HopD1-HA or NTL91-330-HA. (A) Expression of HopD1-HA in 
Arabidopsis was analyzed using immunoblots with anti-HA antibodies. Plants 
from line 2 were used in Fig. 3B, line 11 in Fig. 3A, and line 4 in Figs 1B and 7C. 
(B) Arabidopsis plants expressing the constitutively active NTL9 derivative 
NTL91-330-HA were confirmed using immunoblots with anti-HA antibodies. These 
plants were used in Fig. 6B and Fig. 7A. 
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Supplemental Fig. 2. No HR or ion leakage observed in the Arabidopsis 
rpm1 mutant in response to bacterial strains. Arabidopsis rpm1 mutant plants 
were syringe-inoculated with 1 x 108 cells ml-1 of Pseudomonas 
fluorescens(Pf)(pLN1965 + pavrRpm1) carrying a vector control or a plasmid 
constitutively expressing hopD1-flag. HR was scored 48 h after infiltration (A) 
and ion leakage was measured in leaf disks over time as an indicator of cell 
death (B). No difference was observed in HR or ion leakage between 
Pf(pLN1965 + pavrRpm1) and Pf(pLN1965 +pavrRpm1 + phopD1-flag).  
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Supplemental Fig. 3. The first splice variant of NTL9 is the dominant form in 
Arabidopsis. RT-PCR on Arabidopsis (Col-0) plants treated with water or 
syringe-inoculated with 1 x 107 cells ml-1 of Pf(pLN1965 + pavrRpm1) or 
Pf(pLN1965 + pavrRpm1 + phopD1-flag). RNA was made from tissue harvested 
4 h post-infiltration. Primers 5’-ATCCGGGCTCGACAGCCTCA-3’ and 5’-
TAGACTCACCAGTGTCCTCCATATAC CCATCC-3’ flanking the differentially 
spliced intron were used to distinguish between splice variants 1 and 2 of NTL9 
and compared to plasmid controls (pNTL9.1 and pNTL9.2). Splice variant NTL9.1 
was the predominant form of NTL9 expressed under the conditions tested. 
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Supplemental Fig. 4. NTL9 regulated BZIP9 expression is repressed by ETI. 
Wild-type  Arabidopsis (Col-0) plants were infiltrated with a mock control or 1 x 
107 cells ml-1 of Pf(pLN1965 + pavrRpm1) with an empty vector control or with a 
plasmid constitutively expressing hopD1-flag. Infiltrated leaves were sampled 
after 4 h and gene expression of BZIP9 was measured using semi-qRT-PCR with 
primers 5’-TGCACAGTCCTCAATCTGCGAGAA-3’ and 5’-
TGCCCTGCTTCTGTCTCGGC-3’. Gene expression is relative to untreated Col-0. 
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Supplemental Fig. 5. GFP-NTL9 inside plant cells is not altered by the 
presence of HopD1-HA. Nicotiana benthamiana leaves were co-infiltrated with 
Agrobacterium strains carrying GFP-NTL9 and HopD1-HA or empty vector 
control in the presence of the proteasome inhibitor MG132 (100 µM). After 24 h 
leaves were infiltrated with DC3000 (1 x 106 cells ml-1) and visualized with 
confocal microscopy. 
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Supplemental Fig. 6. HopD1 does not alter NTL9-dependent gene 
expression in the yeast one-hybrid system. Yeast strain Y187 (pGBKT7 
containing NTL9 or an empty vector (EV)) mated with yeast strain AH109 (pGilda 
containing hopD1 or an EV) were tested for the ability of HopD1 to block NTL9 
autoactivation. Mated yeast strains were plated on Sc-Trp-His galactose plates 
and photographed after 2 d. 
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CHAPTER 3 
Structure function analysis of the Pseudomonas syringae 
type III effector HopA1 shows similarity to phosphothreonine 
lyases from animal pathogens 
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ABSTRACT 
Pseudomonas syringae is a plant bacterial pathogen that injects type III effector 
proteins into plant cells for pathogenicity. One such effector is HopA1, which 
exists in two distinct classes and these classes are recognized differently by 
plants. HopA1 found in P. syringae pathovar syringae 61 (HopA161) but not 
HopA1 found in P. syringae pathovar tomato DC3000 (HopA1DC) elicits a 
hypersensitive response in both Nicotiana tabacum (tobacco) and Arabidopsis. 
Moreover, expression of HopA161 but not HopA1DC in the virulent P. syringae pv. 
tabaci 11528 converts it to an avirulent strain, indicating that only HopA161 acts 
as an inducer of effector-triggered immunity in tobacco. Expression of HopA1 in 
yeast revealed that only HopA161 inhibits yeast growth, suggesting that these 
HopA1 classes have different virulence activities and/or targets. A DC3000 
hopA1 deletion mutant was only reduced subtly in virulence. In addition, in planta 
expression of HopA1DC allowed increased growth of P. syringae strains and 
inhibition of PAMP-triggered immunity responses. HopA1 shares sequence 
similarity with the Photorhabdus luminescens insecticidal toxin Mcf2. We 
determined the structure of HopA161 and HopA1DC proteins and both resemble 
phosphothreonine lyases from animal pathogens. Five conserved residues 
between HopA1 and Mcf2, which also correspond to solvent exposed residues in 
the predicted active site, were mutated to alanine. All of these residues were 
required for the majority of HopA1-dependent phenotypes consistent with HopA1 
being an enzyme structurally related to phosphothreonine lyases. 
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Introduction 
Pseudomonas syringae is a Gram-negative bacterial pathogen that causes 
diseases in a wide range of plants. P. syringae is classified into 50 pathovars 
based on host plant specificity (18). P. syringae pv. tomato (Pto) DC3000 causes 
bacterial speck on tomato and is also pathogenic on the plant model organism 
Arabidopsis thaliana. Pto DC3000 relies on the injection of about 35 type III 
effector proteins inside plant cells through a type III protein secretion system as a 
virulence strategy to suppress host immunity (15, 37). The type III secretion 
system is a nanosyringe used by Gram-negative bacterial pathogens of plants 
and animals to inject or translocate effectors into host cells for pathogenicity (46). 
In plants, immunity can be initiated in two ways. One layer of immunity is induced 
by recognition of pathogen-associated molecular patterns (PAMPs), highly 
conserved molecules found commonly in nonpathogenic and pathogenic 
microbes. These include bacterial flagellin, elongation factor EF-Tu, and fungal 
chitin. PAMPs are recognized by plant pattern-recognition receptors (PRRs) at 
the cell surface, leading to PAMP-triggered immunity (PTI) (9, 50). A second 
layer of immunity is induced by recognition of injected type III effectors, which are 
indirectly recognized by intracellular immune receptors known as resistance (R) 
proteins. This immunity pathway is known as effector-triggered immunity (ETI) (1). 
PTI and ETI induce similar immune responses, including oxidative burst, 
transcriptional reprogramming, mitogen-activated protein kinases (MAPKs) 
signaling cascades, and callose fortification. However, ETI actives these immune 
responses in a more robust and prolonged fashion than PTI and usually includes 
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the hypersensitive response (HR), a programmed cell death at the site of 
infection to prevent spread of the pathogen (1, 30).  
 The type III effector inventory is one of the central factors that dictate P. 
syringae host specificity. Homologs of type III effectors that are distributed across 
several P. syringae pathovars represent common effector families (47). One such 
effector is HopA1 (previously named HrmA or HopPsyA). HopA1 was the first P. 
syringae effector known to be active inside plant cells eliciting an HR and was 
first isolated from P. syringae pv. syringae 61 from cosmid pHIR11, which 
allowed Escherichia coli and other nonpathogenic bacteria to elicit an HR in 
plants (2, 26, 27). HopA1 is present in several P. syringae pathovars including 
tomato, lachrymans and actinidiae (2, 26, 40). HopA1 from P. syringae pv. 
syringae 61 (HopA161) causes an HR in Nicotiana species and in A. thaliana 
ecotype Ws-0, but not in Col-0 (2, 22). Interestingly, expression of HopA161 in Pto 
DC3000 triggers resistance in A. thaliana ecotypes Col-0 and Ws-0 and this 
resistance is dependent on enhanced disease susceptibility 1 (EDS1) (22). EDS1 
is a resistance regulator required for immunity mediated by Toll/Interleukin-1 
receptor (TIR) nucleotide-binding site (NBS) leucine-rich repeat (LRR) R proteins 
(21). The TIR-NBS-LRR R protein RPS6 in Arabidopsis recognizes HopA161 (32) 
whereas the R protein that recognizes HopA161 in Nicotiana spp. has not been 
identified.  
 The function of the majority of type III effectors to disrupt host processes 
and promote virulence remains to be elucidated. However, enzymatic activities of 
a subset of P. syringae type III effectors have been determined; these activities 
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include mono-ADP-ribosyltransferases, cysteine proteases, E3 ligases, protein 
tyrosine phosphatases and phosphothreonine lyases (7, 17, 20). The enzymatic 
activity of HopA1 is not known. Nevertheless it shares sequence similarity with 
the N-terminal region of the bacterial toxin makes caterpillars floppy 2 (Mcf2) first 
described in Photorhabdus luminescens (53), but also found in other 
Photorhabdus, Vibrio and Providencia species. Besides the domain with 
homology to HopA1, Mcf2 shares similarities with two other toxins: toxin B (CdtB) 
from Clostridium difficile and RTX-repeat containing cytotoxin from Vibrio 
vulnificus (53).  
 Here we show that HopA1DC contributes weakly to P. syringae virulence. 
Unlike HopA161, HopA1DC does not induce ETI in Arabidopsis and tobacco but 
suppresses PAMP-induced oxidative burst and cell wall fortification. We identified 
that an N-terminal portion of HopA161 is recognized in Arabidopsis while a C-
terminal portion is recognized in tobacco. We report the structure of HopA1DC 
covering residues 122-380. The structure of HopA1 resembles phosphothreonine 
lyases from animal pathogens and site-directed mutations in the putative active 
site residues abrogate HopA1-dependent phenotypes. 
Initial characterization of the T3E HopA1 was done by Dr. Ming Guo, a 
research assistant professor in Dr. James R. Alfano’s research group at the 
Center for Plant Science Innovation and the Department of Plant Pathology, 
University of Nebraska, Lincoln, NE. 
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Results 
 
HopA161, but not HopA1DC, acts as an avirulence protein in tobacco and 
Arabidopsis. Because HopA161 is recognized by tobacco and Arabidopsis 
inducing ETI (.i.e., an avirulence protein), we wanted to determine the extent that 
HopA1DC could induce ETI. Plasmid constructs containing hopA161 or hopA1DC 
were transformed into a nonpathogenic P. fluorescence (Pf) strain carrying 
cosmid pLN1965, which encodes a functional P. syringae type III secretion 
system (24). Tobacco and A. thaliana ecotype Ws-0 were syringe-infiltrated with 
Pf(pLN1965+hopA161) or Pf(pLN1965+hopA1DC) and monitored for the 
development of an HR. As expected Pf(pLN1965+hopA161) elicited an HR in 
tobacco or A. thaliana Ws-0 within twenty-four hours (Fig. 1A). However, 
Pf(pLN1965+hopA1DC) was unable to elicit an HR in tobacco or A. thaliana Ws-0 
(Fig. 1A), suggesting that HopA1DC does not act as an avirulence protein in these 
plants. Whether a type III effector is an Avr protein can also be evaluated by 
transient expression in planta using agroinfiltrations. In contrast to Pf(pLN1965)-
delivered HopA161 or HopA1DC, we found that Agrobacterium-mediated transient 
expression of both HopA1s induced the HR in tobacco (Fig. S1). Because the 
Pf(pLN1965) delivery system resembles how type III effectors are injected into 
plant cells in nature, the HR elicited using agroinfiltrations of HopA1DC may be 
artefactual, possibly due to high expression levels.  
 To further evaluate the extent that HopA1DC could act as an Avr protein we 
heterologously expressed it in P. syringae pv. tabaci (Pta) 11528. This strain is 
virulent in tobacco and when it heterologously expresses HopA161 it converts this  
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Fig. 1. HopA1 classes have different host recognition and localization, and 
effector activity in yeast (A) Pseudomonas fluorescens Pf(pLN1965) strain 
expressing a functional P. syringae type III secretion system and carrying 
hopA161 or hopA1DC was syringe-infiltrated into leaves of Nicotiana tabacum 
cultivar Xanthi (tobacco) and Arabidopsis thaliana ecotype Ws-0 at cell density of 
1 x 109 cells mL-1. Leaves were evaluated for the development of a 
hypersensitive response (HR) and were photographed 48 h after infiltration. Only 
HopA161 elicited an HR in tobacco and A. thaliana Ws-0. (B) Tobacco leaves 
were syringe-inoculated with 1 X 105 cells mL-1 of P. syringae pathovar tabaci 
(Pta) 11528 carrying a vector control, hopA161 or hopA1DC. Bacterial growth was 
measured at 0 and 6 d postinoculation. Different letters indicate that values are 
significantly different (p ≤ 0.05); SE bars are shown. Pta 11528 expressing 
HopA161 had reduced bacterial growth compared to Pta 11528 (vector or 
HopA1DC). (C) Disease symptoms in tobacco infiltrated with Pta 11528 strains as 
described in B. Leaves were photographed 6 d postinoculation. Only HopA161 
converted Pta 11528 to an avirulent strain in tobacco. (D) Saccharomyces 
cerevisiae strain BY4743 harboring the vector pGilda containing hopA161 or 
hopA1DC was grown overnight at 30°C in selective media. The cultures were 
plated on selective media containing glucose or galactose. Photographs were 
taken 2 d later. Only HopA161 inhibited yeast growth. (E) HopA161-GFP and 
HopA1DC-GFP were transiently expressed in N. benthamiana by Agrobacterium-
mediated transformation. GFP was visualized using a confocal microscope 2 d 
postinfiltration. HopA161-GFP and HopA1DC-GFP localize to the plasma 
membrane, cytoplasm, nucleus and nucleolus of plant cells. Insets display a 
zoom-in area of a nucleus. Chloroplasts aggregate around the nucleus only in 
HopA161-GFP micrographs. Experiment was repeated three times with similar 
results. 
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strain to an avirulent strain (2). Pta 11528 was transformed with a construct 
carrying hopA161 or hopA1DC. These strains were infiltrated into tobacco, and 
bacterial growth was evaluated. The growth of Pta 11528 expressing HopA161 
was restricted (Fig. 1B). However, Pta 11528 expressing HopA1DC grew to 
similar levels as the wild type control (Fig. 1B) and produced disease symptoms 
on tobacco similar to the wild type control (Fig. 1C). These results are consistent 
with HopA161, but not HopA1DC, acting as an Avr protein in tobacco.  
HopA161, but not HopA1DC inhibits yeast growth. We discovered that yeast 
expressing HopA161 grew poorly in yeast two-hybrid experiments. To investigate 
if HopA1DC behaved similarly, we expressed both in Saccharomyces cerevisiae. 
We transformed strain BY4743 with constructs containing hopA161 or hopA1DC. 
Induction of hopA161 and hopA1DC expression in galactose media showed that 
HopA161 inhibited yeast growth, but HopA1DC did not cause this phenotype (Fig. 
1D). To determine if the phenotype caused by expression of HopA161 was due to 
growth inhibition or cell death, we used a LIVE/DEAD yeast viability assay. When 
hopA161 or hopA1DC were induced in yeast, they had similar number of dead cells 
(Fig. S2). However, induction of hopA161 resulted in fewer number of cells 
compared to hopA1DC, indicating that HopA161 inhibits yeast growth.  
HopA1 localizes to the plasma membrane, cytoplasm, and nucleus. To test 
if both HopA1 proteins localized to the same sub-cellular compartment in plants, 
we delivered hopA161 or hopA1DC fused at their 3’ ends to DNA encoding the 
green fluorescence protein (GFP) into N. benthamiana leaves. Both HopA161-
GFP and HopA1DC-GFP localized to the plasma membrane, cytoplasm, and the 
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nucleus and nucleolus of plant cells (Fig. 1E). We noticed two differences in the 
micrographs of HopA161-GFP compared to HopA1DC-GFP. In the HopA161-GFP 
micrographs there were punctate fluorescent spots mostly along the plasma 
membrane. Also, several nuclei in the HopA161-GFP expressing cells had 
chloroplasts surrounding each nucleus. Similar nuclei were observed in plant 
cells in the mid to late stages of programmed cell death (57).Thus, it is likely that 
HopA161-GFP is inducing programmed cell death in these cells, which is 
consistent with it acting as an Avr protein in tobacco, N. benthamiana, and 
Arabidopsis. 
An N-terminal portion of HopA161 is recognized in Arabidopsis while a C-
terminal portion is recognized in tobacco. We wanted to determine which 
regions within HopA161 were required for HR induction. Four constructs were 
made that contains different hopA1 derivatives that corresponded to different N-
terminal truncations and transformed into Pf(pLN1965). These strains were 
infiltrated into tobacco leaves. All of them, with the exception of the full-length 
HopA161, failed to elicit an HR (Fig. 2A). Interestingly, the first 122 amino acids 
were sufficient for the elicitation of an HR in A. thaliana Ws-0 (Fig. 2A). This 
suggests that distinct R proteins recognize HopA161 in tobacco and Arabidopsis. 
The ability of an effector protein to induce ETI results in reduced growth of the 
bacterial strain from which it is expressed. To confirm that the first 122 amino 
acids were sufficient for the recognition of HopA161 in Arabidopsis, we 
transformed Pto DC3000 with a plasmid expressing full-length HopA161 
(HopA161(1-375)) or N-terminal truncations and determined the extent that these  
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Fig. 2. Different portions of HopA161 are recognized in Arabidopsis and 
tobacco. (A) Pf(pLN1965) strains carrying full-length hopA161 or N-terminal 
truncations were syringe-infiltrated into leaves of tobacco and A. thaliana Ws-0 at 
cell density of 1 x 109 and 5 x 108 cells mL-1, respectively. Leaves were monitored 
for the development of an HR 2 d postinoculation. None of the N-terminal 
truncations elicited an HR in tobacco whereas the first 122 amino acids were 
sufficient for the elicitation of an HR in A. thaliana Ws-0. (B) P. syringae pv. 
tomato DC3000 (Pto) strains expressing full-length HopA161 or N-terminal 
truncations were syringe-infiltrated into leaves of A. thaliana Ws-0 at 2 x 105 cells 
mL-1. Bacterial growth was measured at 0 and 3 d after inoculation. Full-length 
HopA161 and N-terminal truncations that elicited an HR in A. thaliana Ws-0 
restricted in planta Pto DC3000 growth. (C) Tobacco leaves were syringe-
inoculated with 1 X 105 cells mL-1 of Pta 11528 strains expressing full-length 
HopA161 or N-terminal truncations. Bacterial growth was measured at 0 and 6 
postinoculation. Only Pta 11528 expressing full-length HopA161 had reduced 
growth in tobacco. (D) Tobacco leaves were syringe-infiltrated with 8 x 108 cells 
mL-1 of Agrobacterium C58C1 strains carrying full-length hopA161 or truncations. 
Pictures of infiltrated leaves were taken 2 d postinoculation. Only full length 
HopA161 and C-terminal truncations (HopA161(98-375), HopA161(123-375), and 
HopA161(189-375)) elicited an HR in tobacco. Experiments repeated twice with 
similar results. Different letters in B and C indicate statistical differences (p ≤ 
0.05) and SE bars are shown. 
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strains could grow in A. thaliana Ws-0 leaves. As expected, DC3000 expressing 
full-length HopA161 had reduced growth compared to the DC3000 vector control 
(Fig. 2B). DC3000 expressing a HopA161 truncation corresponding to the N-
terminal 85 amino acids (HopA161(1-85)) had similar growth to the wild type control 
indicating that this portion does not induce ETI. However, DC3000 strains 
expressing larger HopA161 truncations that elicited an HR in A. thaliana Ws-0 had 
similar growth to DC3000 expressing the full-length HopA161.  
Consistent with these results, in planta transgenic expression of full-length 
HopA161 or the N-terminal truncation corresponding to the N-terminal 122 amino 
acids (HopA161(1-122)) induced an HR-like cell death in Arabidopsis but not in the 
rps6-1 mutant (Fig. S3). This confirms that full-length HopA161 and HopA161(1-122) 
are recognized in Arabidopsis in an RPS6-dependent manner. To confirm that N-
terminal truncations of HopA161 are not recognized in tobacco, Pta 11528 
carrying the full-length hopA161 or one of the truncations were infiltrated into 
tobacco leaves and in planta bacterial growth was determined. Consistent with 
our earlier results, none of the N-terminal HopA161 truncations restricted Pta 
11528 growth or altered disease symptom production (Fig. 2C and Fig. S4). 
Altogether, these data indicate that the N-terminal 122 amino acids of HopA161 
are sufficient to induce ETI in Arabidopsis but not in tobacco. 
Since N-terminal truncations of HopA161 are not recognized in tobacco, we 
made additional HopA161 truncation constructs in an Agrobacterium binary vector 
that corresponded to different regions of HopA161. These constructs were 
transformed into Agrobacterium C58C1 and HopA1 truncations were transiently 
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expressed in tobacco. We found that three HopA161 C-terminal truncations 
(HopA161(98-375), HopA161(123-375) and HopA161(189-375)) elicited an HR in tobacco 
(Fig. 2D), indicating that a C-terminal portion of HopA161 contained with 
HopA161(189-375) was sufficient to elicit an HR in tobacco. To further confirm these 
results, transgenic A. thaliana Ws-0 plants expressing full-length HopA161, 
HopA161(1-122), and two C-terminal truncations (HopA161(98-375) and HopA161(123-
375)) that were recognized in tobacco were made. Dexamethasone (DEX)-
inducible expression of these HopA161 derivatives resulted in lethality only when 
full-length HopA161 and the N-terminal truncation HopA161(1-122) were induced, but 
not with the C-terminal truncations HopA161(98-375) and HopA161(123-375) (Fig. S5). 
Collectively these data indicate that N-terminal 122 amino acids of HopA161 is 
sufficient to induce ETI in Arabidopsis whereas the C-terminal truncation 
HopA161(189-375) was sufficient to induce ETI in tobacco. 
HopA1 contributes subtly to P. syringae virulence. To determine the 
contribution that HopA1 makes to virulence, a Pto DC3000 hopA1 mutant was 
made. We measured bacterial growth of Pto DC3000 and the hopA1 mutant in A. 
thaliana Col-0. The hopA1 mutant was slightly reduced in growth in planta 
compared to wild type Pto DC3000 (Fig. 3A). Introduction of wild type hopA1 into 
the DC3000 hopA1 mutant complemented the reduced growth phenotype. To 
determine if stably expressed HopA1DC allowed wild type Pto DC3000 or the type 
III defective DC3000 hrcC mutant to grow better we made transgenic plants 
expressing HopA1DC (HopA1DC-HA) after induction with DEX. Wild type DC3000 
and the DC3000 hrcC mutant both grew slightly better in transgenic plants  
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Fig. 3. HopA1 contributes subtly to P. syringae virulence and suppresses 
PTI. (A) A. thaliana Col-0 plants were syringae-inoculated with 2 X 105 cells mL-1 
of Pto DC3000, the hopA1 mutant, complemented hopA1 mutant [hopA1 (Tn7-
hopA1)], or the type III secretion defective hrcC mutant. Bacterial growth was 
measured at 0 and 4 d postinoculation. The growth of the hopA1 mutant was 
slightly reduced compared to wild type Pto DC3000. (B) Wild type Col-0 and 
dexamethasone (DEX)-inducible transgenic plants expressing HopA1DC-HA were 
sprayed with 30 µM DEX. Twenty-four hours later plants were syringe-inoculated 
with 2 X 105 cells mL-1 of Pto DC3000 or the hrcC mutant. Bacterial growth 
numbers were counted at 0 and 4 d after inoculation. Both strains grew slightly 
better in transgenic plants expressing HopA1DC-HA. Different letters indicate 
values that are significantly different (p ≤ 0.05) and SE bars are shown. (C) Wild 
type Col-0 and HopA1DC-HA expressing plants were sprayed with 30 µM DEX. 
Leaf disks were harvested 24 h later and the reactive oxygen species (ROS) 
burst (reported in relative light units, RLU) was measured for 30 min after 
treatment with 1 µM flg22 in the luminol derivative L-012 buffer. HopA1DC 
suppressed flg22-induced ROS production in planta. (D) Twenty-four h after 30 
µM DEX treatment plants were infiltrated with 10 µM flg22. Leaves were 
harvested 16 h later, stained with aniline blue and callose foci were enumerated. 
HopA1DC suppressed flg22-induced callose deposition. Letters “a” and “b” are 
statistically different (p ≤ 0.05). Standard error values are indicated as mean ± 
SE. Each experiment was repeated three times with similar results. 
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expressing HopA1DC-HA than they did in wild type Col-0 plants (Fig 3B). This 
data indicates that HopA1DC contributes to the virulence of Pto DC3000. 
HopA1 suppresses PAMP-triggered ROS production and callose deposition. 
To determine if HopA1DC was capable of suppressing Arabidopsis plant immunity, 
transgenic plants expressing HopA1DC-HA were assessed for their ability to 
suppress two main PTI responses: ROS production and callose deposition in the 
cell wall. We measured ROS production in wild type Col-0 and HopA1DC-HA 
expressing plants after treatment with flg22, a peptide derived from the flagellin 
PAMP. Transgenic plants expressing HopA1DC-HA treated with flg22 have 
reduced ROS production compared to wild type Col-0 plants (Fig. 3C). Moreover, 
transgenic plants expressing HopA1DC-HA treated with flg22 also exhibited 
reduced callose deposition compared to wild type Col-0 plants (Fig. 3D). These 
data indicates that HopA1DC suppresses PTI responses. 
The structure of the HopA1 C-terminal domain has similarities to 
phosphothreonine lyases from animal pathogens. To gain insight into the 
potential function of HopA1, Alexander U. Singer and Alexei Savchenko 
(Department of Chemical Engineering and Applied Chemistry, University of 
Toronto, Toronto, Ontario, Canada) undertook its structural characterization. The 
recombinant expression of a HopA1DC fragment encompassing residues 122 to 
380 (HopA1DC(122-380)) yielded a soluble polypeptide of the correct molecular 
mass supporting the notion that this part of HopA1DC forms a distinct domain. 
The structure of HopA1DC(122-380) fragment was solved to 2.3 Å resolution by the 
single-wavelength anomalous dispersion (SAD) technique using a 
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selenomethionine-enriched protein sample. The final model contained all 
HopA1DC residues from 122 to 380, with the exception of residues 201, 202 and 
380, which appear disordered. The model shows good stereochemistry, with no 
residues giving backbone torsion angles in the disallowed region of the 
Ramachandran plot (Table 3). The overall structure of HopA1DC(122-380) adopts a 
α/β fold with seven β strands (β1 – β7) forming an antiparallel β-sheet and nine 
α-helices (α1 – α9). The two most N-terminal and C-terminal α-helices (α1-α2 
and α8-α9 respectively) form a four-helix bundle capping the central β-sheet, 
while the rest of the α-helices (α3- α7) shield the β-sheet from one side (Fig. 4A). 
 A search for structural homologues using the DALI server (25) 
demonstrated that the HopA1DC(122-380) structure shares significant similarity with 
the structures of the Shigella type III effector OspF (PDB 3I0U, Z-scores 8.5) and 
its homologues SpvC  from Salmonella (PDB 2Z8M, Z-score 8.4) and VirA from 
Chromobacterium violaceum (3BO6, Z-core 8). The HopA1DC(122-380) and OspF 
structures superimpose with rms deviation of 3.2 Å over 134 Ca atoms that 
correspond primarily to the central β-sheet and to the helices α6 and α7 in the 
HopA1DC(122-380) structure (Fig. 4B). Interestingly, the four-helix bundle in the 
HopA1DC(122-380) structure does not have a matching partner in OspF/SpvC/VirA 
structures. 
 The OspF/SpvC/VirA family of effectors has been characterized as 
phosphothreonine lyases that promote the irreversible removal of the phosphate 
moiety from the phosphothreonine residue in the activation loop of host MAP 
kinases (36, 59). The active site of these proteins was located within the large  
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Fig. 4. Structure of HopA1DC(122-380) has similarity to the structure of SpvC 
phosphothreonine lyase. (A) Ribbon diagram of HopA1DC(122-380). Secondary 
elements are colored (red helices, blue beta strands and gray turns) and labeled, 
as well as the position of the N- and C-terminus. (B) Superimposition of 
HopA1DC(122-380) (blue) with Salmonella SpvC phosphotreonine lyase (PDB 2Z8M) 
(red). Similar to A, the N- and C-terminus of SpvC is denoted N’ and C’, 
respectively. (C) Close-up of the alignment between HopA1DC(122-380) and the 
SpvC/phosphopeptide complex (PDB code 2Q8Y) in a similar position and 
orientation as A.  The ribbons of HopA1DC and SpvC are colored cyan and white, 
respectively, and the five residues in HopA1DC(122-380) targeted for mutation and 
their corresponding residues in SpvC are emphasized by a stick representation 
and labeled.  The position of K136 (an Ala in PDB 2Q8Y) was modeled to the 
conformation present in apo-SpvC structures. (D) Semi-transparent surface 
representation of HopA1DC(122-380) in which five conserved residues are 
highlighted as sticks and shaded blue on an otherwise white surface. 
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open groove formed by the central β-sheet, which adapts a “cupped hand” shape 
(Fig. 4B). The HopA1DC(122-380) structure also features a large open groove in the 
central β-sheet formed by strands β3, β4 and β5 and by the loop between the β7 
strand and the α8 helix (Figs. 4A-B). Further analysis of this groove in the 
HopA1DC(122-380) structure demonstrated that it harbors a significant number of 
residues conserved among HopA1 alleles (Fig. S6). Specifically, residues R235,  
T237, K266, D278 and Y283, are completely conserved among HopA1 
homologues as well as in Mcf2 toxins, and are co-localized at the bottom of the 
central groove (Figs. 4C and S6). Superimposition of the HopA1DC(122-380) 
structure with the structures of the SpvC and OspF effectors demonstrated that 
these conserved HopA1DC residues correspond to the functionally important 
residues in the phosphothreonine lyase active site (Figure 4C). In particular R235, 
K266, and Y283 in HopA1DC correspond to SpvC K104, K136, and Y158, 
respectively. The HopA1DC T237 residue corresponds to H106 of SpvC, while the 
HopA1DC D278 residue side chain occupies the position corresponding to the 
phosphate group of the phosphothreonine in the SpvC-phosphopeptide complex 
structure. The SpvC H106, K136, Y158 and K104 residues and their analogues 
in OspF are directly involved in catalysis and substrate binding (59), suggesting 
that the corresponding HopA1 residues may be part of the catalytic and/or 
binding site in this protein. We also determined the structure of an analogous 
region of HopA161 and this structure looked nearly identical to HopA1DC(122-380) 
(Fig. S11). 
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 Taken together our structural analysis demonstrated that the HopA1DC(122-
380) fragment represents a distinct domain with a general fold similar to that of 
OspF and SpvC type III effectors. The similarity between HopA1 and OspF/SpvC 
structures extends into the arrangement of specific residues co-localized in the 
open groove formed by the central β-sheet in each of these protein structures. 
Considering the critical role of conserved residues for the OspF/SpvC 
phosphothreonine lyase activity and that the five HopA1DC residues are also 
solvent exposed (Fig. 4D), we speculate that these residues in HopA1DC form 
part of this protein active site.  
Residues in the putative active site of HopA1 are required for HopA1-
dependent phenotypes. The structural analysis presented above suggested 
that the HopA1DC(122-380) domain may possess enzymatic activity similar to the 
phosphothreonine lyase activity of OspF and SpvC effectors. General in vitro 
enzymatic assays using a library of phosphopeptide substrates did not reveal any 
significant phosphothreonine lyase activity for the full-length HopA1DC and 
HopA1DC(122-380) fragment (not shown). Individual alanine substitutions of active 
site residues in OspF or SpvC effectors abrogated their activity in vivo (59). Thus, 
we sought to test the effect of site-directed mutations in the putative HopA1 
active site. Accordingly, HopA1DC residues R235, T237, K266, D278 and Y283 
and HopA161 residues R231, T233, K262, D274, and Y279 were individually 
substituted to alanine by site-directed mutagenesis. First we tested the extent 
that the HopA161 site-directed mutation derivatives could elicit an HR in tobacco 
and inhibit yeast growth. The five HopA161 site-directed mutation derivatives  
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Fig. 5. Solvent exposed residues in the putative active site of HopA1 are 
required for the HopA1-dependent phenotypes (A) Pf(pLN1965) strain 
carrying wild type hopA161 or site-directed mutants were syringe-infiltrated into 
tobacco leaves at cell density of 1 x 109 cells mL-1. Leaves were evaluated for the 
development of an HR and photographed 48 hours after infiltration. All five 
HopA161 residues were required for the elicitation of an HR in tobacco. (B) 
Tobacco leaves were syringe-infiltrated with 1 X 105 cells mL-1 of Pta 11528 
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strains expressing HopA161 or site-directed mutation derivatives and bacterial 
growth was monitored at 0 and 6 d after inoculation. All five HopA161 residues, 
except T233, were required to convert Pta 11528 to an avirulent strain. (C) 
Disease symptoms in tobacco infiltrated with Pta 11528 strains described in B. 
Leaves were photographed 6 d postinoculation. The residue T233 was not 
required for the avirulence function of HopA161. (D) Yeast strain BY4743 
expressing wild type hopA161 or site-directed mutants was grown overnight at 
30°C in selective media. The cultures were plated in selective media containing 
glucose or galactose. Photographs were taken 2 days later. All but one HopA161 
residues were required to inhibit yeast growth. (E) The ROS production was 
assessed in wild type Col-0 and transgenic plants expressing wild type HopA1DC 
or site-directed mutants after treatment with 1 µM flg22. All five HopA1DC 
residues were required for the suppression of flg22-induced ROS production. (F) 
Wild type Col-0 and transgenic plants expressing wild type HopA1DC or site-
directed mutants were infiltrated with 10 µM flg22. The plant tissue was 
harvested 16 h later, stained with aniline blue and callose foci were enumerated 
using Image J software. All five HopA1DC residues were required for the 
suppression of flg22-induced callose deposition.  
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were transformed into Pf(pLN1965) strain and infiltrated into tobacco leaves. All 
five HopA161 site-directed mutants were unable to elicit an HR (Fig. 5A). Pta 
11528 was also transformed with constructs containing genes corresponding to 
the wild type HopA161 and each site-directed mutant and these strains were 
infiltrated into tobacco to determine how well they grew in tobacco. We found that 
strains expressing all of the site-directed mutants, with the exception of 
HopA161(T233A), grew and produced wildfire disease symptoms similar to the wild 
type Pta 11528 control (Figs. 5B-C). We observed similar results when the 
HopA161 site-directed mutants were expressed in yeasts to evaluate the extent 
that these residues were required for the HopA161-dependent growth restriction 
phenotype. All HopA161 site-directed mutants, except HopA161(T233A), failed to 
exhibit the growth restriction phenotype (Fig. 5D). Therefore, these conserved 
solvent exposed residues were all required for the elicitation of the HR in tobacco 
and, with the exception of residue T233, were required for HopA161-dependent 
yeast growth inhibition and converting Pta 11528-tobacco interaction to an 
incompatible interaction. 
 Next we evaluated the extent that these solvent exposed residues were 
required for HopA1DC‘s ability to suppress flg22-induced ROS production and 
callose deposition. Transgenic Arabidopsis plants expressing HopA1DC 
derivatives with alanine substitution mutations in residues R235, T237, K266, 
D278, and Y283 lost their ability to suppress flg22-induced ROS production (Fig. 
5E) and callose deposition in Arabidopsis (Fig. 5F). Therefore, all of these 
residues were required for HopA1DC’s ability to suppress PTI. We also wanted to 
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evaluate the requirement of the HopA1DC solvent exposed residues to the 
virulence of Pto DC3000. However, the hopA1 mutant had a weak virulence 
phenotype (Fig. 3A) and complementation of the hopA1 mutant with site directed 
mutation derivatives would have not been robust enough to evaluate the 
contribution of these HopA1DC residues to the virulence of Pto DC3000. 
 
Discussion 
In this study we characterized two classes of the P. syringae type III effector 
HopA1. We found that in contrast to HopA161, HopA1DC does not act as an 
avirulence protein in tobacco and Arabidopsis (Fig. 1). HopA1 is among the most 
diverse type III effector families based on its pairwise amino acid diversity and 
high pairwise nucleotide diversity value (π) compared to π values for 
housekeeping genes (4). The high degree of diversification in the HopA1 family 
suggests that HopA161 and HopA1DC have undergone different evolutionary 
pressures that likely altered their specificity.  
The P. syringae type III effector family HopZ1 provides an example of how 
allelic diversification is the result of selective pressures imposed by plant 
immunity. Members of the HopZ1 family have diversified into three functional 
allelic variants (HopZ1a, HopZ1b and HopZ1c) and two degenerate alleles 
(ψHopZ1a and ψHopZ1b) via pathoadaptation in response to plant immunity (35, 
39, 58). In this sense, we speculate that HopA1DC has diversified from HopA161 
to avoid recognition by host resistance proteins, which further suggests that the 
HopA161 class of HopA1 is more ancient than the HopA1DC class.  
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In addition, expression of HopA1DC in yeast does not inhibit growth of 
yeast cells as HopA161 does (Fig. 1D). In plants we observed that HopA161 elicits 
an HR as a result of an R protein-mediated recognition and in yeast it inhibits cell 
growth. Since yeasts lack R genes, it is likely that the virulence activity of HopA1 
is responsible for the growth inhibition phenotype. The fact that HopA1DC did not 
inhibit yeast growth suggests that its virulence activity has also diversified from 
HopA161. The virulence target of HopA161 in yeast and the mechanism of growth 
inhibition remain to be elucidated. 
 HopA161 and HopA1DC localized predominately to the plasma membrane. 
However, significant amounts also were found in the nucleus and nucleolus of 
plant cells (Fig. 1E). Our data is in agreement with two previous reports that 
show nuclear localization in mammalian cells of the N-terminal region of the 
insecticidal toxin Mcf2 that has homology to HopA1 (53) and plasma membrane 
localization of HopA1 in tomato epidermal cells and yeast cells (48).  
 We observed that chloroplasts aggregated around the nucleus only when 
HopA161 was transiently expressed into N. benthamiana cells. Mitochondria and 
chloroplasts have been reported to move on transvacuolar strands to form a ring 
structure around the nucleus during late stages of programmed cell death (38, 54, 
57). Thus, the phenomenon we observed is the result of the HopA161-dependent 
elicitation of a hypersensitive response, a localized programmed cell death 
response in plants. 
 We determined the structure of the C-terminal regions of HopA1DC and 
HopA161 (Fig. 4A). They share structural similarity to phosphothreonine lyases 
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from animal pathogens, including Shigella OspF, Salmonella SpvC and 
Chromobacterium VirA (Fig. 4B). Phosphothreonine lyases irreversibly remove 
the phosphate from the threonine residue on the activation loop of host MAP 
kinases, thus rendering the MAPK inactive (36). This post-translational 
modification is referred as Eliminylation (10). We identified five solvent exposed 
conserved residues that reside within regions structurally related to the active site 
of the SpvC and OspF phosphothreonine lyases (Fig. 4C-D) (11, 43, 52). Site-
directed mutagenesis of these residues in HopA1DC blocked the ability of 
HopA1DC to suppress flg22-induced callose deposition and ROS production (Fig. 
5E-F). Moreover, site-directed mutagenesis of these residues in HopA161 
abrogated the HR production in tobacco (Fig. 5A), the ETI-induced restricted 
growth of Pta 11528 in tobacco, and the yeast growth inhibition phenotype (with 
the exception of HopA161(T233A)) (Fig. 5B-D). The conservation of the putative 
active site of HopA1DC and HopA161 and their requirement for HopA1-dependent 
phenotypes in planta and yeast, are consistent with HopA1 being a 
phosphothreonine lyase or a related enzyme. 
It has been reported that HopA1 targets the immunity regulator EDS1 (6). 
However we did not find any interaction of HopA1 with EDS1 in a yeast two-
hybrid assay (Fig. S10). Even though EDS1 could be a potential target of HopA1, 
is not known to be a phosphorylated protein. We therefore could not directly test 
the phosphothreonine lyase enzymatic activity of HopA1 using EDS1 as a 
substrate. 
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The fact that HopA161 elicits an HR in tobacco and A. thaliana Ws-0 prompted 
us to identify the avirulence portion of HopA161. We found that the C-terminus of 
HopA161 elicited an HR in tobacco (Fig. 2), indicating that the virulence domain of 
HopA161 resides in its C-terminus. This agrees with the fact that the virulence 
domain of type III effectors usually resides in their C-terminal region, after the 
secretion signal domain and/or type III chaperone-binding domain. However, we 
found that the N-terminus of HopA161 was recognized in A. thaliana Ws-0, and to 
our surprise, the first 122 amino acids were sufficient to elicit an HR (Fig. 2A). 
The type III secretion signal resides in the N-termini of type III effectors (13, 45). 
The structure of the HopA1DC secretion signal and chaperone-binding site bound 
to its type III chaperone has been elucidated and correspond to the N-terminus 
102 amino acids (29). Since the majority of the N-terminal 122 amino acids 
contain the type III secretion signal and chaperone-binding site, it is not likely that 
the virulence domain resides in this region. This suggests that instead HopA161 is 
directly recognized by the R protein RPS6 in A. thaliana Ws-0. Direct recognition 
of HopA161 in Arabidopsis is unusual because the majority of type III effectors are 
indirectly recognized by R proteins as explained in the guard model (16). This 
model states that R proteins monitor modifications executed by type III effectors 
on their target proteins. Therefore, R proteins indirectly recognized virulence 
activities of type III effectors to initiate effector-triggered immunity. We concluded 
that while HopA161 is indirectly recognized in tobacco, is recognition in 
Arabidopsis is direct. 
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Materials and methods 
DNA manipulation. Plasmids used in this work and primers used for cloning are 
listed in tables 1 and 2. For cloning of entry vectors we used Gateway technology 
(Invitrogen). Pf(pLN1965), Pto DC3000 or Pta 11528 strains were transformed 
with pLN615 derivatives; Agrobacterium C58C1 was transformed with pLN462, 
pK7FWG2, or pTA7002 derivatives; and S. cerevisiae strains were transformed 
with pGilda, pGBKT7 or pGADT7 derivatives. A DC3000 hopA1 mutant was 
generated using the pKnockout-Ω suicide vector pLN23. For the 
complementation of the hopA1 mutant, pLN1028 was recombined into the Tn7 
vector pLN2992. The resulting Tn7 construct was integrated into the 
chromosome of the hopA1 mutant strain. HopA1DC and HopA161 site-directed 
mutations were generated following the QuikChange® site-directed mutagenesis 
instructions (Stratagene). 
Plant assays. For pathogenicity assays, P. syringae strains were grown 
overnight at 30°C on King’s B (KB) plates with appropriate antibiotics and 
resuspended in 5 mM MES (morpholinoethanesulfonic acid, pH 5.6). Bacterial 
suspensions of 1 X 105 and 2 X 105 cells ml-1 were syringe-infiltrated into leaves 
of tobacco and Arabidopsis, respectively. Four leaf discs of 0.8-cm2 were excised 
for each infiltrated P. syringae strain at the indicated time points. Samples were 
ground in 250 µL of sterile water, 10-fold serially diluted, and plated on KB agar 
plates with appropriate antibiotics. Bacterial numbers were counted 2 days later. 
Statistical differences were calculated using one-way ANOVA. 
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For HR assays, Pf(pLN1965) strains were grown overnight in KB medium 
at 30°C. Cells were resuspended in 5 mM MES and bacterial suspensions of 1 x 
109 and 5 x 108 cells ml-1 were infiltrated into leaves of tobacco and A. thaliana 
Ws-0, respectively. The development of the HR was monitored and infiltrated 
leaves were photographed after 2 days. 
ROS and callose assays were done as described before (8). The ROS 
burst was determined by counting photons from L-012-mediated 
chemiluminescence using a Synergy 2 luminometer. Luminescence was 
recorded every minute for 30 minutes. Callose stained leaves were analyzed 
under a Zeiss Axionplan 2 imaging microscope. The number of callose deposits 
were counted using ImageJ software. 
Generation of transgenic Arabidopsis plants. To make DEX-inducible 
transgenic plants, A. thaliana Col-0 plants were transformed with Agrobacterium 
C58C1 strains carrying pTA7002 derivatives using the floral dip method (5). 
Transgene expression was confirmed with immunoblots using anti-HA primary 
antibodies (Roche, Basal, Switzerland) and anti-rat immunoglobulin G alkaline-
phosphatase conjugates as secondary antibodies (Sigma Chemical Co., St. 
Louis, U.S.A.). Proteins on immunoblots were visualized using the CDP-Star 
chemiluminescence detection kit (Tropix, Bedford, MA, U.S.A.) followed by 
autoradiography. For plant assays with DEX-inducible transgenic Arabidopsis 
lines, plants were sprayed a day before with 30 µM DEX.  
Yeast assays. The pGILDA derivatives were transformed into S. cerevisiae 
using the lithium acetate transformation method (23). Yeast strains were grown 
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overnight at 30°C in SD (-His) glucose non-inducing liquid culture. Yeast cultures 
were normalized at OD600 of 0.1 and 10-fold serially diluted. Five microliters of 
each dilution were dropped onto SD (-His/Glucose) or SD (-His/Galactose) plates. 
Cells were incubated at 30°C for 2 days and photographed. 
For yeast viability assay, yeast strain EGY48 harboring the vector pGilda 
containing hopA1DC, hopA161 or vector control was grown overnight at 30°C in 
SD (-His) glucose non-inducing liquid media. Yeast cultures were normalized to 
an OD600 of 0.2 in SD (-His) galactose-inducing media and incubated for 3 hours 
in a 30°C shaker. Cultures were resuspended in 1 mL of sterile water containing 
2% D-(+)-glucose and 10 mM Na-HEPES (pH 7.2) and stained with 10 µM FUN® 
1 and 25 µM Calcofluor™ White MR2 (LIVE/DEAD Yeast viability kit, Cat. No. 
L7009, Molecular Probes). Cells were incubated at 30°C in the dark for 30 
minutes and visualized with a fluorescence microscope. 
For yeast two-hybrid analyses, strain Y187 carrying pGBKT7:eds1 was 
mated to strain AH109 carrying pGADT7:hopA1 in a mating plate (yeast extract 
peptone dextrose, YPD). To test interaction of target proteins mated yeast strains 
were grown in SD (-Trp-Leu) media overnight. Cells were plated in quadruple 
dropout (QDO) selective media. Cells were photographed 2 days later. 
Confocal microscopy. Agrobacterium strains were transiently expressed in 
leaves of N. benthamiana as described previously (28). Infiltrated leaves were 
visualized 45 hours later using a Nikon A1 confocal mounted on a Nikon 90i 
compound microscope with sequential imaging at 488 nm excitation and 500-550 
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nm emission wavelengths (GFP). For chloroplast autofluorescence, 640.6 nm 
excitation and 663-738 nm emission wavelengths were used. 
Protein purification and structure determination. Fragments of hopA1DC were 
cloned into the expression plasmid p15TvLic, and the plasmid was transformed 
into E. coli BL21(DE3)-RIPL (Stratagene). Following determination of solubility in 
test expression studies, E. coli cells carrying a construct that contained 
hopA1DC(122-380) were then cultured in 1 L of Luria Broth (LB) medium at 37°C to 
an OD600 of approximately 1.2, and 0.4 mM IPTG was added to induce protein 
expression. After induction, cells were incubated overnight with shaking at 25°C. 
Cells were harvested by centrifugation, disrupted by sonication, and the insoluble 
material was removed by centrifugation. The HopA1DC C-terminal domain was 
purified from the supernatant using Ni-NTA affinity chromatography. Tobacco 
Etch Virus (TEV) protease was added to the eluted protein, and the mixture was 
dialyzed at 4°C overnight in a buffer with 10 mM HEPES (pH 7.5), 300 mM NaCl 
and 0.5 mM TCEP, concentrated to 69 mg ml-1 and stored at -70°C. 
Crystallization trials were performed using hanging-drop vapor diffusion with an 
optimized sparse matrix crystallization screen (33). The crystal used for data 
collection (see Table 3) was grown from crystallization liquor containing 0.2 N 
disodium tartrate, 25% PEG3350, and 0.1 M Tris (pH 8.5) and cryoprotected with 
N-paratone oil (Hampton Research) and flash-frozen in liquid nitrogen prior to 
data collection. 
Data Collection, Structure Determination and Refinement. The structure of 
HopA1DC(122-380) was determined by SAD phasing using a crystal derived from 
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selenomethionine-enriched protein at the peak wavelength l=0.97943. Diffraction 
data was collected at 100°K at beamline 19-ID. Diffraction data were integrated 
and scaled using HKL3000 (41). Positions of heavy atoms were found using 
SHELXD (49), followed by solvent flattening using SHELXE (51), which was in 
turn used to automatically build an initial model using ArpWARP (44), which was 
all used within the CCP4 program suite (12). The model was then improved by 
alternate cycles of manual building and water-picking using COOT (19) and 
restrained refinement against a maximum-likelihood target with 5% of the 
reflections randomly excluded as an Rfree test set. All refinement steps were 
performed using REFMAC (42) in the CCP4 program suite. Only three residues 
(residues 201, 202 and 380) of the 260-residue fragment of HopA1DC were 
omitted from the model due to poor electron density. The final model contains 
one molecule of HopA1DC(122-380) and 150 solvent molecules and was refined to 
an Rwork of 16.3% and Rfree of 22.7%, including TLS parameterization (55, 56).  
Data collection, phasing and structure refinement statistics are summarized in 
Table 3. The Ramachandran plot generated by PROCHECK (34) showed very 
good stereochemistry overall with 100% of the residues in the most favored and 
additional allowed regions (see Table 3). 
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Supplemental figures and tables 
Supplemental Table 1. Plasmids used in this study 
Plasmid Description Primers used Reference 
pENTR/D-
TOPO 
Gateway entry vector, Kmr  Invitrogen 
pGilda Yeast expression vector under 
a galactose-inducible 
promoter, Apr 
 Clontech 
pK7FWG2 Gateway binary vector with a 
C-terminal GFP gene for 
fusions, Spr 
 (31) 
pLN23 pKnockout-Ω derivative 
carrying hopA1DC, Spr 
 (28) 
pLN458 Entry vector carrying hopA161, 
Kmr 
 (28) 
pLN462 pPZP212 derivative gateway 
destination binary vector 
containing 35S promoter and 
HA tag for C-terminal fusion, 
Spr 
 (28) 
pLN474 pLN462 derivative carrying 
hopA161, Spr 
 This work 
pLN479 pLN462 derivative carrying 
hopA1DC, Spr 
 This work 
pLN532 pGilda derivative carrying 
hopA1DC, Apr 
P0474, P0475 This work 
pLN533 pGilda derivative carrying 
hopA161, Apr 
P0963, P0964 This work 
pLN615 pML123 derivative gateway 
destination binary vector 
containing an HA tag for C-
terminal fusion, Gmr 
 (24) 
pLN666 pK7FWG2 derivative carrying 
hopA161, Spr 
 This work 
pLN668 pK7FWG2 derivative carrying 
hopA1DC, Spr 
 This work 
pLN714 Entry vector carrying hopA161 
with its cognate chaperone 
shcA61 and a ribosome binding 
site, Kmr 
 (28) 
pLN1028 Entry vector carrying hopA1DC 
with its cognate chaperone 
shcADC and a ribosome 
binding site, Kmr 
 (24) 
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pLN1323 pLN615 derivative carrying 
hopA1DC with its cognate 
chaperone shcADC and a 
ribosome binding site, Gmr 
 (24) 
pLN1658 pGADT7 derivative gateway 
destination vector containing 
GAL4 activation domain, 
LEU2, Apr 
 Tian, F 
(unpublished) 
pLN2232 pGBKT7 derivative gateway 
destination vector containing 
GAL4 DNA binding domain, 
TRP1, Spr 
 Tian, F 
(unpublished) 
pLN2992 pUC18T-mini-Tn7 derivative 
destination vector containing 
C-terminal HA tag and avrPto1 
promoter, Apr Cmr Gmr 
 (14) 
pLN3203 Entry vector carrying hopA1DC, 
Kmr 
P2844, P2845 This work 
pLN3207 pTA7002 derivative carrying 
hopA161, Kmr 
P4117, P2843 This work 
pLN3208 pTA7002 derivative carrying 
hopA1DC, Kmr 
P4187, P2845 This work 
pLN3873 Entry vector carrying 
hopA161(1-188), Kmr 
P0787, P3476 This work 
pLN3874 Entry vector carrying 
hopA161(189-375), Kmr 
P3477, P2880 This work 
pLN3886 Entry vector carrying 
hopA161(R231A), Kmr 
P3577, P3578 This work 
pLN3887 Entry vector carrying 
hopA161(K262A), Kmr 
P3581, P3582 This work 
pLN3888 Entry vector carrying 
hopA161(D274A), Kmr 
P3583, P3584 This work 
pLN3889 Entry vector carrying 
hopA161(Y279A), Kmr 
P3585, P3586 This work 
pLN3936 Entry vector carrying 
hopA1DC(R235A), Kmr 
P3564, P3565 This work 
pLN3937 Entry vector carrying 
hopA1DC(K266A), Kmr 
P3568, P3569 This work 
pLN3938 Entry vector carrying 
hopA1DC(D278A), Kmr 
P3570, P3571 This work 
pLN3939 Entry vector carrying 
hopA1DC(Y283A), Kmr 
P3572, P3573 This work 
pLN3956 Entry vector carrying 
hopA1DC(T237A), Kmr 
P3566, P3567 This work 
pLN4000 Entry vector carrying 
hopA161(T233A), Kmr 
P3579, P3580 This work 
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pLN4006 pGilda derivative carrying 
hopA161(R231A), Apr 
P0963, P0964 This work 
pLN4007 pGilda derivative carrying 
hopA161(T233A), Apr 
P0963, P0964 This work 
pLN4008 pGilda derivative carrying 
hopA161(K262A), Apr 
P0963, P0964 This work 
pLN4009 pGilda derivative carrying 
hopA161(D274A), Apr 
P0963, P0964 This work 
pLN4010 pGilda derivative carrying 
hopA161(Y279A), Apr 
P0963, P0964 This work 
pLN4126 Entry vector carrying shcA61 
hopA161(R231A) with a ribosome 
binding site, Kmr 
P3577, P3578 This work 
pLN4127 Entry vector carrying shcA61 
hopA161(T233A) with a ribosome 
binding site, Kmr 
P3579, P3580 This work 
pLN4128 Entry vector carrying shcA61 
hopA161(K262A) with a ribosome 
binding site, Kmr 
P3581, P3582 This work 
pLN4129 Entry vector carrying shcA61 
hopA161(D274A) with a ribosome 
binding site, Kmr 
P3583, P3584 This work 
pLN4130 Entry vector carrying shcA61 
hopA161(Y279A) with a ribosome 
binding site, Kmr 
P3585, P3586 This work 
pLN4135 pLN615 derivative carrying 
shcA61 hopA161(R231A) with a 
ribosome binding site, Gmr 
 This work 
pLN4136 pLN615 derivative carrying 
shcA61 hopA161(T233A) with a 
ribosome binding site, Gmr 
 This work 
pLN4137 pLN615 derivative carrying 
shcA61 hopA161(K262A) with a 
ribosome binding site, Gmr 
 This work 
pLN4138 pLN615 derivative carrying 
shcA61 hopA161(D274A) with a 
ribosome binding site, Gmr 
 This work 
pLN4139 pLN615 derivative carrying 
shcA61 hopA161(Y279A) with a 
ribosome binding site, Gmr 
 This work 
pLN4186 Entry vector carrying 
hopA161(1-85), Kmr 
P0787, P3669 This work 
pLN4186b pLN462 derivative carrying 
hopA161(1-85), Spr 
 This work 
pLN4187 Entry vector carrying 
hopA161(1-122), Kmr 
P0787, P3670 This work 
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pLN4374 Entry vector carrying shcA61 
hopA161(1-85) with a ribosome 
binding site, Kmr 
P1082, P3669 This work 
pLN4374b pLN615 derivative carrying 
shcA61 hopA161(1-85) with a 
ribosome binding site, Gmr 
 This work 
pLN4424 pLN615 derivative carrying 
hopA161 with its cognate 
chaperone shcA61 and a 
ribosome binding site, Gmr 
 This work 
pLN4437 Entry vector carrying 
hopA161(98-275), Kmr 
P3834, P3835 This work 
pLN4437b pLN462 derivative carrying 
hopA161(98-275), Spr 
 This work 
pLN4438 Entry vector carrying 
hopA161(98-375), Kmr 
P3834, P2880 This work 
pLN4438b pLN462 derivative carrying 
hopA161(98-375), Spr 
 This work 
pLN4514 Entry vector carrying shcA61 
hopA161(1-188) with a ribosome 
binding site, Kmr 
P1082, P3476 This work 
pLN4515 Entry vector carrying shcA61 
hopA161(1-275) with a ribosome 
binding site, Kmr 
P1082, P3835 This work 
pLN4516 pLN615 derivative carrying 
shcA61 hopA161(1-188) with a 
ribosome binding site, Gmr 
 This work 
pLN4517 pLN615 derivative carrying 
shcA61 hopA161(1-275) with a 
ribosome binding site, Gmr 
 This work 
pLN4550 pLN2992 derivative carrying 
hopA1DC with its cognate 
chaperone shcADC and a 
ribosome binding site, Apr Gmr 
 This work 
pLN4642 pTA7002 derivative carrying 
hopA161(98-375), Kmr 
P4118, P2843 This work 
pLN4644 pTA7002 derivative carrying 
hopA1DC(R235A), Kmr 
P4187, P2845 This work 
pLN4645 pTA7002 derivative carrying 
hopA1DC(T237A), Kmr 
P4187, P2845 This work 
pLN4646 pTA7002 derivative carrying 
hopA1DC(K266A), Kmr 
P4187, P2845 This work 
pLN4647 pTA7002 derivative carrying 
hopA1DC(D278A), Kmr 
P4187, P2845 This work 
pLN4648 pTA7002 derivative carrying 
hopA1DC(Y283A), Kmr 
P4187, P2845 This work 
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pLN4909 Entry vector carrying eds1, 
Kmr 
P4878, P5385 This work 
pLN4912 Entry vector carrying 
hopA161(123-375), Kmr 
P4442, P2880 This work 
pLN4914 pLN462 derivative carrying 
hopA161(123-375), Spr 
 This work 
pLN4925 pGADT7 derivative carrying 
hopA1DC, Apr 
 This work 
pLN4941 pGBKT7 derivative carrying 
eds1, Spr 
 This work 
pLN4954 pTA7002 derivative carrying 
hopA161(1-122), Kmr 
P4117, P4443 This work 
pLN4955 pTA7002 derivative carrying 
hopA161(123-375), Kmr 
P4440, P2843 This work 
pLN5207 pLN462 derivative carrying 
hopA161(1-122), Spr 
 This work 
pLN5208 pLN462 derivative carrying 
hopA161(189-375), Spr 
 This work 
pLN5326 Entry vector carrying shcA61 
hopA161(1-122) with a ribosome 
binding site, Kmr 
P1082, P3670 This work 
pLN5327 pLN615 derivative carrying 
shcA61 hopA161(1-122) with a 
ribosome binding site, Gmr 
 This work 
    
pLN5630 pLN462 derivative carrying 
hopA161(1-188), Spr 
 This work 
pLN5631 Entry vector carrying 
hopA161(1-275), Kmr 
P0787, P3835 This work 
pLN5632 pLN462 derivative carrying 
hopA161(1-275), Spr 
 This work 
pTA7002 Binary vector for 
glucocorticoid-inducible 
expression containing a C-
terminal HA tag, Kmr 
 (3) 
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Supplemental Table 2. Primers used in this study 
Primer Sequence 
P0474 5’-TTGAATTCATGAACCCCATTCAGTCAC-3’ 
P0475 5’-TTCTCGAGTCAAGTGCGCACCTCAATGCC-3’ 
P0787 5’-CACCTTAGCGTAAGGAGCTAACAATGAACCC-3’ 
P0963 5’-TTGAATTCGGCAGACGCTTCGATCTG-3’ 
P0964 5'-TTCTCGAGTCAGTTTCGCGCCCTGAGC-3' 
P1082 5’-CACCCACCCGACAAATCCACAG-3’ 
P2843 5’-GCTCACTAGTTCAAGCGTAATCTGGAACATCGTATGGGTAG 
TTTCGCGCCCTGAGCGCCG-3’ 
P2844 5’-CACCCTCGAGATGAACCCCATTCAGTCACG-3’ 
P2845 5’-GCTCACTAGTTCAAGCGTAATCTGGAACATCGTATGGGTAT 
TTCGTGTTTCGAAGGGCCG-3’ 
P2880 5’-GTTTCGCGCCCTGAGCGCC-3’ 
P3476 5’-CTGCGGGGCGTATGATAAGG-3’ 
P3477 5’-CACCATGATCCATGATGATCGGGAAGAG-3’ 
P3564 5’-CGAGAAGATAAGAATCAAGGGGCATTGACCATTGGCGTGC 
AACCC-3’ 
P3565 5’-GGGTTGCACGCCAATGGTCAATGCCCCTTGATTCTTATCTT 
CTCG-3’ 
P3566 5’-GATAAGAATCAAGGGCGATTGGCCATTGGCGTGCAACCCC 
AATAT-3’ 
P3567 5’-ATATTGGGGTTGCACGCCAATGGCCAATCGCCCTTGATTCT 
TATC-3’ 
P3568 5’-GAAAGTGCAATCACGCATGGCGCAGTAATAGGCCCCGCCT 
GCCAC-3’ 
P3569 5’-GTGGCAGGCGGGGCCTATTACTGCGCCATGCGTGATTGCA 
CTTTC-3’ 
P3570 5’-GCCTGCCACGGCCAAATGACCGCTTCGGCAGTTTTGTATAT 
CAAC-3’ 
P3571 5’-GTTGATATACAAAACTGCCGAAGCGGTCATTTGGCCGTGGC 
AGGC-3’ 
P3572 5’-ATGACCGATTCGGCAGTTTTGGCTATCAACGGTGATGTTGC 
AAAG-3’ 
P3573 5’-CTTTGCAACATCACCGTTGATAGCCAAAACTGCCGAATCGG 
TCAT-3’ 
P3577 5’-GCACCTGAGACAAACTCGGGAGCACTTACCATTGGTGTAGA 
ACCT-3’ 
P3578 5’-AGGTTCTACACCAATGGTAAGTGCTCCCGAGTTTGTCTCAG 
GTGC-3’ 
P3579 5’-GAGACAAACTCGGGACGACTTGCCATTGGTGTAGAACCTAA 
ATAT-3’ 
P3580 5’-ATATTTAGGTTCTACACCAATGGCAAGTCGTCCCGAGTTTGT 
CTC-3’ 
P3581 5’-CACAAATCTGTGACACAAGGTGCAGTCGTCGGTCCGGCAA 
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AATAT-3’ 
P3582 5’-ATATTTTGCCGGACCGACGACTGCACCTTGTGTCACAGATT 
TGTG-3’ 
P3583 5’-GCAAAATATGGCCAGCAAACTGCCTCTGCCATTCTTTACATA 
AAT-3’ 
P3584 5’-ATTTATGTAAAGAATGGCAGAGGCAGTTTGCTGGCCATATTT 
TGC-3’ 
P3585 5’-CAAACTGACTCTGCCATTCTTGCCATAAATGGTGATCTTGCA 
AAA-3’ 
P3586 5’-TTTTGCAAGATCACCATTTATGGCAAGAATGGCAGAGTCAG 
TTTG-3’ 
P3669 5’-TTTCTCGTTGAGTACCTGGGC-3’ 
P3670 5’-TGTCAGTCGGCTGTCGGCAGC-3’ 
P3834 5’-CACCTTAGCGTAAGGAGCTAACAATGAGACGCTTCG-3’ 
P3835 5’-AGAGTCAGTTTGCTGGCCATA-3’ 
P4117 5’-ATGCCTCGAGACCATGGATGAACCCTATCCATGCACGC-3’ 
P4118 5’-ATGCCTCGAGACCATGGATGAGACGCTTCGATCTGGAG-3’ 
P4187 5’-ATGCCTCGAGACCATGGATGAACCCCATTCAGTCACG-3’ 
P4442 5’-CACCATGTCAAAACAGACATTTGCCAG-3’ 
P4443 5’-GCTCACTAGTTCAAGCGTAATCTGGAACATCGTATGGGTAT 
GTCAGTCGGCTGTCGGCAG-3’ 
P4878 5’-CACCATGGCGTTTGAAGCTCTTACC-3’ 
P5385 5’-GATCCTCGAGGGTATCTGTTATTTCATCCAT-3’ 
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Supplemental Table 3. Data Collection and Refinement Statistics for 
HopA1DC(122-380) 
Data collection  
Space group P65 
Cell dimensions  
a=b, c (Å) 80.6, 96.0 
Wavelength (Å) 0.97943 
Resolution (Å) 50-2.30(2.38-2.30) 
Rmerge (%)a 0.105(0.488) 
I/σI 40.07(7.6) 
Completeness (%) 100.0(100.0) 
Redundancy 14.7(14.8) 
  
Refinement  
Resolution (Å) 19.78-2.30 
No. reflections 15742 
Rwork (%)b 16.3 
Rfree (%)c 22.7 
No. atoms  
Protein 2001 
Water 150 
Other 5 
B-factors (Å2)  
Overall 38.8 
Protein 38.5 
Water 42.7 
Other 43.8 
r.m.s. deviations  
Bond lengths (Å) 0.018 
Bond angles (º) 1.66 
Ramachandran Plot  
% in Most Favored Regions 91.4 
% in Additionally Allowed Regions 8.6 
% in Generously Allowed or 
Disallowed Regions 
0 
 
Notes: 
Values in parentheses are for the highest-resolution shell. 
a  
b , where Fobs and Fcalc are the observed and the 
calculated structure factors, respectively.	  
c Rfree calculated using 5% of total reflections randomly chosen and excluded 
from the refinement 
Rmerge = I ! I / Ihkl"hkl"
Rwork = Fobs !Fcalc" / Fobs"
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Supplemental Fig. 1. HopA161 and HopA1DC elicit an HR in tobacco when 
delivered by Agrobacterium. HopA161 and HopA1DC were transiently 
expressed in tobacco by Agrobacterium-mediated transformation. Leaves were 
photographed 2 d postinoculation. Both HopA161 and HopA1DC elicited an HR in 
tobacco. 
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Supplemental Fig. 2. HopA161 inhibits yeast growth but is not lethal. Yeast 
strain EGY48 expressing hopA161 or hopA1DC was grown overnight at 30°C in 
selective non-inducing media. Cells were induced in galactose media for 3 hours 
and stained with FUN® 1 and Calcofluor™ White MR2 following the LIVE/DEAD 
Yeast viability kit and visualized with a fluorescence microscope. Number of dead 
cells (white cells) and total number of cells were counted using ImageJ software. 
The number of dead cells was similar when either HopA161 or HopA1DC were 
expressed in yeast, however there was less number of cells in HopA161 
expressing cells. Error bars designate standard error. 
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Supplemental Fig. 3. Recognition of HopA161 in Arabidopsis is RPS6-
dependent. Wild type Arabidopsis and rps6-1 mutant plants expressing full-
length HopA161 or HopA161(1-122) in a DEX-inducible manner, were sprayed with 
30 µM DEX. Plants were photographed 3 d later. Expression of HopA161 was 
lethal in wild type Arabidopsis but not in the rps6-1 mutant. 
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Supplemental Fig. 4. HopA161 converts Pta 11528 to an avirulent strain in 
tobacco. Tobacco leaves were syringe-inoculated with 1 X 105 cells mL-1 of Pta 
11528 strains expressing HopA1DC, full-length hopA161 or N-terminal truncations. 
Plants were monitored for the development of disease symptoms and 
photographed 6 d after inoculation. Only full-length HopA161 restricted 
development of disease symptoms. 
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Supplemental Fig. 5. In planta expression of full-length HopA161 and an N-
terminal truncation, but not C-terminal truncations, caused lethality in 
Arabidopsis. Transgenic A. thaliana Ws-0 plants expressing full-length HopA161, 
HopA161(1-122), HopA161(98-375) and HopA161(123-375) were induced after 30 µM DEX 
treatment. Only expression of full-length HopA161 and HopA161(1-122) were lethal 
to A. thaliana Ws-0. 
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Supplemental Fig. 6. Sequence alignment of HopA1 and Mcf2 alleles. 
Positions of helices (red cylinders) and beta strand (blue arrows) based on the 
structure of HopA1DC(122-380) are shown above the alignment. Residues targeted 
for site-directed mutagenesis are indicated with cyan circles. The alignment was 
generated using ClustalX and plotted using BoxShade. The alignment contains 
the four most divergent HopA1 alleles as well as the region with homology to 
Mcf2 toxins. 
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Supplemental Fig. 7. Immunoblots show expression of HopA161 and 
HopA1DC from bacterial strains and transgenic Arabidopsis. Expression of 
HopA161 and HopA1DC from Pf(pLN1965) (A), Pta 11528 (B), and transgenic 
Arabidopsis plants (C) was confirmed by immunoblots with anti-HA antibody. 
Expected protein size: HopA1DC or HopA161 = 42 kDa. 
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Supplemental Fig. 8. Expression of HopA161 truncations and site-directed 
mutation derivatives. Immunoblots with anti-HA antibody show expression of 
HopA161 derivatives from agroinfiltrated N. benthamiana leaves (A) and from 
bacterial strains Pta 11528 (B), Pto DC3000 (C), and Pf(pLN1965) (D). Asterisks 
indicate the expected size for each derivative. Expected protein size: full-length 
HopA161 or site-directed mutants = 42 kDa; HopA161(1-85) = 10 kDa; 1 HopA161(1-
122) = 14 kDa; HopA161(1-188) = 21 kDa; HopA161(1-275) = 31 kDa; HopA161(98-275) = 
20 kDa; HopA161(98-375) = 31 kDa; HopA161(123-375) = 29 kDa; HopA161(189-375) = 21 
kDa. 
 
	  	   150	  
 
 
Supplemental Fig. 9. Immunoblots indicate expression of HopA161 site-
directed mutants in yeast. Yeast strain BY4743 carrying wild type hopA161 or 
site-directed mutations derivatives were grown at 30°C in selective media 
containing either glucose or galactose. Immunoblots with anti-LexA antibody 
confirm expression of each derivative in inducing media. 
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Supplemental Fig. 10. HopA1 does not interact with EDS1. Yeast two-hybrid 
interaction between EDS1 and HopA1DC did not show growth of yeast strain 
expressing EDS1 and HopA1 when plated in selective media (Quadruple dropout, 
QDO). 
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CHAPTER 4 
The Pseudomonas syringae type III effector HopA1 targets 
Arabidopsis type 2C protein phosphatases to suppress plant 
immunity 
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ABSTRACT 
The Gram-negative plant pathogenic bacterium Pseudomonas syringae causes 
diseases in many crops. For pathogenicity, P. syringae relies on a type III protein 
secretion system to inject type III effector proteins (T3Es) into plant cells. T3Es 
are the main virulence determinants of this pathogen and are known to hijack the 
plant immune system, both pathogen-associated molecular pattern-triggered 
immunity and effector-triggered immunity pathways. P. syringae pv. tomato 
DC300 (Pto DC3000) injects about 35 type III effectors into plants to promote 
bacterial virulence.  
One of them is the effector HopA1 that suppresses immune responses and its 
structure resembles phosphothreonine lyases from animal pathogens. Here I 
show that HopA1 interacts with PLL4 and PLL5, two Arabidopsis type 2C protein 
phosphatases from clade C (PP2C-C) involved in leaf development. I 
demonstrate that the interaction occurs at the plasma membrane of plant cells. 
PLL4 and PLL5 act as negative regulators of plant immunity and they are 
induced after pathogen infection. While Arabidopsis plants with T-DNA insertions 
in PLL4 and PLL5 are more resistant to bacterial infections and have stronger 
immune responses, in planta expression of these phosphatases results in plants 
more susceptible to bacterial infections with reduced immune responses. This is 
the first report of members of the PP2C-C family being targeted by a pathogen 
effector to suppress plant immunity.  
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Introduction 
P. syringae is a plant pathogenic Gram-negative bacterium that infects a wide 
range of crops. There are about 50 P. syringe pathovars (pv.) that are capable of 
infecting specific plant species, therefore P. syringe is a host-specific pathogen 
(25). Pto DC3000 infects tomato (Solanum lycopersicum) causing bacterial speck 
disease, and is also pathogenic on the model plant Arabidopsis thaliana. To 
become a successful pathogen, DC3000 relies on the injection of about 35 
virulence proteins known as type III effector proteins into plant cells, which are 
injected through a type III protein secretion system (1). To counteract pathogenic 
infections, plants evolved two ways to trigger innate immunity. The first layer of 
immunity is induced after recognition of conserved microbial molecules like 
bacterial flagellin or fungal chitin. These molecules are known as PAMPs and are 
recognized by extracellular plant receptor kinases. This immunity pathway is 
known as PAMP-triggered immunity (PTI). The second way immunity is activated 
is by recognition of pathogen effectors by plant immune receptors known as 
resistance (R) proteins leading to effector-triggered immunity (ETI) (19). In the 
case of bacterial pathogens, ETI is induced by the recognition of T3Es inside 
plant cells by intracellular R proteins. Activation of these immunity pathways 
induces responses and signal transduction pathways including the mitogen-
activated protein kinases (MAPKs) and Calcium-Dependent Protein Kinases 
signaling cascades, transcriptional reprogramming of immunity-related genes, 
callose deposition at the cell wall, and production of reactive oxygen species 
(ROS) (32). T3Es disrupt several host processes to suppress plant immunity and 
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favor bacterial multiplication and the development of the disease. T3Es suppress 
plant immunity at different levels. Some T3Es disable PAMP receptor complexes 
or R protein complexes, several inactivate MAPKs signaling cascades, and 
others act post-transcriptionally to suppress immune responses (4, 33). However, 
the enzymatic activity and plant targets for the majority of T3Es remain to be 
elucidated (5, 10). 
PP2Cs have been implicated in plant stress signaling, as inhibitors of MAPK 
signaling pathways or co-receptors of the stress hormone abscisic acid (ABA) 
(27). A. thaliana encodes 80 PP2Cs that are classified into 11 clades (13). The 
most studied clade of Arabidopsis PP2Cs is clade A (PP2C-A), whose members 
are negative regulators of ABA signaling pathways. ABA is involved in plant 
development and tolerance to abiotic and biotic stresses (8). PP2C-D members 
regulate phosphorylation of the plasma membrane H+-ATPase to regulate cell 
expansion (16, 31). Clade C of the PP2C family includes POL and PLL1-5. POL 
and PLL1 are two dually acetylated plasma membrane phosphatases that 
promote shoot and root meristem and embryo formation (14, 30). PLL4 and PLL5 
regulate leaf development and the role of PLL2 and PLL3 have not been 
identified (30). Negative roles in plant development and abiotic/biotic stress 
perception have become a common theme for PP2Cs. Recently, PP2C-A 
members have been identified as negative regulators of plant immunity by 
regulating the phosphorylation status of PAMP receptor complexes (28).  
In chapter three of this thesis, I showed that HopA1 suppresses PTI-induced 
callose deposition and ROS production, two PTI responses. I also showed that in 
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planta transgenic expression of HopA1 allowed better growth of wild type 
DC3000 and the type III secretion defective hrcC mutant compared to growth in 
wild type Col-0 plants. Here I report that the DC3000 type III effector HopA1 
interacts at the plasma membrane of plant cells with two PP2C-C members, 
PLL4 and PLL5. I provide evidence that these phosphatases play roles in plant 
immunity as negative regulators. This is the first report of PP2Cs from clade C 
with roles in plant immunity. 
 
Results 
HopA1 interacts with PLL4 and PLL5, two Arabidopsis type 2C protein 
phosphatases. In an effort to elucidate the mechanism of PTI suppression, we 
searched for proteins that interacted with HopA1 in plant cells. In a yeast two-
hybrid screen done by Dr. Ming Guo, a research assistant professor in Dr. Jim 
Alfano’s research group, we identified that HopA1 interacts with two Arabidopsis 
PP2Cs: PLL4 (AT2G28890) and PLL5 (AT1G07630). A large interactome screen 
also provided preliminary evidence that these phosphatases are putative targets 
of HopA1 (23). First I confirmed the interaction of HopA1 with PLL4 and PLL5. 
Yeast two-hybrid analyses between HopA1 in the DNA-binding domain pGBKT7 
vector and PLL4 or PLL5 in the activation domain pGADT7 vector resulted in a 
positive interaction (Fig. 1A). When PLL4 or PLL5 were mated to the empty 
pGBKT7 vector, no interaction was detected. To explore if HopA1 interacts with 
other members of this PP2C clade, I carried out yeast two-hybrid analyses with 
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PLL1 and PLL2. I did not find any interaction between HopA1 and PLL1 or PLL2 
(Fig. S1). Therefore, HopA1 interacted specifically with PLL4 and PLL5. 
To confirm the interaction of HopA1 with these phosphatases in planta, I 
performed bimolecular fluorescence complementation (BiFC) assays. 
Agrobacterium-mediated transient expression of HopA1-nYFP and PLL4-cYFP in 
Nicotiana benthamiana leaves resulted in fluorescence, indicating that HopA1 
and PLL4 interacted (Fig. 1B). When Agrobacterium strains expressing HopA1-
nYFP and PLL5-cYFP were coinfiltrated in N. benthamiana leaves, similar results 
were obtained, although it resulted in lower fluorescence compared to the 
HopA1-PLL4 interaction. These results suggested that HopA1 interact with PLL4 
and PLL5 in plant cells and based on the location of the fluorescent reporter they 
may interact at the plasma membrane. To investigate if the HopA1-PLL4 and 
HopA1-PLL5 interactions occur at the plasma membrane, I performed 
plasmolysis experiments to visualize Hechtian strands connecting the plasma 
membrane to the cell wall. Plasmolysis of cells coinfiltrated with HopA1-nYFP 
and PLL4-cYFP and HopA1-nYFP and PLL5-cYFP in the presence of 5% NaCl 
confirmed that these interactions occurred at the plasma membrane as indicated 
by the presence of reconstituted YFP in Hechtian strands (Fig. 1B). To further 
confirm that HopA1 interacted with PLL4 and PLL5 at the plasma membrane, I 
did colocalization experiments with hopA1 fused to red fluorescence protein 
(RFP) gene and PLL4 or PLL5 fused to green fluorescence protein (GFP) gene. 
When Agrobacterium strains expressing HopA1-RFP and PLL4-GFP were 
coinfiltrated into N. benthamiana leaves I found that they both localized to the  
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Figure 1. HopA1 interacts with the Arabidopsis type 2C protein 
phosphatases PLL4 and PLL5. (A) Yeast two-hybrid analyses show interaction 
when strains containing HopA1 with PLL4 or PLL5 were grown on selective 
media (QDO and -Trp-Leu+XαGal). No interaction was seen when strains 
containing PLL4 or PLL5 with the empty vector (EV) control were plated on 
selective media. (B) Bimolecular fluorescence complementation (BiFC) assays 
between HopA1 and PLL4 and HopA1 and PLL5. Nicotiana benthamiana leaves 
were coinfiltrated with HopA1-nYFP and PLL4-cYFP or PLL5-cYFP by 
Agrobacterium-mediated transformation. Green fluorescence indicates in planta 
interaction between HopA1 and PLL4 or PLL5. No fluorescence was observed 
when nYFP control was coinfiltrated with PLL4-cYFP or PLL5c-YFP. Red 
fluorescence represents chloroplast autofluorescence. Pictures were taken 2 
days after infiltration. (C) HopA1-RFP and PLL4-GFP and HopA1-RFP and 
PLL5-GFP were transiently co-expressed in N. benthamiana by Agrobacterium-
mediated transformation. HopA1-RFP colocalized with PLL4-GFP or PLL5-GFP 
mainly at the plasma membrane, as seen in merged pictures of the green and 
red channels. Chlorophyll autofluorescence appears blue in these micrographs. 
Infiltrated cells were photographed 2 days after infiltration. For panels B and C, 
plasmolysis experiments were performed in the presence of 5% NaCl for 10 m. 
Arrows indicate visible Hechtian strands. 
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plasma membrane (Fig. 1C). HopA1-RFP and PLL5-GFP coinfiltrations showed 
similar localization at the plasma membrane. Plasmolysis experiment confirmed 
colocalization of HopA1 and PLL4 and HopA1 and PLL5 in Hechtian strands (Fig. 
1C). Plasma membrane localization has been described for POL and PLL1, two 
other members of PP2C-C (14). In addition, localization to the plasma membrane 
has also been reported for HopA1 (chapter 3 of this thesis and (26)). These data 
confirm that the interactions of HopA1 with PLL4 and HopA1 with PLL5 occur at 
the plasma membrane. 
PLL4 and PLL5 have roles in leaf development and are induced after 
pathogen infection. Members of the PP2C-C are regulators of meristem and 
organ development as abnormal leaf development was observed in T-DNA 
insertion mutants in each of these genes (30). Leaf phenotypes described for 
these T-DNA mutants were mainly in the A. thaliana ecotype Ler background, 
and it was reported that the phenotypes of pll4-1 and pll5-1 mutants were weaker 
in the A. thaliana Col-0 background. I acquired seeds of T-DNA insertion mutants 
in PLL4 and PLL5 in the A. thaliana Col-0 background. The pll4 
(SALK_206631C) and pll5 (SALK_044162C) mutants were genotyped to confirm 
T-DNA insertion mutagenesis of these genes (Fig. S2). I found abnormal leaf 
development in pll4 and pll5 mutants compared to wild type Col-0 plants (Fig. 2A). 
Leaves were longer and more curled on the mutants than wild type Col-0. This 
phenotype was much more pronounced in pll5 than in pll4. I crossed these 
mutants to generate the pll4 pll5 double mutant. I observed that the Col-0 pll4 
pll5 double mutant carried the pll5 phenotype. I performed qRT-PCR analysis to 
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determine the expression of PLL4 and PLL5 in the single and double mutants 
and confirmed that their expression was greatly reduced in mutants compared to 
wild type Col-0 (Fig. S3). To begin characterization of these phosphatases in 
regards to plant immunity, I investigated if they were previously reported to be 
induced during biotic stress using the eFP browser (http://bar.utoronto.ca). I 
found that PLL4 and PLL5 were induced by several biotic stresses including 
DC3000 hrcC mutant and flg22, the 22-amino acid epitope from bacterial flagellin 
PAMP. Next I wanted to confirm if PLL4 and PLL5 were induced by DC3000 
infections. I measured gene expression of PLL4 and PLL5 in A. thaliana Col-0 
plants infiltrated with DC3000 or mock treatments 6 hours after inoculation. 
Interestingly, both PLL4 and PLL5 were induced by DC3000 (Fig. 2B). FRK1 and 
NHL10 have been extensively used as hallmark immunity-regulated genes (6, 7, 
17, 22, 28). Therefore, I also measured expression of FRK1 and NHL10 after 
DC3000 treatment as positive controls. As expected, these genes were highly 
induced by DC3000 (Fig. 2B). In addition, I tested induction of PLL4 and PLL5 by 
an avirulent strain DC3000(pavrRpm1), which produces the T3E AvrRpm1 that is 
recognized in A. thaliana Col-0 by the R protein RPM1 inducing ETI (9). PLL4 
and PLL5 were both induced by this avirulent strain indicating that they are 
induced during ETI (Fig. 2C). To explore if PLL4 and PLL5 are induced during 
PTI, I infiltrated A. thaliana Col-0 with flg22. PLL4 and PLL5 were highly induced 
by flg22 (Fig. 2D). Altogether, these data indicate that PLL4 and PLL5 are 
induced by P. syringae during ETI and PTI. This suggests that PLL4 and PLL5 
play roles in plant immunity.  
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Figure 2. PLL4 and PLL5 are induced after pathogen infection. (A) Pictures 
of A. thaliana Col-0, pll4 (SALK_206631C), pll5 (SALK_044162C), and pll4 pll5 
double mutant. Mutations in PLL4 and PLL5 resulted in altered leaf development, 
even more pronounced in the pll5 mutant. Col-0 plants were syringe-infiltrated 
with 1 x 106 cells/mL of DC3000 (B), DC3000(pavrRpm1) (C) or 1 µM flg22 (D). 
Infiltration with 5mM MES buffer (pH 5.6) was used as mock control for each 
experiment. Leaves were harvested 6 h after infiltration for RNA extraction. 
Expression of PLL4 and PLL5, as well as the immunity-regulated genes FRK1 
and NHL10, was measured by qRT-PCR analyses. PLL4 and PLL5 were induced 
by all treatments. Different lowercase letters in panels B, C and D indicate that 
the values are significantly different (p ≤ 0.05). Standard error bars are shown. 
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PLL4 and PLL5 act in plant immunity as negative regulators. No role in plant 
immunity has been described for any members of the PP2C-C family of 
phosphatases including PLL4 and PLL5. I first investigated the role of these 
phosphatases during pathogen infection. Transgenic plants expressing PLL4 or 
PLL5 both fused to a hemagglutinin (HA) tag, hereinafter referred to as PLL4-OX 
and PLL5-OX, were generated in A. thaliana Col-0 using an estradiol-inducible 
vector. Expression of each protein was confirmed with immunoblots using anti-
HA antibody (Fig. S4). Wild type Col-0, PLL4-OX, and PLL5-OX plants, as well 
as pll4, pll5, and pll4 pll5 mutant plants were syringe-inoculated with 2 x 105 
cells/mL of DC3000. I found that DC3000 grew better in plants expressing either 
PLL4-HA or PLL5-HA but worse in pll4, pll5, and pll4 pll5 mutants comparing 
each transgenic or mutant plants to wild type Col-0 (Fig. 3A). DC3000 growth 
was greatly reduced in pll4 pll5 double mutant and disease symptoms were 
barely visible compared to wild type Col-0 plants (Fig. 3B). To further 
characterize the involvement of these phosphatases in plant immunity, I analyzed 
how well these plants were able to induce PTI by measuring flg22-induced ROS 
production and flg22-induced callose deposition. Wild type Col-0, PLL4-OX , and 
PLL5-OX plants were treated with estradiol to induce expression of each 
phosphatase and 24 hours later samples were harvested for ROS assay. I found 
that flg22 treatment induced higher levels of ROS production in wild type Col-0 
compared to PLL4-OX and PLL5-OX pretreated with estradiol (Fig. 3C). These 
data suggest that PLL4 and PLL5 are negative regulators of immunity since 
overexpression of these phosphatases resulted in plants with reduced PTI-  
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Figure 3. PLL4 and PLL5 are negative regulators of plant innate immunity. 
(A) Wild type Col-0, transgenic plants overexpressing PLL4 (PLL4-OX) and PLL5 
(PLL5-OX), pll4, pll5, and pll4 pll5 mutant plants were syringe-inoculated with 2 x 
105 cells/mL of DC3000. Bacterial growth was counted 0 and 3 days after 
inoculation (dai). DC3000 grew better in PLL4-OX and PLL5-OX plants and were 
reduced in growth in pll4 and pll5 mutants (B) Disease symptoms of plants 
inoculated with DC3000 as described in A. Pictures taken 4 dai. (C). Wild type 
Col-0 and estradiol inducible PLL4-OX and PLL5-OX plants were infiltrated with 
20 µM estradiol (+EST) or water (-EST). Twenty-four hours later, leaves were 
treated with 1 µM flg22 and ROS production was determined. Estradiol-inducible 
expression of PLL4 and PLL5 suppressed the flg22-induced ROS production. (D) 
Plants were syringe-infiltrated with 10 µM flg22 and callose deposition was 
determined; leaves were harvested after 16 h and callose was stained with 
aniline blue. Pictures were taken using a fluorescence microscope and the 
number of callose deposits were counted using Image J software. T-DNA 
mutants in PLL4 and PLL5 have increased flg22-induced callose deposition, 
while PLL4-OX and PLL5-OX lines were suppressed in this immune response. 
The different lowercase letters in A, C, and D indicate statistical differences (p < 
0.05) and SE bars are shown. 
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related ROS production. Next I examined callose deposition in plants induced by 
flg22. I infiltrated wild type Col-0, pll4, pll5, and pll4 pll5 plants with 10 µM flg22 
and carried out callose deposition assays. I observed more callose deposits in 
the pll4, pll5, and pll4 pll5 mutants compared to Col-0 plants (Fig. 3D). In addition, 
lower amounts of callose were observed in PLL4-OX and PLL5-OX plants after 
flg22 treatment (Fig. 3D). Collectively, these results indicate that PLL4 and PLL5 
act as negative regulators of plant immunity. 
To further investigate PLL4’s and PLL5’s effect on plant immunity, I analyzed 
expression of the PTI-induced genes FRK1 and NHL10 in pll4, pll5, and pll4 pll5 
mutants and in plants overexpressing PLL4 and PLL5. Expression of FRK1 and 
NHL10 was induced by the avirulent P. syringae strain DC3000(pavrRpm1) in 
Col-0 compared to a mock inoculation (Fig. 4A). Expression of these genes after 
DC3000(pavrRpm1) treatment was reduced in PLL4-OX and PLL5-OX plants but 
greatly enhanced in pll4, pll5, and pll4 pll5 mutants. Additionally, I measured 
FRK1 and NHL10 after flg22 treatment.  FRK1 and NHL10 expression was 
reduced in plants expressing PLL4 and PLL5, but enhanced in pll4, pll5, and pll4 
pll5 mutant plants (Fig. 4B). These findings confirm that PLL4 and PLL5 act as 
negative regulators of plant immunity. These data provide the first evidence of 
the involvement of PP2C-C, including PLL4 and PLL5, in plant immunity and 
provide the first evidence that a plant pathogen effector targets PP2C-C 
members. 
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Figure 4. PLL4 and PLL5 overexpressors suppressed and pll4 and pll5 T-
DNA mutants increased the expression of immunity-regulated genes. 
Expression analysis of the immunity-regulated genes FRK1 and NHL10 was 
measured by qRT-PCR after induction with 1 x 106 cells/mL of 
DC3000(pavrRpm1) (A) or 1 µM flg22 (B). Infiltrated leaves were harvested after 
6 h for RNA extraction. Expression of FRK1 and NHL10 was down-regulated in 
PLL4-OX and PLL5-OX and up-regulated in pll4, pll5, and pll4 pll5 mutant plants 
after DC3000(pavrRpm1) and flg22 treatments. Different letters indicate 
statistical differences (p < 0.05).  Error bars represent the standard error. 
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Discussion 
In this study I examined the role of the type III effector HopA1 from P. syringae 
pv. tomato DC3000. I identified the Arabidopsis targets of HopA1, which are the 
PP2C-C PLL4 and PLL5. I showed that HopA1 interacts with PLL4 and PLL5 
using the yeast two-hybrid, BiFC and co-localization assays (Fig. 1). HopA1 
interacts with PLL4 and PLL5 at the plasma membrane as plasma membrane-
cell wall connections known as Hechtian strands were observed if the tissue was 
subjected to plasmolysis (Fig. 1B-C). PP2C-C family members have N-terminal 
myristoylation and palmitoylation signal peptides that mediate their localization to 
the plasma membrane (14). POL and PLL1 are dual-acetylated plasma 
membrane proteins that require phospholipids, mainly phosphatidylinositol (4) 
phosphate [PI(4)P], for activation and phosphatase activity in planta (14). 
Furthermore, the rice homolog of PLL4 and PLL5, XB15, also localizes to the 
plasma membrane of rice protoplast cells (24).  
HopA1 from P. syringae pv. syringae 61 is recognized in Arabidopsis by the R 
protein RPS6 (21). It was recently reported that EDS1, a positive regulator of 
immunity, forms complexes with the R proteins RPS6 and RPS4 and that two P. 
syringae effectors, AvrRps4 and HopA1, target EDS1 (3). In chapter three of this 
thesis I presented data that indicates that I could not discern any interaction of 
HopA1 with EDS1 in a yeast two-hybrid assay. However, I observed weak 
interaction between HopA1 and EDS1 in BiFC assays (Fig. S5). Since HopA1 
interacts with PLL4 and PLL5 and possibly with EDS1, I investigated whether 
PLL4 and/or PLL5 interacted with EDS1. Preliminary results indicate that EDS1 
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interacts with PLL4 and PLL5 in a yeast two-hybrid assay (Fig. S6). However I 
could not detect any interaction in planta using BiFC assays (not shown). EDS1 
localizes to the cytoplasm and nucleus of plant cells, and HopA1, PLL4, and 
PLL5 localize to the plasma membrane. Differences in their subcellular 
localization and the fact that I could not detect interactions in multiple assays 
suggest that EDS1 does not interact with HopA1, PLL4, or PLL5. This 
phenomenon needs to be further investigated and is outside the scope of this 
chapter. 
Because PLL4 and PLL5 localize to the plasma membrane, it is likely that 
their targets are plasma membrane-localized proteins. Several examples of 
plasma membrane-localized targets of PP2Cs exist. For example, XB15, the rice 
homolog of PLL4 and PLL5, interacts and dephosphorylates the plasma 
membrane localized PRR XA21 leading to a negative regulation of XA21-
mediated immunity (24). In addition, the Arabidopsis Kinase-Associated Protein 
Phosphatase interacts with several plasma membrane-localized receptor kinases 
including FLS2, CLV1, SERK1, BRI1, and BAK1 (11, 15, 29). My hypothesis is 
that PLL4 and PLL5 play roles in plant immunity as negative regulators by acting 
on a PRR kinase domain keeping the PRR inactive in the absence of biotic 
stress and that HopA1 prevents these phosphatases from becoming inactive, 
which prevents PTI from being induced even after PAMP detection. 
The evidence that PLL4 and PLL5 act as negative regulators of plant 
immunity are as follows: (i) T-DNA mutants in PLL4 or PLL5 are more resistant to 
DC3000, while overexpressing lines are more susceptible (Fig. 3A-B); (ii) Plants 
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overexpressing PLL4 or PLL5 display reduced flg22-induced callose deposition 
(Fig. 3C); (iii) T-DNA mutants in PLL4 and PLL5 have more flg22-induced ROS 
production, while overexpressing lines are compromised in this response (Fig. 
3D); and (iv) expression of the immunity-regulated genes FRK1 and NHL10 is 
enhanced in T-DNA mutants in PLL4 and PLL5 and decreased in overexpressing 
lines after DC3000(pavrRpm1) and flg22 treatments (Fig. 4). Mutants defective in 
negative regulators of immunity would be expected to be more resistant to 
pathogens because their immune responses are no longer repressed. Moreover, 
plants overexpressing a negative regulator would be expected to be more 
susceptible to pathogens because their immune responses are prevented from 
being induced. The observations of plants affected in PLL4 and PLL5 are 
consistent with both proteins acting as negative regulators of immunity. 
Here I propose a model for PLL4’s and PLL5’s role in plant immunity and why 
HopA1 targets these phosphatases (Fig. 5). PLL4 and PLL5 are negative 
regulators of plant immunity that localized at the plasma membrane of plant cells. 
In the absence of the pathogen, PLL4 and PLL5 keep the PTI pathway off by 
reducing the phosphorylation of PAMP receptor complexes. PAMP receptor 
complexes are the best candidates for PLL4 and PLL5 substrates since they 
reside at the plasma membrane and their kinase domains are activated by 
phosphorylation. Once P. syringae lands on the leaf surface and gains access to 
the apoplast, PLL4 and PLL5 are deregulated by an unknown mechanism. This 
leads to activation of PTI and the induction of immune responses including 
callose deposition and ROS production to restrict pathogen ingress. One way  
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Figure 5. Model for PLL4’s and PLL5’s role immunity and as HopA1 targets. 
PLL4 and PLL5 are two negative regulators of immunity that localize to the plant 
plasma membrane. These phosphatases most likely inhibit the activation of 
PAMP receptors complexes that also reside at the plasma membrane by 
reducing their phosphorylation and maintaining the pathogen-associated 
molecular pattern-triggered immunity (PTI) pathway in an inactivate state in the 
absence of pathogen stress. When P. syringae is in contact with plant cells the 
phosphatase activity of PLL4 and PLL5 is normally inhibited by an unknown 
mechanism. This leads to activation of PTI and immune responses like callose 
deposition and ROS production, which restricts bacterial multiplication. However, 
P. syringae overcomes this restriction by injecting the type III effector HopA1. 
Inside cells, HopA1 interacts with PLL4 and PLL5 most likely inhibiting their 
deregulation to keep PTI off, which allows the pathogen to continue to multiply 
and cause disease. 
 
 
 
 
 
 
 
 
	  	   175	  
that P. syringae overcomes plant immunity is by injecting the type III effector 
HopA1. HopA1 targets PLL4 and PLL5 at the plasma membrane to block their 
deregulation, which keeps PTI from becoming activated. This allows the 
pathogen to grow and ultimately to cause disease. 
In summary, my work demonstrates that HopA1 interacts with the PP2Cs 
PLL4 and PLL5 to suppress PTI. PLL4 and PLL5 are involved in plant immunity 
by acting as negative regulators. Future studies for this project include the 
identification of PLL4 and PLL5 substrates, and determining the mechanism that 
HopA1 uses to inhibits PLL4 and PLL5. 
 
Materials and methods 
Cloning. The hopA1 gene was PCR amplified from DC3000 using primers 
P2844 and P2845. From A. thaliana Col-0 the following genes were amplified 
with the specified primer pair: PLL4 (AT2G28890) with P4580 and P4581; PLL5 
(AT1G07630) with P4594 and P4595; PLL1 (AT2G35350) with P4896 and 
P4897; PLL2 (AT5G02400) with P4611 and P4612; and EDS1 (AT3G48090) with 
P4878 and P4445. The resulting PCR products were cloned into the Gateway 
vector pENTR-D resulting in pLN3203 (hopA1), pLN5173 (PLL4), pLN5176 
(PLL5), pLN5463 (PLL1), pLN5204 (PLL2), and pLN4909 (EDS1). To generate 
estradiol-inducible plants expressing PLL4 or PLL5, pLN5173 (PLL4) and 
pLN5176 (PLL5) were separately recombined into pLN604, the gateway-
compatible pER8 vector (34). For yeast two-hybrid vectors, pENTR-D constructs 
pLN3203 (hopA1) and pLN4909 (EDS1) were recombined into the gateway-
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compatible DNA-binding domain vector pGBKT7 (pLN2232) by LR recombination 
reaction. The pENTR-D constructs pLN5173 (PLL4), pLN5176 (PLL5), pLN5463 
(PLL1), and pLN5204 (PLL2) were recombined into the gateway-compatible 
activation domain vector pGADT7 (pLN1658). 
For BiFC constructs, hopA1 with a 3’ EcoRI restriction site was amplified with 
primers P3560 and P4613. The portion of YFP corresponding to the N-terminal 
region (nYFP) with a 5’ EcoRI restriction site was amplified with primers P4615 
and P4341. The hopA1 and nYFP PCR products were gel-extracted, digested 
with EcoRI, ligated, PCR-amplified with primers P3560 and P4341, and cloned 
into pENTR-D. PLL4 with a 3’ EcoRV restriction site was amplified with primers 
P4580 and P5386; PLL5 with a 3’ EcoRI restriction site was amplified with 
primers P4594 and P4692; and EDS1 with a 3’ XhoI restriction site was amplified 
with primers P4878 and P5385. The portion corresponding to C-terminal region 
of YFP (cYFP) was amplified with reverse primer P4343 and forward primers 
P5081 (containing a 5’ EcoRV restriction site), P4693 (containing a 5’ EcoRI 
restriction site), or P4342 (containing a 5’ XhoI restriction site). The PCR 
products were gel-extracted, digested with the corresponding restriction enzymes, 
and ligated. From ligation products, PLL4-cYFP was amplified with primers 
P4580 and P4343, PLL5-cYFP with P4596 and P4343, and EDS1-cYFP with 
P4878 and P4343. These fusion PCR products were cloned into pENTR-D. All 
BiFC constructs were recombined by LR reaction to the gateway-compatible 
pPZP212 vector (pLN462 (18)).  
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To make C-terminal fusions to eqFP611, the gene encoding the RFP (12), 
hopA1 and EDS1 with a 3’ XhoI site were amplified with primer pairs 
P3560/P2844 and P4878/P5385, respectively. RFP with a 5’ XhoI site was 
amplified with primers P3388 and P3040. PCR fragments were gel-extracted, 
digested with XhoI, ligated and PCR-amplified with the corresponding primer set: 
P3560/P3040 for hopA1-RFP and P4878/P3040 for EDS1-RFP. The hopA1-RFP 
and EDS1-RFP fusions were cloned into pENTR-D and then recombined into 
pLN462. For C-terminal GFP fusions, pLN5173 (PLL4) and pLN5176 (PLL5) 
were recombined into pK7FWG2 (20).  
Yeast two-hybrid analyses. Saccharomyces cerevisiae strain Y187 (MATα) 
was transformed with pGBKT7 constructs (-Trp) and strain AH109 (MATa) was 
transformed with pGADT7 constructs (-Leu). Yeast Y187 (pGBKT7:HopA1, 
EDS1 or EV) was mated to yeast AH109 (pGADT7:PLL4 or PLL5) in a mating 
plate (yeast extract peptone dextrose, YPD). Y187 (pGBKT7:HopA1) was also 
mated to AH109 (pGADT7:PLL1 or PLL2). To test interaction of target proteins 
mated yeast strains were plated in selective QDO and -Trp-Leu+XαGal media 
and photographed 2 days later.	  
Confocal microscopy. BiFC, RFP- and GFP-fusion constructs in the plant 
constitutive expression vector pLN462 were transformed into Agrobacterium 
C58C1. Agrobacterium strains were infiltrated into leaves of N. benthamiana as 
described previously (18) at a final absorbance (OD600) of 0.4 for each strain. 
Infiltrated leaves were imaged in a Nikon A1 confocal mounted on an Eclipse 90i 
Nikon compound microscope 2 days after agroinfiltrations. The following 
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excitation (ex) and emission (em) wavelengths were used for colocalization 
experiments: GFP, 488 nm (ex) and 500-550 nm (em); and RFP, 561.4 nm (ex) 
and 570-620 nm (em). For BiFC assays, pictures were taken sequentially at 
514.5 nm (ex) and 525-555 nm (em). Chloroplasts were imaged at 640.6 nm (ex) 
and 663-738 nm (em). Plasmolysis was performed in the presence of 5% NaCl 
for 10 m. 
Genotyping of Arabidopsis T-DNA lines. T-DNA insertion lines in PLL4 and 
PLL5 were requested from the Arabidopsis Biological Resource Center. Cross-
fertilization was performed using pll5 as female plant and pll4 as pollen donor 
plant. Single and double mutants were genotyped using primers P5087 (right 
border primer of SALK_206631), P5088 (left border primer of SALK_206631), 
P5082 (right border primer of SALK_044162), P5083 (left border primer of 
SALK_044162), and LBa1 (P2630, primer in T-DNA). 
Generation of transgenic Arabidopsis plants. PLL5 and PLL4 in the estradiol-
inducible pER8 vector were transformed into Agrobacterium C58C1. Arabidopsis 
Col-0 plants were transformed using the floral-dip method (2). Transgene 
expression was confirmed with immunoblots using anti-HA primary antibody 
(Roche, Basal, Switzerland) and anti-rat immunoglobulin G alkaline-phosphatase 
conjugates as secondary antibodies (Sigma Chemical Co., St. Louis, U.S.A.). 
Plant assays. For pathogenicity assays DC3000 was grown overnight in King’s 
B (KB) media at 30°C. Arabidopsis plants were syringe-inoculated with 2 x 105 
cells/mL of DC3000. Samples were collected 0 and 3 days after inoculation, 
ground in 250 µL water, serially-diluted and plated on KB agar plates containing 
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25 µg/ml rifampicin. Bacterial numbers were counted after two days. For plants 
over-expressing PLL4 (PLL4-OX) or PLL5 (PLL5-OX) after estradiol treatment, 
plants were sprayed with 30 µM estradiol 1 day before DC3000 inoculations. 
ROS and callose assays were done as published (6) and as previously described 
in chapters 2 and 3 of this thesis. 
qRT-PCR analysis. Total RNA was purified using RNeasy plant mini kit with on-
column DNase treatment (QIAGEN). Reverse transcription was performed 
following RETROscript Reverse transcription kit (Ambion) using oligo(dT) primers 
with heat denaturation of the RNA. qRT-PCR was run using iTaq Universal 
SYBR green supermix (BioRad) on a BioRad iCycler. Gene expression in wild 
type Col-0 and each mutant was measured using primer pairs P5091/P5092 for 
PLL4 and P5084/P5085 for PLL5. Primers to measure gene expression of FRK1 
(AT2G19190) and NHL10 (AT2G35980) were P4476/P4477 and P4562/P4563, 
respectively. Gene expression relative to Col-0 was calculated using the 2-ΔΔCT 
method with actin2 as the reference gene and mock treated Col-0 as the 
reference sample. Primers for actin (AT3G18780) were P3775 and P3776. 
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Supplemental figures and tables 
Supplemental Table 1. Plasmids used in this study 
Primer Sequence 
P2630 5’-TGGTTCACGTAGTGGGCCATCG-3’ 
P2844 5’-CACCCTCGAGATGAACCCCATTCAGTCACG-3’ 
P2845 5’-GCTCACTAGTTCAAGCGTAATCTGGAACATCGTATGGGTATTTC 
GTGTTTCGAAGGGCCG-3’ 
P3040 5’-TCAAAGACGTCCCAGTTTGG-3’ 
P3388 5’-AGTCCTCGAGATGAATTCACTGATCAAGG-3’ 
P3560 5’-CACCATGAACCCCATTCAGTCACG-3’ 
P3775 5’-GGCATCAATTCGATCACTCAGAGC-3’ 
P3776 5’-ACCTTAGAAGATGGTTGGTTGACT-3’ 
P4341 5’-TCAGGCCATGATATAGACGTTGTGG-3’ 
P4342 5’-GATCCTCGAGATGGACAAGCAGAAGAACGGCATC-3’ 
P4343 5’-TCAGATAGATCTCTTGTACAGCTC-3’ 
P4445 5’-CACAGCTCGAGTCAGGTATCTGTTATTTCATCCAT-3’ 
P4476 5’-ACCCCGGATACTATTCGACTCGCCA-3’ 
P4477 5’-TGAGCTTGCAATAGCAGGTTGGCCT-3’ 
P4562 5’-TCACTGTTCCTGTCCGTAACCCAA-3’ 
P4563 5’-TGGTACTAAACCGCTTTCCTCGT-3’ 
P4580 5’-CACCATGGGTAACGGAATCGGGAAG-3’ 
P4581 5’-TACACAAGATTTCCACATTCT-3’ 
P4594 5’-CACCATGGGTAACGGAGTAACAAAA-3’ 
P4595 5’-TACACAAGATTTCCACATTCT-3’ 
P4611 5’-CACCATGGGAAATGGAGTCACCACT-3’ 
P4612 5’-CATTGATGATCTCCATATTCT-3’ 
P4613 5’-GATCGAATTCTTTCGTGTTTCGAAGGGCCGG-3’ 
P4615 5’-GATCGAATTCATGGTGAGCAAGGGCGAGGAG-3’ 
P4692 5’-GATCGAATTCTACACAAGATTTCCACATTCT-3’ 
P4693 5’-GATCGAATTCATGGACAAGCAGAAGAACGGCATC-3’ 
P4878 5’-CACCATGGCGTTTGAAGCTCTTACC-3’ 
P4896 5’-CACCATGGGAAGTGGATTCTCCTCC-3’ 
P4897 5’-AAGATACTTTCCTGATGACTT-3’ 
P5081 5’-GATCGATATCATGGACAAGCAGAAGAACGGCATC-3’ 
P5082 5’-CATTCAAAGAACCAACCTTTGAC-3’ 
P5083 5’-ACGAGGAAACGATGATGAATG-3’ 
P5084 5’-ACAAGGTGAACGAAGACGGT-3’ 
P5085 5’-CAACATAGTACATGATTCAGAGTTGATGA-3’ 
P5087 5’-TCGATTACAAAGGGACGTCAC-3’ 
P5088 5’-AACACTTCCAACACGTATTTGC-3’ 
P5091 5’-ACGTCTTCCTGCGTTTTTGAG-3’ 
P5092 5’-AGGAAGAATGTGGAAATCTTGTGT-3’ 
P5385 5’-GATCCTCGAGGGTATCTGTTATTTCATCCAT-3’ 
P5386 5’-GATCGATATCTACACAAGATTTCCACATTCT-3’ 
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Supplemental Figure 1. HopA1 does not interact with other members of 
clade C of type 2C protein phosphatases. Yeast two-hybrid between HopA1 
and two other members of PP2Cs clade C. HopA1 did not interact with PLL1 and 
PLL2 displaying similar reporter induction as the negative control when plated on 
selective QDO and -Trp-Leu+XαGal media. 
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Supplemental Fig. 2. Characterization of SALK T-DNA knock-out lines in 
PLL4 and PLL5 genes. (A) Schematic representation of PLL4 (AT2G28890) in 
A. thaliana Col-0 in relation to the SALK T-DNA insertion line SALK_206631C. T-
DNA insertion (triangle) is in the fourth exon of PLL4. Primers used to confirm the 
homozygosity of the pll4 mutant are depicted as P1 (P5088), P2 (P2630), and P3 
(P5087). (B) PCR with primer set P1/P3 that amplifies the wild type Col-0 DNA 
(1136 bp) and primer set P2/P3 that amplifies the T-DNA insertion junction in the 
pll4 mutant (509-809 bp). PCR confirmed that three pll4 mutant plants are 
homozygous for the T-DNA insert. (C) Schematic representation of PLL5 
(AT1G07630) in A. thaliana Col-0 in relation to the SALK T-DNA insertion line 
SALK_044162C. T-DNA insertion (triangle) is in the third exon of PLL5. Primers 
used to confirm the homozygosity of the pll5 mutant are depicted as P1 (P5083), 
P2 (P2630), and P3 (P5082). (D) PCR with primer set P4/P6 that amplifies the 
wild type Col-0 DNA (1053 bp) and primer set P5/P6 that amplifies the T-DNA 
insertion junction in the pll4 mutant (533-833 bp). PCR confirmed that three pll5 
mutant plants are homozygous for the T-DNA insert. 
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Supplemental Fig. 3. PLL4 and PLL5 show reduced expression in single 
and double mutants. Gene expression of PLL4 and PLL5 was analyzed by 
qRT-PCR analysis in the corresponding single or double mutant lines. 
Expression of each gene was greatly reduced in mutants compared to wild type 
Col-0. Letters “a” and “b” are statistically different (p < 0.001). Error bars 
designate standard error. 
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Supplemental Fig. 4. Immunoblots showing in planta expression of PLL4 
and PLL5. A. thaliana Col-0 plants expressing PLL4 or PLL5 in an estradiol-
inducible manner were sprayed with 30 µM estradiol to induce expression of 
target proteins. Leaf tissue was collected 24 hours after inoculation and 
performed immunoblots with anti-HA antibody. Expected protein size: PLL4= 
72.48 kDa and PLL5 = 74.27 kDa. 
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Supplemental Fig. 5. HopA1 interacts with the immunity regulator EDS1. 
BiFC assays show interaction between HopA1 and EDS1. HopA1-nYFP and 
EDS1-cYFP were coinfiltrated into N. benthamiana leaves, as well as EDS1-
cYFP with nYFP vector control. Cells were visualized under a confocal 
microscope 2 days after infiltration. HopA1 and EDS1 interacted in planta. 
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Supplemental Fig. 6. EDS1 interacts with PLL4 and PLL5. Yeast two-hybrid 
interactions between EDS1 and PLL4 and PLL5 show growth of yeast strain 
expressing EDS1-PLL4 and EDS1-PLL5 when plated on selective media. No 
interaction was detected when PLL4 or PLL5 and the vector control were plated 
on selective media. 
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The plant pathogenic bacteria Pseudomonas syringae depends on the type III 
protein secretion system (T3SS) for pathogenicity. Type III effectors (T3Es), 
virulence proteins injected into plant cells through the T3SS, are key virulence 
determinants of this pathogen. A casual agent of bacterial speck of tomato, P. 
syringae pv. tomato DC3000 (Pto DC3000), injects about 35 T3Es into plants to 
suppress plant immunity. An important topic of research in the field of molecular 
plant-microbe interactions has been the characterization of T3Es to understand 
how these virulence determinants suppress the plant immune system. Research 
in this field has identified the enzymatic activities and plant targets of only a 
subset of P. syringae T3Es. Thus, the majority of T3E targets and their 
biochemical function remain to be elucidated. 
To better understand plant-microbe interactions, I fully characterized two 
T3Es, HopD1 and HopA1. HopA1 was first isolated from P. syringae pv. syringae 
61 and was one of the first T3E known to elicit a hypersensitive response (HR) in 
plants after being injected into plant cells by the T3SS (1, 7). The HR is a 
programmed cell death response at the site of infection to restrict the spread of 
the pathogen. It is a characteristic response associated with effector-triggered 
immunity (ETI), since it is elicited after recognition of a T3E by the corresponding 
resistance (R) protein in plants. T3Es have been classified based on their ability 
to suppress the HR induced by HopA1 in plants (6, 8). Among the strongest ETI 
suppressors was HopD1 (6). I investigated the activities of HopD1 and HopA1 in 
planta, their subcellular localization and host targets to elucidate the host 
component(s) inhibited by these T3Es to hijack the plant immune system. Main 
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conclusions of this thesis and questions that remain to be addressed are 
highlighted below. 
 
HopD1 suppresses ETI but not PAMP-triggered immunity 
T3Es can suppress both branches of plant immunity: pathogen-associated 
molecular pattern (PAMP)-triggered immunity (PTI) and ETI. PTI likely evolved 
first to inhibit the growth of pathogens and nonpathogens in plant tissue because 
it recognizes general conserved molecules on microbes and ETI later as a 
stronger more prolonged immunity that is induced by pathogen effectors that 
were first delivered to plants to suppress PTI. In bacterial-plant interactions these 
effectors are all T3Es. However, our data shows that HopD1 evolved after PTI to 
exclusively suppress ETI responses. While this would be predicted based on 
evolution, HopD1 is the first published account of an effector that suppresses ETI 
but not PTI. Besides being one of the strongest ETI suppressors, expression of 
HopD1 in Arabidopsis thaliana allowed better growth of ETI-inducing Pto DC3000 
strains. Pathogen strains that are recognized by R proteins and, therefore, 
induce ETI are historically known as avirulent strains. Two examples of Pto 
DC3000 avirulent strains are DC3000(pavrRpm1) and DC3000(pavrRpt2) that 
are recognized by the Arabidopsis R proteins RPM1 and RPT2, respectively (2, 4, 
14). In planta expression of HopD1 did not allow better growth of the Pto DC3000 
hrcC mutant strain. This strain is a PTI-inducer since it has a defective T3SS and 
cannot inject any T3Es; thus plants can sense bacterial PAMPs from this strain 
and the strain cannot suppress PTI. These results suggested that while HopD1 is 
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a strong ETI suppressor, it did not suppress PTI. Furthermore, we also showed 
that HopD1 could suppress the AvrRpm1-induced HR, ion leakage and callose 
deposition responses but not PTI-induced callose deposition and production of 
reactive oxygen species (ROS). Altogether, our data indicates that HopD1 is a 
T3E that was acquired later in the coevolution of the Pto DC3000-Arabidopsis 
interaction after establishment of the R protein immune receptor surveillance 
system. 
 
HopD1 targets Arabidopsis NAC transcription factor NTL9 to 
inhibit expression of NTL9-regulated genes 
Our characterization of HopD1 provides the first evidence of a Pto DC3000 T3E 
targeting a NAC transcription factor as a way to suppress plant immunity. We 
showed that HopD1 interacts with the Arabidopsis NTL9, a membrane-bound 
NAM, ATAF1/2, CUC2 (NAC) transcription factor. NAC transcription factors are 
involved in plant development, and biotic and abiotic stress regulation (20). NTL9 
belongs to the NAC with transmembrane motif 1 (NTM1) family of transcription 
factors that are tethered to intracellular membranes (10, 11). NTL9 has been 
implicated in regulating osmotic stress during leaf senescence (21). HopD1 
interacted with NTL9 at the endoplasmic reticulum (ER) of plant cells. As a 
transcription factor, NTL9 mediates activation of target genes. We identified and 
confirmed several genes induced by NTL9. To understand the role of NTL9 in 
plant immunity, we selected a subset of NTL9-regulated genes that are known to 
be induced during biotic stress or involved in plant immunity. These genes were 
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upregulated by NTL9 during ETI but not PTI, and HopD1 suppressed induction of 
these NTL9-regulated genes. We hypothesize that NTL9 is anchored to the 
endoplasmic reticulum in a ready state and upon stress perception (osmotic 
stress and ETI) NTL9 is cleaved from the ER and translocated to the nucleus 
where it regulates expression of target genes. 
Recent studies have identified NAC transcription factors as cellular hubs for 
targets of effectors and virulence factors from several plant pathogens. The 
RxLR effector Pi03192 from the potato late blight pathogen Phytophthora 
infestans targets two potato membrane-bounds NAC transcription factors, NTP1 
and NTP2. Pi03192 interacts with NTP1/2 at the endoplasmic reticulum and 
blocks NTP1/2 relocalization from the ER to the nucleus after pathogen 
perception (13). In addition, the capsid protein (CP) of Turnip crinkle virus (TCV) 
targets the Arabidopsis NAC transcription factor TCV-interacting protein (TIP) (16, 
17). The virus CP binds to TIP to block its ability to localize to the nucleus. These 
data show that NAC transcription factors are important host targets for pathogens 
to suppress the plant immunity system. 
 
What is the mechanism of action for the HopD1 inhibition of 
NTL9-regulated genes? 
In an attempt to investigate the mechanism that HopD1 uses to inhibit NTL9 
function, we tested the subcellular localization of NTL9 with and without HopD1 
in Nicotiana benthamiana using Agrobacterium-mediated transient assays. 
Although we found that NTL9 relocalizes to the nucleus after Pto DC3000 
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treatment, we could not detect any inhibition of NTL9 relocalization to the nucleus 
by HopD1. Membrane bound NAC transcription factors are activated by 
proteolytic cleavage mediated by proteases or ubiquitination-dependent 
proteasome activities. The specific proteolytic event that mediates cleavage of 
NTL9 from the ER is not known and, therefore, remains to be identified. We also 
tested the ability of HopD1 to inhibit NTL9 transcription. We could not see a 
decreased in NTL9 transcription in the presence of HopD1 using a yeast one-
hybrid assay. Based on these results, HopD1 most likely affects NTL9’s function 
postranscriptionally. The precise mechanism of HopD1 inhibition of NTL9 
remains an important question to be answered as well as the role of NTL9 in 
plant immunity. 
There are 13 members of membrane-bound NAC transcription factors in 
Arabidopsis (10). Since HopD1 localizes to the endoplasmic reticulum, it is 
possible that HopD1 interacts with other membrane-bound NAC transcription 
factors to suppress plant defenses. That is, it is possible that NTL9 may not be 
the true HopD1 target and that the true target is a similar NAC transcription factor. 
This would explain why we were unable to see any effect on NTL9 by HopD1. If 
this is true, that another NAC transcription factor is the actual target of HopD1, 
then yeast two-hybrid and bimolecular fluorescence complementation (BiFC) 
assays can be performed to answer this question. If other NAC targets are 
identified, then similar experiments as the ones described in Chapter 2 would 
need to be done to determine if the new NAC targets are affected by HopD1. The 
best hypothesis to explain HopD1’s effect on NAC transcription factors remains 
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that HopD1 prevents the relocalization of the NAC transcription factor to the 
nucleus to prevent ETI-related transcription. It seems through the course of 
evolution if one effector evolved to target a specific component of immunity other 
effectors might have also evolved to target the same protein or process. Thus, 
the field of Pto DC3000-Arabidopsis interactions will also benefit from screening 
the complete T3E inventory for interaction with NTL9 and any other NAC 
transcription factors that is shown to interact with HopD1. 
 
Diversification of the HopA1 family of T3Es 
HopA1 is present in several P. syringae pathovars. I characterized two HopA1 
classes, one from P. syringae pv. syringae 61 (HopA161) and another class from 
P. syringae pv. tomato DC3000 (HopA1DC). HopA161 is an avirulence (Avr) 
protein in N. tabacum cultivar Xanthi (tobacco) and A. thaliana ecotype Ws-0. 
However, these plants do not recognize HopA1DC as an Avr protein. Avr proteins 
are different types of proteins in different pathogens. In bacterial pathogens, all  
Avr proteins to date are T3Es and when Avr proteins are recognized by R 
proteins they induce ETI including the HR. Even though these HopA1 classes 
share 56% amino acid sequence similarity, HopA1DC was not able to elicit an HR 
in tobacco and A. thaliana Ws-0. Thus, unlike HopA161, HopA1DC is not an Avr 
protein in N. tabacum cv. Xanthi or A. thaliana ecotype Ws-0. I also explored the 
expression of HopA1 proteins in a heterologous system. When I induced 
expression of HopA161 or HopA1DC in the model eukaryotic yeast 
Saccharomyces cerevisiae, I discovered that HopA161, but not HopA1DC, 
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inhibited yeast growth. Differences between HopA161 and HopA1DC were also 
observed when I explored their subcellular localization in N. benthamiana using 
the Agrobacterium-mediated transient assay. Both HopA1’s localize to the 
plasma membrane, cytoplasm, nucleus and nucleolus of plant cells. However I 
observed punctate spots along the plasma membrane and aggregation of 
chloroplasts around the nucleus only when HopA161 was transiently expressed in 
plants. Chloroplast aggregation around the nucleus is associated with late stages 
of programmed cell death (PCD) in plants and, since the HR is a type of PCD, it 
confirms the HR-eliciting phenotype of HopA161. I hypothesize that at a certain 
point in the evolution of the HopA1 family of T3Es, HopA1DC diverged such that it 
was no longer recognized as an Avr protein most likely as a result of selective 
pressures imposed by the ETI. 
Since HopA161 is recognized in tobacco (cv Xanthi) and A. thaliana Ws-0, I 
explored which portions of HopA161 were responsible for the elicitation of an HR 
in these plants. I discovered that a portion containing the C-terminal 186 amino 
acids of HopA161 was recognized in tobacco. These data indicate that the Avr 
domain of HopA161 resides in its C-terminus and is responsible for the elicitation 
of an HR in tobacco. However, I found that the N-terminal region of HopA161 was 
recognized in A. thaliana Ws-0, with the first 122 amino acids being sufficient for 
the elicitation of an HR. I was surprised by these results since all P. syringae 
T3Es to date have been recognized indirectly by the modifications that they carry 
out on their targets. The modification of the target is detected by an R protein 
inducing ETI as predicted by the guard hypothesis. The effector domains of T3Es 
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reside in their C-terminal region after the secretion signal and chaperone-binding 
site. In fact, the HopA1DC secretion signal and chaperone-binding site reside in 
the N-terminus 102 amino acids (9). Because of this it is not likely that the 
HopA161 portion from amino acids 1-122 has any virulence activity. These results 
indicate that HopA161 is probably directly recognized in A. thaliana Ws-0 by the R 
protein RPS6. However, the virulence domain of HopA161, which resides in its C-
terminus, is likely indirectly recognized in tobacco by a yet unknown R protein. 
This agrees with the guard hypothesis that states that R proteins monitor 
modifications on host proteins targeted by pathogen effectors; in this manner 
T3Es are indirectly recognized by R proteins inducing ETI. Indirect recognition 
has been demonstrated for the T3Es that have been looked at in manner. Thus, 
the direct recognition of HopA161 by the RPS6 R protein in A. thaliana Ws-0 
represents an exceptional case and warrants further study. 
 
HopA1DC suppresses PTI in Arabidopsis and resemble 
phosphothreonine lyases from animal pathogens 
To investigate the contribution of HopA1DC to the virulence of Pto DC3000, I 
performed pathogenicity assays in Arabidopsis. I found that the hopA1 mutant 
had reduced growth compared to wild type Pto DC3000 and that in planta 
expression of HopA1DC allowed better growth of wild type Pto DC3000 and the 
type III secretion defective hrcC mutant. Although the contribution of HopA1DC to 
the virulence of Pto DC3000 was subtle, it greatly reduced PTI responses, 
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including callose deposition and ROS production. Thus, HopA1DC suppresses 
PTI.  
The structure of HopA1DC encompassing residues 122 to 380 was determined 
and has similarity to a class of enzymes known as phosphothreonine lyases. 
Examples of this enzyme in animal pathogens include SpvC from Shigella, OspF 
from Salmonella and VirA from Chromobacterium (12, 22). The OspF/SpvC/VirA 
family of effectors with phosphothreonine lyase enzymatic activity irreversible 
removes the phosphate moiety from the phosphothreonine residue in the 
activation loop of host MAP kinases. Alignment of the structures of HopA1DC and 
SpvC identified five HopA1DC residues in regions with similarity to important 
residues in the active site of phosphothreonine lyases. These HopA1DC residues 
were also solvent exposed and I changed each of these to alanine by site-
directed mutagenesis. I found that these residues were required for the ability of 
HopA1DC to suppress PTI-induced callose deposition and ROS production. I also 
matched these five HopA1DC residues to the corresponding residues in HopA161 
and did site-directed mutagenesis. I discovered that the majority of HopA161 
residues were required for the HopA61-dependent phenotypes: HR elicitation in 
tobacco and yeast growth inhibition. I, therefore, concluded that these residues 
are important for the enzymatic activity of HopA1 and that HopA1 might be a 
phosphothreonine lyase or a related enzyme based on its similarity to this 
enzyme. Furthermore, the fact that the conserved residues were required for 
HopA1DC virulence activity (i.e., suppression of PTI) and HopA161’s Avr activity, 
this further suggests that HopA161 is recognized in tobacco indirectly by whatever 
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modification that it carries out on its target protein, which would be predicted to 
be monitored by an R protein. 
 
HopA1 interacts with two Arabidopsis type 2C protein 
phosphatases involved in plant immunity 
To further investigate the virulence function of HopA1 and understand the way it 
suppresses PTI, I explored the targets of HopA1 in Arabidopsis. I discovered that 
HopA1 interacts with two type 2C protein phosphatases (PP2C): PLL4 and PLL5. 
PLL4 and PLL5 belong to clade C of PP2C (PP2C-C) and have known roles in 
leaf development (19). HopA1 interacts with PLL4 and PLL5 at the plasma 
membrane of plant cells. I observed BiFC and colocalization of HopA1 and PLL4 
and PLL5 in Hechtian strands, typical cell wall-plasma membrane connections 
detectable after plasmolysis. These results agree with plasma membrane 
localization of members of the PP2C-C family (5). 
Up until now, PLL4 and PLL5 were not known to be associated with plant 
immunity. I explored if these phosphatases are induced during biotic stress, 
specifically during bacterial infections. Compared to mock inoculations in A. 
thaliana Col-0 plants, PLL4 and PLL5 were both induced after inoculations with 
virulent DC3000, avirulent DC3000(pavrRpm1) and flg22 (the 22 amino acid 
epitope of bacterial flagellin). These data indicate that PLL4 and PLL5 are 
involved in plant immunity. I further investigated how pll4 and pll5 T-DNA 
insertion mutants and plants overexpressing these phosphatases respond to P. 
syringae inoculations and flg22-induced defense responses. I found that pll4 and 
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pll5 mutants are more resistant to Pto DC3000, while plants overexpressing 
PLL4 or PLL5 are more susceptible. Flg22-induced ROS production was 
suppressed in plants overexpressing PLL4 or PLL5 compared to wild type Col-0 
plants. In addition, flg22-induced callose deposition was restricted in PLL4 or 
PLL5 overexpressing plants and enhanced in pll4 and pll5 mutants. Lastly, 
DC3000(pavrRpm1)- and flg22-mediated induction of the immunity-regulated 
genes NHL10 and FRK1 was suppressed in PLL4 or PLL5 overexpressing plants 
and highly induced in pll4 and pll5 mutants. Altogether, these data indicate that 
PLL4 and PLL5 are negative regulators of plant immunity. Members of the PP2C 
family have been described as negative regulators of immunity. For instance, 
clade A PP2Cs members are negative regulators of immunity by modulating the 
phosphorylation status of PAMP receptor complexes (18). In addition, the rice 
homolog of PLL4 and PLL5, XB15, interacts and dephosphorylates the plasma 
membrane pathogen recognition receptor XA21 leading to a negative regulation 
of XA21-mediated immunity (15). Therefore, negative regulation of PP2Cs in 
plant immunity appears to becoming a common theme for this family of 
phosphatases. 
 
What are the substrates of PLL4 and PLL5? 
Now that we know that PLL4 and PLL5 are involved in plant immunity as 
negative regulators, and since they are plasma membrane-localized proteins, it is 
likely that they regulate plasma membrane proteins to suppress plant immunity. 
PAMP receptor complexes localize to the plasma membrane and recognize 
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microbial PAMPs to initiate PTI. Therefore, PAMP receptor complexes are good 
candidates as targets of PLL4 and PLL5. I hypothesize that PLL4 and PLL5 
negatively regulate these PAMP receptor complexes to keep PTI off in the 
absence of the pathogen. After initial P. syringae infection, by a yet unknown 
mechanism, these phosphatases are inactivated leading to activation of PTI and 
initiation of immune responses including ROS production and callose deposition. 
However, it appears that P. syringae evolved to inject the T3E HopA1 to target 
PLL4 and PLL5 at the plasma membrane to inhibit their deregulation and prevent 
PTI induction. I predict that PLL4 and PLL5 act on components of immunity 
associated with PTI, most likely PAMP receptor complexes. Yeast two-hybrid 
analysis between PLL4 and PLL5 and PAMP receptor complexes, as well as 
immunoprecipitation followed by mass spectrometry analyses need to be done to 
identify the substrates of PLL4 and PLL5. This will help elucidate the mechanism 
of negative regulation achieved by PLL4 and PLL5 as well as their roles in plant 
immunity. 
 
Does HopA1 interact with EDS1? 
It has been reported that HopA1 interacts with the immunity regulator EDS1 (3). 
That report shows that EDS1 interacts with the R proteins RPS4 and RPS6 and 
that HopA1 disrupts EDS1 association with R protein complexes. Because I was 
interested in targets of HopA1, I wanted to confirm the interaction of EDS1 with 
HopA1. I found that EDS1 only interacted weakly with HopA1 in BiFC assays and 
not at all in yeast-two-hybrid assays. Based on our structural analyses, HopA1 is 
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a phosphothreonine lyase or a related enzyme. Phosphothreonine lyases remove 
phosphates from their substrates. EDS1 is not known to be a phosphorylated 
protein. Therefore, if HopA1 is a phosphothreonine lyase, EDS1 does not seem 
to be a true target for HopA1. Unfortunately, because EDS1 is not 
phosphorylated, I could not test phosphothreonine lyase enzymatic activity of 
HopA1 using EDS1 as a substrate.  
Since HopA1 interacts with PLL4 and PLL5 and EDS1 is a putative target, I 
wanted to investigate if PLL4 and PLL5 interact with EDS1. I found interaction 
between PLL4 and PLL5 with EDS1 in a yeast two-hybrid analysis, but I could 
not detect interaction using BiFC assays. In Chapter 4 of this thesis I confirmed 
interaction of HopA1 with PLL4 and PLL5 by yeast two-hybrid and BiFC assays. I 
also provided evidence that HopA1 and PLL4 and PLL5 colocalize at the plasma 
membrane of plant cells. EDS1 is not known to localize to the plasma membrane 
and has been shown to be a cytoplasmic and nuclear protein (3). The difference 
in localization and the fact that EDS1 does not interact with HopA1 and PLL4 and 
PLL5 by both yeast two-hybrid and BiFC assays suggest that EDS1 is not a true 
target of HopA1. In addition, my model for the PLL4- and PLL5-HopA1 interaction 
suggests that they might target components of immunity associated with PTI at 
the plasma membrane. The fact that EDS1 is involved in ETI and not PTI also 
implies that EDS1 is likely not a true HopA1 target. 
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